# Patent

## Title
Tyrosine derivatives as PPAR-γ-modulators

## Abstract

Compounds of general formula I, and the salts and solvates thereof, wherein R1 represents the radical 2-benzoylphenylamino; R2 represents —(CH2)s—N(COR3)-A-J-T or —(CH2)s—N(R4)—B-J-T; and s. R3, R4, A, B, J and T have the meanings disclosed in the description. These compounds are PPARγ modulators and, therefore, are useful for the treatment or prevention of a condition or a disease mediated by these receptors.

## Background
CROSS-REFERENCE TO RELATED APPLICATION
The present application is a national stage filing under 35 U.S.C. §371 of PCT/EP2005/053728, filed on 29 Jul. 2005. The present application also claims priority under 35 U.S.C. §119 to Spain patent application Serial No. 200401966 filed on 30 Jul. 2004.
The present invention relates to new tyrosine derivatives acting as PPARγ modulators, as well as to processes and intermediates useful for their preparation, to pharmaceutical compositions containing them and their application in medicine.
BACKGROUND ART
Peroxisome proliferator activated receptors (PPARs) belong to the superfamily of transcription factors known as nuclear receptors. This family includes steroid, retinoid and thyroid hormone receptors. Three sub-types of PPARs have been identified in humans, rodents and Xenopus laevis. They are PPARα, PPARβ/δ and PPARγ, each encoded by a different gene and showing different tissue distribution.
The gene encoding for PPARγ is transcribed in humans in three different mRNA isoforms (PPARγ1, PPARγ2 and PPARγ3) through different splicing and promoter usage (Fajas et al., J. Biol. Chem. 1997, vol. 272, p. 18779-18789). The PPARγ1 isoform shows a wide tissular distribution, while PPARγ2 and PPARγ3 are confined to certain tissues: PPARγ2 is expressed only in adipose tissue and PPARγ3 in adipose tissue as well as in macrophages (Fajas et al., FEBS Lett. 1998, vol. 438, p. 55-60).
Differences detected in tissue distribution as well as in the activation profile of the PPARγ isoforms suggest they are involved in a variety of physiological functions playing a central role in glucose homeostasis and lipid metabolism (Vamecq et al., Lancet 1999, vol. 354, p, 141-148). These functions include, for example, lipidic transport in plasma and catabolism of fatty acids, regulation of insulin sensitivity and blood glucose levels, differentiation of macrophages that form atherosclerotic plaques, inflammatory response, carcinogenesis, hyperplasia, and adipocyte differentiation, the latter being the most verified function of the PPARγ (Grimaldi, Prog. Lipid Res. 2001, vol. 40, p. 269-281; Schiller et al., J. Biol. Chem. 2001, vol. 276, p. 14133-14137). Thus, the discovery of these transcription factors has provided new pharmacological targets for the development of useful therapeutic agents for the prevention and treatment of metabolic diseases such as diabetes, obesity and dyslipidaemia.
Non-insulin dependent diabetes mellitus (NIDDM) or type 2 diabetes is characterized by an insulin resistance in peripheral tissues, including muscle, liver, and adipose tissue. Glitazones, selective PPARγ agonist compounds, are drugs that reduce insulin resistance and lower blood glucose levels. Currently two products belonging to this family, rosiglitazone and pioglitazone, have been approved for the treatment of type 2 diabetes in humans.
A great effort has been made in recent years to design new drugs that improve the side effect profile of the first glitazones, show a greater affinity as a PPARγ ligands, and increase their potency in type 2 diabetes. This rational design has yielded structurally diverse compounds that show great potency and selectivity (e.g. farglitazar).
PPARγ agonists have had shortcomings which have so far detracted from their attractiveness, such as liver toxicity (especially troglitazone), weigh gain, edema, heart weight gain (in rodents) and adiposity, as well as modest efficacy in monotherapy for type 2 diabetes. These facts have provided an incentive to develop improved insulin sensitizers.
Compounds totally or partially blocking PPARγ activity have demonstrated to inhibit adipocyte differentiation. Thus, full antagonists constitute an effective treatment for obesity. Moreover, compounds that are partial agonists in addition of being antagonists may be particularly desirable because they are effective in treating not only obesity but also in controlling hyperglycemia. The PPARγ antagonists/partial agonists are therefore effective in treating obesity and other symptoms that generally occur in non-insulin dependent diabetes, such as elevated plasma levels of glucose, tryglicerides, and insulin.
Recently, there have been reports of compounds that are PPARγ antagonists or partial agonists (WO01/30343, WO02/08188, WO2004/020408), which are useful for the treatment of obesity and type 2 diabetes, with reduced side effects (Berger et al., Trends Pharmacol. Sci. 2005, vol. 26, p. 244-51).
Examples of partial agonists in clinical development for diabetes are (−)-halofenate (metaglidasen), FK 614 (Minoura et al., Eur. J. Pharmacol. 2004, vol. 494, p. 273-8), T131 (Li et al., 64th Annu. Meet Sci. Sess. Am. Diabetes Assoc. (June 4-June 8, Orlando) 2004, Abst 659-P), LY818 (Reifel-Miller et al., Diabetes 2003, 52 (Suppl. 1): Abst 614-P) and telmisartan, an angiotensin II blocker approved for the treatment of hypertension, with PPAR partial agonistic activity at concentrations achievable at plasmatic levels during treatment (Kurtz et al., Acta Diabetol. 2005; vol. 42 Suppl 1: S 9-16) which are currently in phase II of clinical development.
In Henkel et al., J. Med. Chem. 1998, vol. 41, p. 5020-5036; Collins et al., J. Med. Chem. 1998, vol. 41, p. 5037-5054; Cobb et al., J. Med. Chem. 1998, vol. 41, p. 5055-5069, WO 94/29285 and in WO 97/31907 de N-(2-benzoylphenyl)-L-tyrosine derivatives are described as being potent and selective PPARγ agonists. Documents WO 03/011814 and WO 03/011834 disclose N-(2-benzoylphenyl)-L-tyrosine derivatives as partial PPARγ agonists. Document U.S. Pat. No. 6,274,608 describes N-(2-benzoylphenyl)-L-tyrosine derivatives as being useful in the treatment and/or prevention of conditions mediated by Retinoid X Receptor (RXR) and the PPAR families.
Obviously, it is of great interest to provide new therapeutic agents that modulate PPARγ.
SUMMARY OF THE INVENTION
One aspect of the present invention relates to the provision of new compounds of general formula I,




their stereoisomers and mixtures thereof, their polymorphs and mixtures thereof, and the pharmaceutically acceptable solvates and addition salts of all of them, wherein

    R1 represents the radical 2-benzoylphenylamino;
    R2 represents —(CH2)s—N(COR3)-A-J-T or —(CH2)s—N(R4)-B-J-T;
    R3 represents —(C1-C10)alkyl optionally substituted by one or more substituents selected from —F, —Cl, —Br and —O(C1-C4)alkyl; —(C2-C6)alkenyl; —(C2-C6)alkynyl; —(C1-C3)alkylene-Y; —(C2-C3)alkenylene-Y; —(C2-C3)alkynylene-Y or —Y;
    R4 represents —(C4-C10)alkyl optionally substituted by one or more substituents selected from —F, —Cl, —Br and —O(C1-C4)alkyl; —(C2-C6)alkenyl; —(C2-C6)alkynyl; —(C1-C4)alkylene-Y; —(C2-C4)alkenylene-Y; —(C2-C4)alkynylene-Y or —Y;
    s represents 2 or 3;
    A represents —(C1-C4)alkylene-; —(C2-C4)alkenylene-; —(C2-C4)alkynylene-; —(C1-C4)alkylene-Z-, wherein the alkylene part is attached to the N atom and Z is attached to J; or -Z-;
    B represents —(C4)alkylene-; —(C2-C4)alkenylene-; —(C2-C4)alkynylene-; —(C1-C4)alkylene-Z-, wherein the alkylene part is attached to the N atom and Z is attached to J; or -Z-;
    J represents a single bond or a biradical selected from the following groups:
    
        a) —(CH2)1-4—, —O—, —S—, —SO—, —SO2—, —CO—, —OCO—, —COO—, —OCONR5-, —NR5COO—, —CONR5-, —NR5CO—, —NR5-, —NR5SO2—, —SO2NR5-; and
        b) —O(C1-C4)alkyl-, —(C1-C4)alkyl-O—, —S(C1-C4)alkyl-, —(C1-C4)alkyl-S—, —SO(C1-C4)alkyl-, —(C1-C4)alkyl-SO—, —SO2(C1-C4)alkyl-, —(C1-C4)alkyl-SO2—, —OCO—C1-C4)alkyl-, —COO—(C1-C4)alkyl-, —(C1-C4)alkyl-OCO—, —(C1-C4)alkyl-COO—, —OCONR5-(C1-C4)alkyl-, —NR5COO—(C1-C4)alkyl-, —(C1-C4)alkyl-OCONR5-, —(C1-C4)alkyl-NR5COO—, —CONR5-(C1-C4)alkyl-, —NR5CO—(C1-C4)alkyl-, —(C1-C4)alkyl-CONR5-, —(C1-C4)alkyl-NR5CO—, —NR5-(C1-C4)alkyl-, —(C1-C4)alkyl-NR5-, —SO2NR5-(C1-C4)alkyl-, —NR5SO2—(C1-C4)alkyl-, —(C1-C4)alkyl-SO2NR5-, —(C1-C4)alkyl-NR5SO2—;
    
    
    T represents —H, —C1-C4)alkyl, —(C2-C4)alkenyl, —(C2-C4)alkynyl or —Y;
    Y represents a monoradical coming from a cycle selected from a (C3-C6)cycloalkane, cyclohexene, a heterocycle, benzene and a bicycle, wherein all these cycles can be optionally substituted with one or more substituents selected from the group —OH, —CHO, —SH, —NO2, —CN, —F, —Cl, —Br, —CO(C1-C4)alkyl, —COO(C1-C4)alkyl, —OCO(C1-C4)alkyl, —S(C1-C4)alkyl, —SO(C1-C4)alkyl, —SO2(C1-C4)alkyl, —SO2—O(C1-C4)alkyl, —O—SO2(C1-C4)alkyl, —NR5R6, —CONR5R6, —(C1-C4)alkyl optionally substituted by one or more —OH or —F and —O(C1-C4)alkyl optionally substituted by one or more —OH or —F, and wherein the cycles (C3-C6)cycloalkane, cyclohexene and bicycle can also be optionally substituted with one or more substituents oxo (═O);
    Z represents a biradical coming from a cycle selected from a (C3-C6)cycloalkane, cyclohexene, a heterocycle, benzene and a bicycle, wherein all these cycles can be optionally substituted with one or more substituents selected from the group —OH, —CHO, —SH, —NO2, —CN, —F, —Cl, —Br, —CO(C1-C4)alkyl, —COO(C1-C4)alkyl, —OCO(C1-C4)alkyl, —S(C1-C4)alkyl, —SO(C1-C4)alkyl, —SO2(C1-C4)alkyl, —SO2—O(C1-C4)alkyl, —O—SO2(C1-C4)alkyl, —NR5R6, —CONR5R6, —(C1-C4)alkyl optionally substituted by one or more —OH or —F and —O(C1-C4)alkyl optionally substituted by one or more —OH or —F, and wherein the cycles (C3-C6)cycloalkane, cyclohexene and bicycle can also be optionally substituted with one or more substituents oxo (═O);
    R5 and R6 independently represent —H or —(C1-C4)alkyl;
    a heterocycle in the above definitions represents a five- or six-membered aromatic ring containing from one to three heteroatoms independently selected from O, S and N, wherein said ring can be attached to the rest of the molecule through a carbon or a nitrogen atom; and

a bicycle in the above definitions represents a partially unsaturated, saturated or aromatic seven- to ten-membered ring optionally containing from one to three heteroatoms independently selected from O, S and N, wherein said ring or rings can be attached to the rest of the molecule through a carbon or a nitrogen atom.



The compounds of formula I are PPARγ modulators and, therefore, useful as active pharmaceutical substances.
Thus, another aspect of this invention relates to the pharmaceutical compositions which comprise an effective amount of a compound of formula I or a pharmaceutically acceptable salt or solvate thereof and one or more pharmaceutical acceptable excipients.
Another aspect of the present invention relates to the use of a compound of formula I for the manufacture of a medicament for the treatment or prevention of diseases mediated by PPARγ. Another aspect of the present invention relates to the use of a compound of formula I for the manufacture of a medicament for the treatment or prevention of metabolic diseases in a subject in need thereof, including a human. Another aspect of the present invention relates to the use of a compound of formula I or a pharmaceutically acceptable salt or solvate thereof for the manufacture of a medicament for the treatment or prevention of metabolic diseases selected from non-insulin-dependent diabetes mellitus and obesity in a subject in need thereof, including a human. Another aspect of the present invention relates to the use of a compound of formula I or a pharmaceutically acceptable salt or solvate thereof for the manufacture of a medicament for the treatment or prevention of cardiovascular diseases associated with metabolic syndrome, inflammatory diseases, cancer, bone diseases, skin wound healing, cutaneous disorders associated with an anomalous differentiation of epidermic cells, and other disorders where insulin resistance is a component in a subject in need thereof, including a human.
Another aspect of the present invention relates to the method for the treatment or prevention of diseases mediated by PPARγ comprising the administration to a mammal, including a human, an effective amount of a compound of formula I or a pharmaceutically acceptable salt or solvate thereof. Another aspect of the present invention relates to the method for the treatment or prevention of metabolic diseases comprising the administration to a mammal, including a human, an effective amount of a compound of formula I or a pharmaceutically acceptable salt or solvate thereof. Another aspect of the present invention relates to the method for the treatment or prevention of metabolic diseases selected from non-insulin-dependent diabetes mellitus and obesity comprising the administration to a mammal, including a human, an effective amount of a compound of formula I or a pharmaceutically acceptable salt or solvate thereof. Another aspect of the present invention relates to the method for the treatment or prevention of cardiovascular diseases associated with metabolic syndrome, inflammatory diseases, cancer, bone diseases, skin wound healing, cutaneous disorders associated with an anomalous differentiation of epidermic cells and other disorders where insulin resistance is a component, comprising the administration to a mammal, including a human, an effective amount of a compound of formula I or a pharmaceutically acceptable salt or solvate thereof.


In the previous definitions, the terms “alkyl” and “alkylene” mean respectively a monoradical or biradical straight or branched saturated hydrocarbon chain having the indicated number of carbon atoms. Examples of alkyl include, but are not limited to, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl and the like.
The terms “alkenyl” and “alkenylene”, as used herein, mean respectively a monoradical or biradical straight or branched unsaturated hydrocarbon chain, having the indicated number of carbon atoms and also containing one or more double bonds. Examples of alkenyl include, but are not limited to, ethenyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1,3-butadienyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl and the like.
The terms “alkynyl” and “alkynylene”, as used herein, mean respectively a monoradical or biradical straight or branched unsaturated hydrocarbon chain, having the indicated number of carbon atoms and also containing one or more triple bonds. Examples of alkynyl include, but are not limited to, ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1,3-butadiynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl and the like.
The term heterocycle as used herein refers to a five- or six-membered monocyclic aromatic ring containing from one to three heteroatoms independently selected from O, S and N. As mentioned previously, these heterocycles can be optionally substituted with one or more substituents, which can be placed on any available position of the cycle, and can be attached to the rest of the molecule via any available carbon or nitrogen atoms. Examples include, but are not limited to, 1, 2, 4-oxadiazole, 1, 2, 4-thiadiazole, 1,3,4-oxadiazole, 1,3,4-thiadiazole, furan, imidazole, isoxazole, isothiazole, oxazole, pyrazol, pyrrole, thiazole, thiophene, 1,2,3-triazole, 1,2,4-triazole, pyrazine, pyridazine, pyridine, pyrimidine and the like.
The term (C3-C6)cycloalkane as used herein refers to saturated monocyclic carbocyclic ring having the indicated number of carbon atoms. As mentioned previously, it can be optionally substituted with one or more substituents, which can be placed on any available position of the cycle. Examples of (C3-C6)cycloalkanes include, but are not limited to, cyclopropane, cyclobutane, cyclopentane and cyclohexane.
The term bicycle, as used herein refers to a partially unsaturated, saturated or aromatic seven- to ten-membered ring optionally containing from one to three heteroatoms independently selected from O, S and N, wherein said ring or rings can be attached to the rest of the molecule through a carbon or a nitrogen atom. As mentioned previously, it can be optionally substituted with one or more substituents, which can be placed on any available position of the cycle. Examples of bicyclic groups include, among others, naphthalene, 1,2,3,4-tetrahydronaphthalene, quinoline, 1,2,3,4-tetrahydroquinoline, isoquinoline, benzofuran, 2,3-dihydrobenzofuran, benzothiophene, indole, benzimidazole, benzotriazol, bicyclo[2.2.1]heptane, bicyclo[3.2.1]octane and bicyclo[3.2.2]nonane.
The expression “optionally substituted with one or more” means that a group can be unsubstituted or substituted with one or more, preferably with 1, 2, 3 or 4 substituents, provided that this group has 1, 2, 3 or 4 positions susceptible of being substituted.
Throughout the description and claims the word “comprise” and variations of the word, such as “comprising”, are not intended to exclude other additives, components, elements or steps. The disclosures in the abstract accompanying this application and in the application from which priority is claimed, are incorporated herein as reference.
As used therein the term “treatment” includes treatment, prevention and management of such condition. The term “pharmaceutically acceptable” as used herein refers to those compounds, compositions, and/or dosage forms which are, within the scope of medical judgement, suitable for use in contact with the tissues of humans and animals without excessive toxicity, irritation, allergic response, or other problem or complication, commensurate with a reasonable benefit/risk ratio.
Compounds of formula I of the present invention comprise at least one chiral center. The present invention includes both the racemic compounds and the enantiomeric compounds, i.e. compounds of formula Ia (wherein the configuration of the chiral carbon attached to R1 is (S)) and compounds of formula Ib (wherein the configuration of the chiral carbon attached to R1 is (R)) as shown below.




In a particular embodiment of the invention the configuration of the chiral carbon attached to R1 is (S).
In another embodiment in a compound of formula I or Ia, R2 represents —(CH2)s—N(COR3)-A-J-T. In another embodiment in a compound of formula I or Ia, R2 represents —(CH2)s—N(R4)-B-J-T. In another embodiment in a compound of formula I or Ia, J represents a single bond and T represents —H. In another embodiment in a compound of formula I or Ia, J represents —(CH2)1-4—, —O—, —S—, —SO—, —SO2—, —O(C1-C4)alkyl- or —S(C1-C4)alkyl-. In another embodiment in a compound of formula I or Ia, T represents —H or —(C1-C4)alkyl.
In another embodiment in a compound of formula I or Ia, R2 represents —(CH2)s—N(COR3)-A-J-T; R3 represents —(C1-C10)alkyl optionally substituted by one or more substituents selected from —F, —Cl, —Br and —O(C1-C4)alkyl; —(C2-C6)alkenyl; —(C1-C3)alkylene-Y; —(C2-C3)alkenylene-Y; —(C2-C3)alkynylene-Y or —Y; and Y in R3 represents a monoradical coming from a cycle selected from a (C3-C6)cycloalkane, a heterocycle, benzene and a bicycle, wherein all these cycles can be optionally substituted as defined above.
In another embodiment in a compound of formula I or Ia, R2 represents —(CH2)s—N(COR3)-A-J-T; A represents —(C1-C4)alkylene-; —(C1-C4)alkylene-Z- or -Z-; Z in A represents a biradical coming from a cycle selected from a (C3-C6)cycloalkane, a heterocycle, benzene and a bicycle, wherein all these cycles can be optionally substituted with one or more substituents selected from the group —F, —Cl, —Br, —S(C1-C4)alkyl, —(C1-C4)alkyl optionally substituted by one or more —OH or —F and —O(C1-C4)alkyl optionally substituted by one or more —OH or —F; J represents a single bond; and T represents —H.
In another embodiment in a compound of formula I or Ia, R2 represents —(CH2)s—N(COR3)-A-J-T; A represents —(C1-C4)alkylene-; —(C1-C4)alkylene-Z- or -Z-; Z in A represents an unsubstituted biradical coming from a cycle selected from a (C3-C6)cycloalkane and benzene; J represents a single bond; and T represents —H.
In another embodiment in a compound of formula I or Ia, R2 represents —(CH2)s—N(R4)-B-J-T; R4 represents —(C4-C10)alkyl optionally substituted by one or more substituents selected from —F, —Cl, —Br and —O(C1-C4)alkyl; —(C1-C4)alkylene-Y; or —Y; and Y in R4 represents a monoradical coming from a cycle selected from a (C3-C6)cycloalkane, a heterocycle, benzene and a bicycle, wherein all these cycles can be optionally substituted as defined above.
In another embodiment in a compound of formula I or Ia, R2 represents —(CH2)s—N(R4)-B-J-T, B represents —(C1-C4)alkylene-Z- or -Z-; Z in B represents a biradical coming from a cycle selected from a (C3-C6)cycloalkane, a heterocycle, benzene and a bicycle, wherein all these cycles can be optionally substituted as defined above; J represents a single bond; and T represents —H.
Furthermore, all possible combinations of the above-mentioned embodiments form also part of this invention.
The compounds of the present invention may contain one or more basic nitrogen atoms and, therefore, they may form salts with acids, that also form part of this invention. Examples of pharmaceutically acceptable salts include, among others, addition salts with inorganic acids such as hydrochloric, hydrobromic, hydroiodic, nitric, perchloric, sulphuric and phosphoric acid, as well as addition salts of organic acids such as acetic, methanesulfonic, trifluoromethanesulfonic, ethanesulfonic, benzenesulfonic, p-toluenesulfonic, benzoic, camphorsulfonic, mandelic, oxalic, succinic, fumaric, tartaric, and maleic acid. Likewise, compounds of the present invention may contain one or more acid protons and, therefore, they may form salts with bases, that also form part of this invention. Examples of these salts include salts with metal cations, such as for example an alkaline metal ion, an alkaline-earth metal ion or an aluminium ion; or it may be coordinated with an organic with an organic or inorganic base. An acceptable organic base includes among others diethylamine and triethylamine. An acceptable inorganic base includes aluminium hydroxide, calcium hydroxide, potassium hydroxide, sodium carbonate, and sodium hydroxide. There may be more than one cation or anion depending on the number of functions with charge and on the valency of cations and anions.
Salts derived from pharmaceutically acceptable organic nontoxic bases include salts of primary, secondary, and tertiary amines, substituted amines including naturally occurring substituted amines, cyclic amines, and basic ion exchange resins, such as arginine, betaine, caffeine, choline, N,N-dibenzylethylenediamine, diethylamine, 2-diethylaminoethanol, 2-dimethylaminoethanol, ethanolamine, ethylenediamine, N-ethylmorpholine, ethylpiperidine, glucamine, glucosamine, histidine, hydrabamine, isopropylamine, lysine, methylglucamine, morpholine, piperazine, piperidine, polyamine resins, procaine, purines, theobromine, triethylamine, trimethylamine, tripropylamine, tromethamine, and the like.
There is no limitation on the type of salt that can be used provided that these are pharmaceutically acceptable when they are used for therapeutic purposes. Salts can be synthesized from the parent compound which contains a basic or acidic moiety by conventional chemical methods. Generally, such salts can be prepared by reacting the free acid or base forms of these compounds with a stoichiometric amount of the appropriate base or acid in water or in an organic solvent, such as ether, ethyl acetate, ethanol, isopropanol, or acetonitrile or in a mixture of the two. The compounds of formula I and their salts differ in some physical properties but they are equivalent for the purposes of the present invention.
Some of the compounds of formula I of the present invention may exist in unsolvated as well as solvated forms such as, for example, hydrates. The present invention encompasses all such above-mentioned forms which are pharmaceutically active.
Some of the compounds of general formula I may exhibit polymorphism, encompassing the present invention all the possible polymorphic forms, and mixtures thereof. Various polymorphs may be prepared by crystallization under different conditions or by heating or melting the compound followed by gradual or fast cooling. The presence of polymorphs may be determined by solid NMR spectroscopy, IR spectroscopy, differential scanning calorimetry, powder X-ray diffraction or such other techniques.
Compounds of formula I of the present invention comprise at least one chiral center. Additionally, compounds of formula I of the present invention may have further chiral centres. The present invention includes each one of the possible stereoisomers and mixtures thereof, particularly racemic mixtures thereof. A single enantiomer may be prepared by any of the commonly used processes, for example, by chromatographic separation of the racemic mixture on a stationary chiral phase, by resolution of the racemic mixture by fractional crystallisation techniques of the diastereomeric salts thereof, by chiral synthesis, by enzymatic resolution or by biotransformation. This resolution can be carried out on any chiral synthetic intermediate or on products of general Formula I. Alternatively, any enantiomer of a compound of the general Formula I may be obtained by enantiospecific synthesis using optically pure starting materials or reagents of known configuration.
Some of the compounds of the present invention may exist as several diastereoisomers, which may be separated by conventional techniques such as chromatography or fractional crystallization. Some compounds of the present invention may exhibit cis/trans isomers. The present invention includes each of the geometric isomers and its mixtures. The present invention covers all isomers and mixtures thereof (for example racemic mixtures) whether obtained by synthesis and also by physically mixing them.
The present invention relates to a process for the preparation of the above said novel compounds, their derivatives, their analogues, their tautomeric forms, their stereoisomers, their polymorphs or their pharmaceutical acceptable salts and solvates.
The compounds of the present invention may be synthesized using the methods described below, as well as other processes known in the field of organic synthesis. Preferred methods include, but are not limited to, the general processes shown in the attached schemes. Unless otherwise stated the groups R1, R2, R3, R4, R5, R6, s, A, B, J, and T have the meaning described in general formula I.
A compound of formula I may be obtained in general by hydrolysis of a compound of formula II, wherein R7 represents (C1-C4)alkyl. This reaction can be carried out in the presence of a base such as an alkaline hydroxide in a solvent such as tetrahydrofuran, aqueous methanol or a mixture thereof, at a temperature comprised between room temperature and the temperature of the boiling point of the solvent, preferably at room temperature.




A compound of formula II may be obtained as shown in the above scheme by Williamson ether synthesis (see for instance Bal-Tembe et al., Bioorg. Med. Chem. 1997, 5, 1381-1388; Cantello et al., J. Med. Chem. 1994, vol. 37, p. 3977-3985 or EP 875510) or by Mitsunobu conditions (Mitsunobu, Synthesis 1981, 1; Hughes, Org. React. 1992, 42, 335).
In the first case, phenol ester III may be reacted with R2-LG (IVa), wherein LG represents a leaving group, such as for instance a halogen including —Cl, —Br, —I or an alkylsulfonate or arylsulfonate, including mesylate, tosylate or nosylate. This reaction is carried out in the presence of a base, such as NaH, K2CO3 or Cs2CO3, in a solvent such as N,N-dimethylformamide, acetone or ethyl acetate, at a temperature comprised between room temperature and the temperature of the boiling point of the solvent, preferably heating.
In the second case, a compound of formula III may be reacted with an alcohol of formula R2-OH (IVb) using for example, diethyl azodicarboxylate (DEAD) and triphenylphosphine in tetrahydrofuran as a solvent, at a temperature comprised between room temperature and the temperature of the boiling point of the solvent, preferably at room temperature.
Isolated enantiomeric forms of formula Ia and Ib can be obtained either by chiral resolution of a compound of formula I or starting from the corresponding chiral compounds IIIa and IIIb respectively.




A compound of formula II wherein R2 represents —(CH2)s—N(COR3)-A-J-T (i.e. compound of formula IIa) may also be obtained by acylation of a compound of formula Va with a compound of formula R3-COX (VIa), wherein X represents halogen, preferably Cl.




This reaction is carried out in the presence of a base such as triethylamine, in a solvent such as dichloromethane or ethyl acetate, at a temperature comprised between room temperature and the temperature of the boiling point of the solvent.
Some compounds of formula IIa can also be obtained by reacting a compound Va with the corresponding acid of formula VIb (see for instance Elmore, Amino Acids Pep. Proteins 2001, 32, 107-162). This reaction is carried out in the presence of a coupling agent, such as the combination of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) and 1-hydroxybenzotriazol (HOBT) in the presence of a base such as triethylamine, in a solvent such as ethyl acetate or tetrahydrofuran, at a temperature comprised between room temperature and the temperature of the boiling point of the solvent.
Some compounds of formula II wherein R2 represents —(CH2)s—N(R4)-B-J-T (i.e. compounds of formula IIb) may also be obtained by reacting a compound of formula Vb with an alkylating agent of formula R4-LG (VII), wherein LG has the meaning previously described.




This reaction is carried out in the presence of a base, such as K2CO3, in a suitable solvent, such as N,N-dimethylformamide or acetonitrile, at a temperature and the temperature of the boiling point of the solvent, preferably room temperature.
Alternatively compounds of formula II can be obtained by solid synthesis using different types of polimeric solid resins, such as Wang or 2-chlorotrityl resins (Collins et al. J. Med. Chem. 1998, 41, 5037-5054). Compounds of formula III can be prepared following similar procedures to those described in Cobb et al., J. Med. Chem. 1998, 41, 5055-69.
Compounds IVa and IVb wherein R2 represents —(CH2)s—N(R4)-B-J-T (i.e. compounds of formula IVaa and IVba respectively) may be obtained as shown in the following scheme:




Compound VIII is acylated with a compound of formula IX to yield a compound of formula X, wherein R9 represents —CO2(C1-C4)alkyl or —OCO(C1-C4)alkyl, under the same conditions as the reaction of compound Va with VIa to give compound. IIa. Reduction of compound X with a reducing agent such as lithium aluminium hydride in diethyl ether affords compound IVba.
Alternatively, compound VIII can be reacted with an alkylating agent of formula XI to afford compound IVba (Daoud et al., J. Indian Chem. Soc. 1989, 66, 316-318). Compound of formula IVaa is obtained by converting the hydroxyl group of compound IVba into a leaving group. This reaction may be carried out using a sulfonyl halide such as methanesulfonyl chloride in the presence of a base, such as pyridine or triethylamine in a solvent such as dichloromethane or chloroform. Alternatively, compound IVba can be reacted with a halogenating agent such as SOCl2 in a a solvent such as tetrahydrofuran.
Compound VIII can be also converted directly into a compound of formula IVaa by reaction with a compound of formula XII, wherein each LG independently represents a leaving group as defined above, in the same conditions as described for the conversion of VIII into IVba.




A compound of formula V (including compounds of formula Va and Vb) may be obtained using two different synthetic sequences as shown in the following scheme:




Phenol III can be reacted with a protected amine of formula XIVa or XIVb, to yield a compound of formula XIII, wherein R8 represents -A-J-T or —B-J-T, LG represents a leaving group as previously described and PG represents a protecting group, such as for example, trifluoroacetyl or 2-nitrobenzenesulfonyl. The reaction is carried out under the same conditions described for the conversion of a compound of formula III into a compound of formula II. Compound V is subsequently obtained by deprotection of compound XIII. This reaction is carried out under different conditions depending upon the nature of the protecting group (see for instance Harland et al. Synthesis 1984, 941-43, Hirschmann et al. J. Amer. Chem. Soc. 1993, 12550-12568 for the group trifluororacetamide and Lin et al. Tetrahedron Letters 2000, 3309-3313 for the 2-nitrobenzenesulfonylamide group).
Alternatively a compound of formula V can be obtained by reacting phenol III with a secondary amine of formula XVa by Williamson ether synthesis. Compounds of formula VIII are commercially available or can be prepared by methods similar to those described for instance in WO 03/53966 or EP 875510. Compounds XIVa and XIVb can be obtained by reaction of the corresponding unprotected amine of formula XV and a protecting group (see Protective Groups in Organic Synthesis, John Wiley & Sons, 3rd Edition, 1999).
A compound of formula XV can be obtained using the following synthetic scheme:




Compound XVI is acylated to afford compound XVII under the same conditions for the reaction of compound Va and VIa to give compound IIa. Reduction of compound XVII gives compound XVb under the conditions described for the reduction of compound X. Compounds XVb wherein the amino group is less reactive than the hydroxyl group can be converted into compounds XVa under the conditions described for the conversion of IVba into IVaa.
Moreover, a compound of formula XVc can be obtained starting from a compound of formula XVIII.




This conversion can be carried out by reaction with an aldehyde of formula R10-CHO (XIX), wherein R10 represents R8 wherein the group attached to the N is —CH2, in the presence of a reducing agent, such as triacetoxyborohydride or cyanoborohydride in a solvent such as 1,2-dichloroethane. Alternatively, compound XVIII can be reacted with compound XX or a derivative thereof to afford the corresponding amide as previously described. The reduction of the resulting product gives rise a compound of formula XVc. Compounds VIa, VIb, VII, IX, XI, XII, XVI, XVIII, XIX and XX are commercially available or can be easily obtained by conventional methods.
As it will be obvious to a person skilled in the art some of the reactions described above can also be carried out on compounds of formula I.
The compounds of the present invention are ligands of the PPARγ receptor. Therefore, they are expectedly useful for the treatment or prevention of a condition mediated by PPARγ in a subject in need thereof, including a human.
Thus, the present invention relates to the use of these compounds for the preparation of a medicament for the treatment or prevention of metabolic diseases, cardiovascular diseases associated with metabolic syndrome (including vascular restenosis), inflammatory diseases, cancer, bone diseases (particularly osteoporosis), skin wound healing, cutaneous disorders associated with an anomalous differentiation of epidermic cells, particularly the formation of keloids, and other disorders where insulin resistance is a component, including Syndrome X.
As an example, metabolic diseases that can be treated or prevented include non-insulin-dependent diabetes mellitus, obesity, hypercholesterolaemia (including raising HDL levels), dyslipidemia (including hyperlipidemia and hypertriglyceridemia), and other lipid-mediated pathologies.
As an example, inflammatory diseases that can be treated or prevented include rheumatoid arthritis, atherosclerosis, psoriasis, inflammatory bowel disease and pancreatitis.
The compounds described herein may be used to treat these diseases or conditions separately, or may be used to treat them concurrently with the treatment of obesity.
The present invention further provides for pharmaceutical compositions comprising a compound of formula I or a pharmaceutical salt or solvate thereof together with one or more pharmaceutically acceptable excipients, in either single or multiple doses. The examples of the excipients mentioned below are given by way of illustration only and are not to be construed as limiting the scope of the invention.
The compounds of the present invention can be administered in the form of any pharmaceutical formulation. The pharmaceutical formulation will depend upon the nature of the active compound and its route of administration. Any route of administration may be used, for example such as oral, buccal, pulmonary, topical, parenteral (including subcutaneous, intramuscular, and intravenous), transdermal, ocular (ophthalmic), inhalation, intranasal, otic, transmucosal, implant or rectal administration. However oral, topical or parenteral administration are preferred.
Solid compositions for oral administration include among others tablets, granulates and hard gelatin capsules, formulated both as immediate release or modified release formulations.
The manufacturing method may be based on a simple mixture, dry granulation, wet granulation or lyophilization of the active compound with excipients. These excipients may be binding agents, such as syrup, acacia, gelatin, sorbitol, gum tragacanth, corn starch or polyvinylpyrrolidone; fillers such as lactose, sugar, microcrystalline cellulose, maize-starch, calcium phosphate or sorbitol; lubricants such as magnesium stearate, stearic acid, talc, polyethylene glycol or silica; disintegrants such as potato starch, alginic acid or sodium starch glycollate; wetting agents, such as sodium lauryl sulfate, sweetening agents such as sucrose, lactose, dextrose, mannitol, sorbitol or saccharin; bioadhesive agents such as hydroxypropyl cellulose, poly(vinyl alcohol), poly(isobutylene), sodium carboxymethyl cellulose; glidants such as magnesium trisilicate, powdered cellulose, starch, talc or tribasic calcium phosphate; flow enhancers such as colloidal silicon dioxide; release modifiers such as xanthan gum, ethylcellulose, carbomer, hydroxypropyl methyl cellulose or wax or osmotic agents such as potassium bicarbonate or sodium chloride.
The tablets may be coated according to methods well-known in the art such as aqueous dispersion coating, solvent-based coating or drying coating. The active compound can also be incorporated by coating onto inert pellets using film-coating agents, by extrusion and spheronization process, by hot melting pelletization or it can be in the form of a troche or lozenge. When a dosage unit form is a capsule, it may contain, in addition to materials of the above type, a liquid carrier such as a fatty oil or wax.
Powders and granulates for the preparation of oral suspensions by the addition of water can be obtained by mixing the active compound with dispersing or wetting agents; suspending agents, anticaking agents, buffering agents and preservatives. Other excipients may also be added, for example sweetening, flavouring and colouring agents.
Alternatively, the compounds of the present invention may be incorporated into oral liquid preparations such as emulsions, solutions, dispersions, suspensions, syrups, elixirs or in the form of soft gelatin capsules. They may contain commonly-used inert diluents, such as purified water, ethanol, sorbitol, glycerol, polyethylene glycols (macrogols) and propylene glycol. Aid compositions can also contain coadjuvants such as wetting, suspending, sweetening, flavouring agents, preservatives, buffers, chelating agents and antioxidants.
Solutions or suspensions may be prepared in water suitably mixed with a surfactant such as sodium lauryl sulfate. Dispersions may also be prepared in glycerol, liquid polyethylene glycols and mixtures thereof in oils. Under ordinary conditions of storage and use, these preparations contain a preservative to prevent the growth of microorganisms. Moreover, formulations containing these compounds may be presented as a dry product constitution with water or other suitable vehicle before use.
Injectable preparations for parenteral administration comprise sterile solutions, suspensions or emulsions in oily or aqueous vehicles, and may contain coadjuvants, such as suspending, stabilizing, tonicity agents or dispersing agents.
For nasal administration, the preparation may contain a compound of formula I dissolved or suspended in a liquid carrier, in particular an aqueous carrier, for aerosol application. The carrier may contain additives such as solubilizing agents, e.g. propylene glycol, surfactants, absorption enhancers such as lecithin (phosphatidylcholine) or cyclodextrin, or preservatives such as parabenes.
The compound can also be formulated for its topical application. Formulations include creams, lotions, gels, powders, solutions, shampoo preparations, oral paste, mouth wash preparations and patches wherein the compound is dispersed or dissolved in suitable excipients. These excipients may be antimicrobial preservatives such as imidurea, propylparaben, propylene glycol or methylparaben; emulsifying agents such as cetyl alcohol, methylcellulose, poloxamer or medium-chain triglycerids; emulsion stabilizers such as glyceril monostearate, magnesium aluminium silicate, cyclodextrins or wax; humectants such as triacetin, glycerin, propylene glycol or sorbitol; penetrants enhancing agents such as isopropyl miristate; buffering agents such as malic acid, potassium citrate or sodium phosphate dibasic; surfactants such as docusate sodium, sodium lauryl sulfate, polysorbates or sorbitan esters; thickening agents such as hydroxyethyl cellulose, hydroxypropyl cellulose or polyethylene oxide.
The effective dosage of active ingredient may vary depending on the particular compound administered, the route of administration, the nature and severity of the disease to be treated, as well as the age, the general condition and body weight of the patient, among other factors. A representative example of a suitable dosage range is from about 0.001 to about 100 mg/Kg body weight per day, which can be administered as a single or divided doses. However, the dosage administered will be generally left to the discretion of the physician.
PPARγ2 Binding Assay
The cDNA encoding for the open reading frame of the hPPARγ2 was amplified by PCR (polymerase chain reaction) and inserted in the plasmid pGEX-4T-2. This construction (pGEX-hPPARγ) was introduced into E. coli where it was overexpressed and semipurified as a fusion protein with glutathione S-transferase (GST) (Elbrecht et al., J. Biol. Chem. 1999, 274, 7913-7922). The binding of the compounds to the GST-hPPARγ2 s was determined by modifications in the method described by Lehmann et al. (J. Biol. Chem. 1995, 270, 12953-12957). The receptors (2.5 μg) were incubated in 96-well plates in the presence or in the absence of the products with [3H]BRL-49853 (100 nM) for 3 h at 4° C., in a final volume of 200 μL of buffer Tris-HCl 10 mM pH:8.0, containing KCl 50 mM and DTT 10 mM. Non-specific binding was determined in the presence of BRL49853 100 μM. The reaction mixture was transferred to a Multiscreen Durapore (Millipore) microplate containing glutathione-Sepharose 4B in every well. The reaction mixture was left to incubate with the resin during 10 min, and then centrifuged at 735 g during 2 min. To dissociate the receptor bound to the resin, reduced glutathione 10 mM is added and incubated during 10 min. The receptor was eluted by centrifugation. Then, scintillation liquid was added to the elution and the contained radioactivity was quantified by liquid scintillation spectroscopy (Microbeta Wallac, Perkin Elmer).
LBD-hPPARs Transactivation Assay
COS-7 cells were cultivated in 24-well plates and transfected with the pFACMV plasmids that encode the chimeric proteins containing the GAL4 DNA binding domain fused to the PPARγ LBD. The reporter plasmid for the foregoing constructions was pFR-Luc, which contains five repetitions of the GAL4-response element in front of a promoter that controls the transcription of the luciferase gene. Lipofectamine was used as a transfection agent. The plasmids of the chimeric receptors and the reporter gene were inserted in the cells by transitory transfection in COS-7 cells in culture. When the products were added to the culture for 48 h, the luciferase activity showed the effect of the PPAR activity modulation on the transcription of the reporter construction (Wright et al., J. Biol. Chem. 2000, 275, 1873).
Cloning of Human PPARγ2
The human PPAR cDNA was amplified through RT-PCR. For hPPARγ2, RNA was obtained from human white adipose tissue. Each amplified fragment was cloned into pBluescript (Stratagene®) and sequenced. One clone for each construction was selected and used as template for further subcloning and PCR amplifications.
GST-Fused Protein Construction
To generate this chimeric protein, the complete cDNA of the human PPAR was cloned into pGEX4T2 (Amersham Biosciences). The fragment was obtained from the pBluescript-cDNAs clones digested with endonucleases. To assess the plasmid identity and to ensure the in-phase cloning of the proteins, pGEX construction was sequenced. GST-hPPARγ2 fusion protein was generated in Escherichia coli (BL21 strain DE3). Cells were cultured in LB medium to a density of A600=1.6 odu, and induced for overexpression by addition of isopropyl-1-thio-β-D-galactopyranoside (IPTG)-induced cultures to a final concentration of 0.5 mM. The IPTG-induced cultures were grown at room temperature o/n, before cells were harvested by centrifugation at 5000 g for 15 min. After sonication, the GST-fusion protein was purified from the cell pellet using glutathione-Sepharose beads, following the procedure recommended by the manufacturer (Amersham Pharmacia Biotech). Excess of gluthatione was removed o/n by dyalisis at 4° C. Receptor purity was visualized by SDS-PAGE and protein content was determined by Bradford method. Receptor aliquots were stored at −80° C. until use.
In Table 1, affinity and functional activity data of some of the compounds of the present invention are shown.











TABLE 1







Example
Affinity
Functional activity



Number
PPARγ(1)
PPARγ









I_121
++
ANTAGONIST



I_128
++
—



I_149
+
—



I_178
+++
—



I_198
++
PARTIAL AGONIST



I_262
+++
AGONIST



I_265
+++
AGONIST



I_280
+++
—



I_303
+++
—



I_375
+++
PARTIAL AGONIST



I_379
++
—



I_391
++
—



I_410
+++
ANTAGONIST



I_412
+++
—



I_418
++
PARTIAL AGONIST



I_438
++
—



I_440
++
—



I_467
+++
—



I_469
++
—







(1)+++: Ki < 500 nM, ++: 500 nM < Ki < 1500 nM, +: Ki > 1500 nM






Additional objects, advantages and novel features of the invention will be set forth in part in the description, and in part will become apparent to those skilled in the art upon examination of the description or may be learned by practice of the invention. The present invention will be further illustrated by the following examples. The examples are given by way of illustration only and are not to be construed as limiting the scope of the invention.
The nomenclature of the different compounds used in the present document is based on the software AUTONOM (Automatic Nomenclature) from the Beilstein Institute, which uses the IUPAC systematic nomenclature.
LC-MS spectra have been performed using the following chromatographic equipment: Hewlett-Packard model 1100, equipped with a selective mass detector model 1100 VL, autosampler, ChemStation software and a laser printer (mass spectrometry ionization mode: Atmospheric pressure ionisation with positive ion detection) and using the following chromatographic methods:
Method A: Column Kromasil 100 C18, 40×4.0 mm, 3.5 μm, flow: 0.7 mL/min, eluent: A=0.1% formic acid in water, B=0.1% formic acid in acetonitrile, gradient: 0 min 5% B−8 min 90% B.
Method B: Column: Gemini 5u C18 110, 40×4.0 mm, flow: 0.7 mL/min, eluent: A=0.1% formic acid in water, B=0.1% formic acid in acetonitrile, gradient: 0 min 5% B−8 min 90% B.
1H-NMR spectra of the compounds have been recorded using a VARIAN GEMINI-200 MHz and a VARIAN UNITY-300 MHz equipment and chemical shifts are expressed as ppm (δ) from the internal reference TMS. Mass spectra have been obtained with an Agilent 1100 VL mass spectrometer.
The following abbreviations have been used in the examples:

    DEAD: diethyl azodicarboxylate
    DMF: N,N-dimethylformamide
    EDC: 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide

eq: molar equivalent

    EtOAc: ethyl acetate
    HOBT: 1-hydroxybenzotriazol
    LC-MS: liquid chromatography-mass spectrometry
    rt: retention time
    THF: tetrahydrofuran
    TMS: trimethylsylane

Intermediates IIIa and IIIb:



Compounds of formula IIIa and IIIb can be prepared following similar procedures to those described in Cobb et al., J. Med. Chem. 1998, 41, 5055-69.
IIIa—1: (S)-2-(2-Benzoylphenylamino)-3-(4-hydroxyphenyl)propionic acid methyl ester; rt: 7.357, MS [M+1]+: 376.
IIIb—1: (R)-2-(2-Benzoylphenylamino)-3-(4-hydroxyphenyl)propionic acid methyl ester; rt: 7.357, MS [M+1]+: 376.
Intermediates XIII:
Compounds of formula XIII shown in Table 2 were obtained starting from a phenol III and an amine derivative of formula XIVa or XIVb following one of the procedures A-D described below.
PROCEDURE A: A 0.5 M suspension-of phenol III (1 eq) in EtOAc containing anhydrous potassium carbonate (3 eq) and compound XIVa (1.3 eq) was refluxed for 18 h. Then, the suspension was allowed to cool down and the white solid was filtered. The solvent was distilled off under reduced pressure, and the obtained residue was purified by column chromatography.
PROCEDURE B: A 0.5 M suspension of phenol III (1 eq) in anhydrous DMF containing cesium carbonate (3 eq), compound XIVa (1.3 eq) and potassium iodide (catalythic amount) was heated at 80° C. for 18 h. Then, the suspension was allowed to cool down at room temperature, and treated with water and EtOAc. The organic layer was washed three times with brine, dried over anhydrous sodium sulfate and filtered. The solvent was distilled off under reduced pressure, and the obtained residue was purified by column chromatography.
PROCEDURE C: To a 0.1 M solution of phenol III (1 eq) in anhydrous DMF, containing a catalythic amount of potassium iodide, sodium hydride (60%, 1.1 eq) was added. The resulting suspension was stirred at room temperature for 1 hour and then compound XIVa (1.1 eq) was added. The reaction mixture was stirred at 80° C. for 18 h, and then allowed to cool down to room temperature. After treating with water and EtOAc, the organic layer was washed three times with brine, dried over anhydrous sodium sulfate and filtered. The solvent was distilled off under reduced pressure, and the obtained residue was purified by column chromatography.
PROCEDURE D: To a 0.2 M solution of phenol III (1 eq) in THF, containing compound XIVb (2.2 eq) and triphenylphosphine (2.2 eq), DEAD (2.2 eq) was added under inert atmosphere. The solution was stirred at room temperature for 18 h. Then, the solvent was distilled off under reduced pressure, and the obtained residue was purified by column chromatography.











TABLE 2





Example
Starting


HPLC


Number
product
Compound name
1H-NMR/LC-MS
Method







XIII_1
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-{2-
8.86(d, 1H),
A




[benzyl-(2,2,2-trifluoroacetyl)amino]-
7.62-7.56(ca, 2H),




ethoxy}phenyl)propionic acid methyl
7.56-7.16(ca,




ester
12H), 6.79(d, 2H),





6.68-6.55(ca,





2H), 4.80(s, 2H),





4.40(q, 1H),





4.10(t, 2H),





3.75-3.60(ca, 5H), 3.19(dd,





1H), 3.09(dd, 1H)


XIII_2
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-{3-
rt: 9.383
A




[benzyl-(2,2,2-trifluoroacetyl)amino]-
MS[M+1]+: 619




propoxy}phenyl)propionic acid methyl




ester


XIII_3
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-{2-
rt: 9.706
A




[cyclohexyl-(2,2,2-trifluoroacetyl)-
MS[M+1]+: 597




amino]ethoxy}phenyl)propionic acid




methyl ester


XIII_4
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-{2-
rt: 9.287
A




[tert-butyl-(2,2,2-trifluoroacetyl)amino]-
MS[M+1]+: 571




ethoxy}phenyl)propionic acid methyl




ester


XIII_5
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-{2-
rt: 8.969
A




[cyclopropylmethyl(2-
MS[M+1]+: 658




nitrobenzenesulfonyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


XIII_6
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-{3-
rt: 9.103
A




[cyclopropylmethyl(2-
MS[M+1]+: 672




nitrobenzenesulfonyl)amino]propoxy}-




phenyl)propionic acid methyl ester


XIII_7
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-{2-
rt: 9.323
A




[(3-methylbenzyl)(2-
MS[M+1]+: —




nitrobenzenesulfonyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


XIII_8
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-{3-
rt: 9.449
A




[(3-methylbenzyl)(2-
MS[M+1]+: —




nitrobenzenesulfonyl)amino]propoxy}-




phenyl)propionic acid methyl ester


XIII_9
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-{2-
rt: 8.948
A




[(2-nitrobenzenesulfonyl)propylamino]-
MS[M+1]+: 646




ethoxy}phenyl)propionic acid methyl




ester


XIII_10
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-{2-
rt: 8.726
A




[ethyl-(2-nitrobenzenesulfonyl)amino]-
MS[M+1]+: 632




ethoxy}phenyl)propionic acid methyl




ester









Intermediates V:

Compounds of formula V shown in Table 3 were obtained starting from phenol III and an amine derivative of formula XVa following one of the procedures A-C described above or alternatively starting from compound XIII using procedures E-F described below.
PROCEDURE E: To a 0.1 M solution of compound XIII (1 eq) (PG=trifluoroacetyl) in a mixture of THF:methanol (3:1), a 1 M aqueous solution of lithium hydroxide (5 eq) was added. The solution was stirred for 18 h at room temperature, then diluted with a mixture of water/EtOAc, and then acidified to pH=5 with HCl 1 N. The organic layer was dried over anhydrous sodium sulfate and filtered. The solvent was distilled off under reduced pressure, and the obtained residue was redissolved in methanol to afford a 0.1 M solution, which was treated with thionyl chloride (3.2 eq). The solution was refluxed for 18 h, and then allowed to cool down to room temperature. The solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography.
PROCEDURE F: To a 0.1 M solution of compound XIII (PG=2-nitrobenzenesulfonyl, 1 eq) in DMF containing thiophenol (1 eq), KOtBu (2 eq) was added. The solution was stirred at room temperature for 6 h and then diluted with a mixture of water/EtOAc. The organic layer was washed three times with brine, dried over anhydrous sodium sulfate and filtered. The solvent was distilled off under reduced pressure, and the obtained residue was purified by column chromatography.











TABLE 3





Example
Starting


HPLC


Number
product
Compound name
1H-NMR/LC-MS
Method







V_1
XIII_1
(S)-2-(2-Benzoylphenylamino)-3-[4-
8.86(d, 1H),
A




(2-benzylaminoethoxy)phenyl]-
7.62-7.56(ca, 2H),




propionic acid methyl ester
7.56-7.40(ca, 6H),





7.40-7.27(ca, 4H), 7.14(d, 2H),





6.83(d, 2H),





6.65-6.53(ca, 2H), 4.63(q, 1H),





4.13(t, 2H), 3.99(s,





2H), 3.68(s, 3H),





3.19(dd, 1H), 3.09(dd,





1H), 3.03(t, 2H)


V_2
XIII_2
(S)-2-(2-Benzoylphenylamino)-3-[4-
rt: 6.385
A




(3-benzylaminopropoxy)phenyl]-
MS[M+1]+: 523




propionic acid methyl ester


V_3
XIII_3
(S)-2-(2-Benzoylphenylamino)-3-[4-
rt: 6.495
A




(2-cyclohexylaminoethoxy)phenyl]-
MS[M+1]+: 501




propionic acid methyl ester


V_4
XIII_4
(S)-2-(2-Benzoylphenylamino)-3-[4-
rt: 6.209
A




(2-tert-butylaminoethoxy)phenyl]-
MS[M+1]+: 475




propionic acid methyl ester


V_5
XIII_5
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 5.882
A




[2-cyclopropylmethylamino)ethoxy]-
MS[M+1]+: 473




phenyl}propionic acid methyl ester


V_6
XIII_6
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 6.354
A




[3-(cyclopropylmethylamino)-
MS[M+1]+: 487




propoxy]phenyl}propionic acid




methyl ester


V_7
XIII_7
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 6.591
A




[2-(3-methylbenzylamino)ethoxy]-
MS[M+1]+: 523




phenyl}propionic acid methyl ester


V_8
XIII_8
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 6.758
A




[3-(3-methylbenzylamino)propoxy]-
MS[M+1]+: 537




phenyl}propionic acid methyl ester


V_9
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-[4-
rt: 8.96
A




(2-phenylaminoethoxy)phenyl]-
MS[M+1]+: 495




propionic acid methyl ester


V_10
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-[4-
rt: 8.993
A




(3-phenylaminopropoxy)phenyl]-
MS[M+1]+: 509




propionic acid methyl ester


V_11
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.131
A




[2-(2-fluorophenylamino)ethoxy]-
MS[M+1]+: 513




phenyl}propionic acid methyl ester


V_12
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.013
A




[2-(3-fluorophenylamino)ethoxy]-
MS[M+1]+: 513




phenyl}propionic acid methyl ester


V_13
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.876
A




[2-(4-fluorophenylamino)ethoxy]-
MS[M+1]+: 513




phenyl}propionic acid methyl ester


V_14
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-[4-
rt: 9.247
A




(2-o-tolylaminoethoxy)phenyl]-
MS[M+1]+: 509




propionic acid methyl ester


V_15
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-[4-
rt: 9.127
A




(2-m-tolylaminoethoxy)phenyl]-
MS[M+1]+: 509




propionic acid methyl ester


V_16
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-[4-
rt: 9.014
A




(2-p-tolylaminoethoxy)phenyl]-
MS[M+1]+: 509




propionic acid methyl ester


V_17
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.431
A




[2-(2-chlorophenylamino)ethoxy]-
MS[M, M+2]+: 530,




phenyl}propionic acid methyl ester
532


V_18
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.293
A




[2-(3-chlorophenylamino)ethoxy]-
MS[M, M+2]+: 530,




phenyl}propionic acid methyl ester
532


V_19
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.265
A




[2-(4-chlorophenylamino)ethoxy]-
MS[M, M+2]+: 530,




phenyl}propionic acid methyl ester
532


V_20
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-[4-
rt: 9.377
A




(3-o-tolylaminopropoxy)phenyl]-
MS[M+1]+: 523




propionic acid methyl ester


V_21
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-[4-
rt: 9.11
A




(3-m-tolylaminopropoxy)phenyl]-
MS[M+1]+: 523




propionic acid methyl ester


V_22
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-[4-
rt: 8.714
A




(3-p-tolylaminopropoxy)phenyl]-
MS[M+1]+: 523




propionic acid methyl ester


V_23
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.632
A




[3-(2-chlorophenylamino)propoxy]-
MS[M, M+2]+: 543,




phenyl}propionic acid methyl ester
545


V_24
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.474
A




[3-(3-chlorophenylamino)propoxy]-
MS[M, M+2]+: 543,




phenyl}propionic acid methyl ester
545


V_25
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.435
A




[3-(4-chlorophenylamino)propoxy]-
MS[M, M+2]+: 543,




phenyl}propionic acid methyl ester
545


V_26
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.202
A




[2-(naphthalen-1-ylamino)ethoxy]-
MS[M+1]+: 545




phenyl}propionic acid methyl ester


V_27
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.189
A




[2-(3-methylsulfanylphenylamino)-
MS[M+1]+: 541




ethoxy]phenyl}propionic acid methyl




ester


V_28
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.178
A




[2-(4-methylsulfanylphenylamino)-
MS[M+1]+: 541




ethoxy]phenyl}propionic acid methyl




ester


V_29
IIIb_1
(R)-2-(2-Benzoylphenylamino)-3-[4-
rt: 8.968
A




(2-phenylaminoethoxy)phenyl]-
MS[M+1]+: 495




propionic acid methyl ester


V_30
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.417
A




[2-(naphthalen-2-ylamino)ethoxy]-
MS[M+1]+: 545




phenyl}propionic acid methyl ester


V_31
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.369
A




[3-(2-fluorophenylamino)propoxy]-
MS[M+1]+: 527




phenyl}propionic acid methyl ester


V_32
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.233
A




[3-(3-fluorophenylamino)propoxy]-
MS[M+1]+: 527




phenyl}propionic acid methyl ester


V_33
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.992
A




[3-(4-fluorophenylamino)propoxy]-
MS[M+1]+: 527




phenyl}propionic acid methyl ester


V_34
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.085
A




[2-(2-methoxyphenylamino)ethoxy]-
MS[M+1]+: 525




phenyl}propionic acid methyl ester


V_35
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.850
A




[2-(3-methoxyphenylamino)ethoxy]-
MS[M+1]+: 525




phenyl}propionic acid methyl ester


V_36
XIII_10
(S)-2-(2-Benzoylphenylamino)-3-[4-
rt: 5.889
A




(2-ethylaminoethoxy)phenyl]-
MS[M+1]+: 447




propionic acid methyl ester


V_37
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.097
A




[3-(2-methoxyphenylamino)propoxy]-
MS[M+1]+: 539




phenyl}propionic acid methyl ester


V_38
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.923
A




[3-(3-methoxyphenylamino)propoxy]-
MS[M+1]+: 539




phenyl}propionic acid methyl ester


V_39
XIII_9
(S)-2-(2-Benzoylphenylamino)-3-[4-
rt: 6.063
A




(2-propylaminoethoxy)phenyl]-
MS[M+1]+: 461




propionic acid methyl ester









Intermediates II:

Compounds of formula II shown in Table 4 were obtained starting from phenol III and a compound of formula IVa or IVb following one of the procedures A-D described above.











TABLE 4





Example
Starting


HPLC


Number
product
Compound name
1H-NMR/LC-MS
Method







II_1
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.561
A




[2-(benzylindan-5-ylamino)ethoxy]-
MS[M+1]+: 625




phenyl}propionic acid methyl ester


II_2
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.023
A




{2-[benzyl(2,6-difluorophenyl)amino]-
MS[M+1]+: 621




ethoxy}phenyl)propionic acid methyl




ester


II_3
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.22
A




{2-[(2-chlorophenyl)-(2-fluorobenzyl)-
MS[M+1]+: 638




amino]ethoxy}phenyl)propionic acid




methyl ester


II_4
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.977
A




{2-[benzyl-(2-fluorophenyl)amino]-
MS[M+1]+: 603




ethoxy}phenyl)propionic acid methyl




ester


II_5
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.123
A




{2-[(2-methylbenzyl)phenylamino]-
MS[M+1]+: 599




ethoxy}phenyl)propionic acid methyl




ester


II_6
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.204
A




{2-[(3-chlorophenyl)-(2-
MS[M+1]+: 650




methoxybenzyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


II_7
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.134
A




{2-[(2-methoxybenzyl)-m-tolylamino]-
MS[M+1]+: 629




ethoxy}phenyl)propionic acid methyl




ester


II_8
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.014
A




{3-[(2-methoxybenzyl)phenylamino]-
MS[M+1]+: 629




propoxy}phenyl)propionic acid




methyl ester


II_9
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.25
A




[2-(benzyl-o-tolylamino)ethoxy]-
MS[M+1]+: 599




phenyl}propionic acid methyl ester


II_10
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.356
A




{2-[benzyl-(3-ethylphenyl)amino]-
MS[M+1]+: 613




ethoxy}phenyl)propionic acid methyl




ester


II_11
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.864
A




{2-[benzyl-(3-fluorophenyl)amino]-
MS[M+1]+: 603




ethoxy}phenyl)propionic acid methyl




ester


II_12
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.119
A




{2-[(2-chlorophenyl)-(3-
MS[M+1]+: 650




methoxybenzyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


II_13
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.012
A




{2-[(3-chlorophenyl)-(3-
MS[M+1]+: 650




methoxybenzyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


II_14
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.004
A




{2-[(3-methoxybenzyl)-m-tolylamino]-
MS[M+1]+: 629




ethoxy}phenyl)propionic acid methyl




ester


II_15
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.931
A




{3-[(3-methoxybenzyl)phenylamino]-
MS[M+1]+: 629




propoxy}phenyl)propionic acid




methyl ester


II_16
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.127
A




[2-(benzyl-m-tolylamino)ethoxy]-
MS[M+1]+: 599




phenyl}propionic acid methyl ester


II_17
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.164
A




{2-[benzyl-(4-chlorophenyl)amino]-
MS[M+1]+: 619




ethoxy}phenyl)propionic acid methyl




ester


II_18
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.863
A




{2-[benzyl-(4-fluorophenyl)amino]-
MS[M+1]+: 603




ethoxy}phenyl)propionic acid methyl




ester


II_19
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.172
A




{2-[(4-methylbenzyl)phenylamino]-
MS[M+1]+: 599




ethoxy}phenyl)propionic acid methyl




ester


II_20
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.879
A




{3-[(4-methoxybenzyl)phenylamino]-
MS[M+1]+: 629




propoxy}phenyl)propionic acid




methyl ester


II_21
IIIa_1
(S)-2-(Benzoylphenylamino)-3-{4-[2-
rt: 10.592
A




(di-p-tolylamino)ethoxy]phenyl}-
MS[M+1]+: 599




propionic acid methyl ester


II_22
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.174
A




[2-(benzyl-p-tolylamino)ethoxy]-
MS[M+1]+: 599




phenyl}propionic acid methyl ester


II_23
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.601
A




[3-(benzylindan-5-ylamino)propoxy]-
MS[M+1]+: 639




phenyl}propionic acid methyl ester


II_24
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.507
A




{3-[benzyl-(3-ethylphenyl)amino]-
MS[M+1]+: 627




propoxy}phenyl)propionic acid




methyl ester


II_25
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.261
A




[3-(benzyl-m-tolylamino)propoxy]-
MS[M+1]+: 613




phenyl}propionic acid methyl ester


II_26
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.27
A




[3-(benzyl-p-tolylamino)propoxy]-
MS[M+1]+: 613




phenyl}propionic acid methyl ester


II_27
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 7.251
A




[3-(benzylcyclohexylamino)propoxy]-
MS[M+1]+: 605




phenyl}propionic acid methyl ester


II_28
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
8.92(d, 1H), 7.60(d,
A




[3-(benzylphenylamino)propoxy]-
2H), 7.60-7.15(ca,




phenyl}propionic acid methyl ester
17H), 6.85-6.55(ca,





4H), 4.55(s, 2H),





4.39(q, 1H), 3.97(t, 2H),





3.69(s, 3H), 3.62(t,





2H), 3.22(dd, 1H),





3.13(dd, 1H),





2.20-2.00(ca, 2H)


II_29
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.281
A




{2-[(2-fluorophenyl)isobutylamino]-
MS[M+1]+: 569




ethoxy}phenyl)propionic acid methyl




ester


II_30
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.614
A




[2-(isobutyl-o-tolylamino)ethoxy]-
MS[M+1]+: 565




phenyl}propionic acid methyl ester


II_31
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.455
A




[3-(isobutyl-o-tolylamino)propoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


II_32
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.109
A




{2-[(3-fluorophenyl)isobutylamino]-
MS[M+1]+: 569




ethoxy}phenyl)propionic acid methyl




ester


II_33
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.397
A




{2-[isobutyl-m-tolylamino]ethoxy}-
MS[M+1]+: 565




phenyl)propionic acid methyl ester


II_34
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.412
A




[3-(isobutyl-m-tolylamino)propoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


II_35
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 7.539
A




[2-(benzylphenethylamino)ethoxy]-
MS[M+1]+: 613




phenyl}propionic acid methyl ester


II_36
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.223
A




[2-(cyclobutylmethyl-o-tolylamino)-
MS[M+1]+: 577




ethoxy]phenyl}propionic acid methyl




ester


II_37
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 7.03
A




[2-(benzylcyclopentylamino)ethoxy]-
MS[M+1]+: 577




phenyl}propionic acid methyl ester


II_38
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 7.811
A




[3-(cyclopentylphenylamino)-
MS[M+1]+: 577




propoxy]phenyl}propionic acid




methyl ester


II_39
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.786
A




{2-[cyclopentylmethyl-(2-
MS[M+1]+: 595




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


II_40
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.602
A




[2-(cyclopentymethylphenylamino)-
MS[M+1]+: 577




ethoxy]phenyl}propionic acid methyl




ester


II_41
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 6.954
A




[2-(benzylcyclopropylmethylamino)-
MS[M+1]+: 563




ethoxyl]phenyl}propionic acid methyl




ester


II_42
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 7.052
A




[3-(benzylcyclopropylmethylamino)-
MS[M+1]+: 577




propoxy]phenyl}propionic acid




methyl ester


II_43
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.936
A




{2-[(2-methoxybenzyl)phenylamino]-
MS[M+1]+: 615




ethoxy}phenyl)propionic acid methyl




ester


II_44
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.8
A




{2-[(3-methoxybenzyl)phenylamino]-
MS[M+1]+: 615




ethoxy}phenyl)propionic acid methyl




ester


II_45
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.831
A




{2-[(3-methoxyphenyl)phenylamino]-
MS[M+1]+: 601




ethoxy}phenyl)propionic acid methyl




ester


II_46
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.788
A




{2-[(4-methoxybenzyl)phenylamino]-
MS[M+1]+: 615




ethoxy}phenyl)propionic acid methyl




ester


II_47
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: —
A




{2-[(4-tert-butylbenzyl)phenylamino]-
MS[M+1]+: 641




ethoxy}phenyl)propionic acid methyl




ester


II_48
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
8.89(d, 1H), 7.59(d,
A




[2-(benzylphenylamino)ethoxy]-
2H), 7.55-7.40(ca,




phenyl}propionic acid methyl ester
4H), 7.40-7.15(ca,





11H), 6.85-6.55(ca,





8H), 4.67(s, 2H),





4.42(m, 1H), 4.18(t, 2H),





3.85(t, 2H), 3.71(s,





3H), 3.30-3.10(ca,





2H)


II_49
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.206
A




[2-(cyclobutylmethylphenylamino)-
MS[M+1]+: 563




ethoxy]phenyl}propionic acid methyl




ester


II_50
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.01
A




[2-(cyclohexylphenylamino)ethoxy]-
MS[M+1]+: 577




phenyl}propionic acid methyl ester


II_51
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: —
A




[2-(cyclohexylmethylphenylamino)-
MS[M+1]+: 589




ethoxy]phenyl}propionic acid methyl




ester


II_52
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.769
A




[2-(cyclopentylphenylamino)ethoxy]-
MS[M+1]+: 563




phenyl}propionic acid methyl ester


II_53
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.696
A




[2-(cyclopropylmethylphenylamino)-
MS[M+1]+: 549




ethoxy]phenyl}propionic acid methyl




ester


II_54
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
8.98(d, 1H),
A




[2-(diphenylamino)ethoxy]phenyl}-
7.70-7.60(ca, 2H),




propionic acid methyl ester
7.60-7.45(ca, 3H),





7.45-7.15(ca, 8H),





7.15-6.95(ca, 6H), 6.85(d,





2H), 6.75-6.60(ca,





2H), 4.44(q, 1H),





4.17(s, 4H), 3.72(s, 3H),





3.30-3.10(ca, 2H).


II_55
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: —
A




{2-[cyclohexylmethyl-(2-
MS[M+1]+: —




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


II_56
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: —
A




{2-[(3-chlorophenyl)-
MS[M+1]+: —




cyclopentylmethylamino]ethoxy}-




phenyl)propionic acid methyl ester


II_57
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.527
A




{3-[cyclobutylmethyl-(3-
MS[M+1]+: 595




fluorophenyl)amino]propoxy}phenyl)-




propionic acid methyl ester


II_58
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.994
A




[3-(cyclobutylmethyl-m-tolylamino)-
MS[M+1]+: 591




propoxy]phenyl}propionic acid




methyl ester


II_59
IIIb_1
(R)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.945
A




[2-(benzylphenylamino)ethoxy]-
MS[M+1]+: 585




phenyl}propionic acid methyl ester


II_60
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: —
A




{2-[(2-chlorophenyl)-
MS[M+1]+: —




cyclopentylmethylamino]ethoxy}-




phenyl)propionic acid methyl ester


II_61
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.831
A




{2-[(2-fluorophenyl)thiophen-2-
MS[M+1]+: 609




ylmethylamino]ethoxy}phenyl)-




propionic acid methyl ester


II_62
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.561
A




{3-[(2-fluorophenyl)isobutylamino]-
MS[M+1]+: 583




propoxy}phenyl)propionic acid




methyl ester


II_63
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: —
A




{3-[cyclopentylmethyl-(2-
MS[M+1]+: —




fluorophenyl)amino]propoxy}phenyl)-




propionic acid methyl ester


II_64
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.655
A




[3-(cyclobutylmethyl-o-tolylamino)-
MS[M+1]+: 591




propoxy]phenyl}propionic acid




methyl ester


II_65
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.752
A




{2-[(3-fluorophenyl)thiophen-2-
MS[M+1]+: 609




ylmethylamino]ethoxy}phenyl)-




propionic acid methyl ester


II_66
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.996
A




[2-(thiophen-2-ylmethyl-m-
MS[M+1]+: 605




tolylamino)ethoxy]phenyl}propionic




acid methyl ester


II_67
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.131
A




[3-(thiophen-3-ylmethyl-m-
MS[M+1]+: 316




tolylamino)propoxy]phenyl}propionic




acid methyl ester


II_68
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.929
A




[3-(furan-2-ylmethyl-m-tolylamino)-
MS[M+1]+: 603




propoxy]phenyl}propionic acid




methyl ester


II_69
IIIa_I
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.744
A




{2-[(4-fluorophenyl)thiophen-2-
MS[M+1]+: 609




ylmethylamino]ethoxy}phenyl)-




propionic acid methyl ester


II_70
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.795
A




[2-(phenylthiophen-2-
MS[M+1]+: 591




ylmethylamino)ethoxy]phenyl}-




propionic acid methyl ester


II_71
IIIa_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.933
A




[3-(phenylthiophen-2-
MS[M+1]+: 605




ylmethylamino)propoxy]phenyl}-




propionic acid methyl ester









Intermediates IIa:

Compounds of formula IIa shown in Table 5 were obtained starting from a compound Va and a compound of formula VIa or VIb, following one of the procedures G-H described below.
PROCEDURE G: To a 0.2 M solution of compound Va (1 eq) in dichloromethane or EtOAc, triethylamine (3 eq) and a solution of an acyl chloride VIa (1.2 eq) were added. After stirring for 18 h, the crude was treated with 5% NaHCO3. The organic layer was washed twice with 5% NaHCO3 and once with brine. The organic layer was dried over anhydrous sodium sulfate and filtered. The solvent was distilled off under reduced pressure. The obtained residue was purified by column chromatography.
PROCEDURE H: To a 0.3 M suspension of compound Va (1 eq) in EtOAc containing HOBT (1.5 eq) and EDC (1.5 eq), triethylamine (3 eq) was added. Then, carboxylic acid VIb (1 eq) was added and stirred for 18 h. The reaction mixture was treated with water, the organic layer was separated and the aqueous layer was extracted once with EtOAc. The combined organic layers were washed once with 5% NaHCO3 and once with brine, dried over anhydrous sodium sulfate, and filtered. The solvent was distilled off under reduced pressure, and the obtained residue was purified by column chromatography.











TABLE 5





Example
Starting


HPLC


Number
product
Compound name
1H-NMR/LC-MS
Method







IIa_1
V_17
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.069
A




{2-[(2-(2-chlorophenyl)-(2-
MS[M+1]+: 597




methylacryloyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_2
V_23
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.926
B




{3-[(2-chlorophenyl-(2-
MS[M, M+2]+: 611,




methylacryloyl)amino]propoxy}-
613




phenyl)propionic acid methyl ester


IIa_3
V_17
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.034
A




{2-[but-2-(E)-enoyl-(2-chlorophenyl)-
MS[M, M+2]+: 597,




amino]ethoxy}phenyl)propionic acid
599




methyl ester


IIa_4
V_17
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.532
A




{2-[(2-chlorophenyl)-(3-
MS[M, M+2]+: 613,




methylbutyryl)amino]ethoxy}phenyl)-
615




propionic acid methyl ester


IIa_5
V_17
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.427
A




{2-[(2-chlorophenyl)-
MS[M, M+2]+: 611,




cyclobutanecarbonylamino]ethoxy}-
613




phenyl)propionic acid methyl ester


IIa_6
V_17
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.657
A




{2-[(2-chlorophenyl)-
MS[M, M+2]+: 625,




cyclopentanecarbonylamino]ethoxy}-
627




phenyl)propionic acid methyl ester


IIa_7
V_17
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.094
A




{2-[(2-chlorophenyl)-
MS[M, M+2]+: 597,




cyclopropanecarbonylamino]ethoxy}-
599




phenyl)propionic acid methyl ester


IIa_8
V_23
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.28
A




{3-[(2-chlorophenyl)-
MS[M, M+2]+: 611,




cyclopropanecarbonylamino]-
613




propoxy}phenyl)propionic acid




methyl ester


IIa_9
V_17
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.049
A




{2-[(2-chlorophenyl)propionylamino]-
MS[M, M+2]+: 585,




ethoxy}phenyl)propionic acid methyl
587




ester


IIa_10
V_23
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.247
A




{3-[(2-chlorophenyl)propionylamino]-
MS[M, M+2]+: 599,




propoxy}phenyl)propionic acid
601




methyl ester


IIa_11
V_17
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.28
A




{2-[(2-chlorophenyl)isobutyrylamino]-
MS[M, M+2]+: 599,




ethoxy}phenyl)propionic acid methyl
601




ester


IIa_12
V_23
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.126
B




{3-[(2-chlorophenyl)isobutyrylamino]-
MS[M, M+2]+: 613,




propoxy}phenyl)propionic acid
615




methyl ester


IIa_13
V_17
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.069
A




{2-[butyryl-(2-chlorophenyl)amino]-
MS[M, M+2]+: 597,




ethoxy}phenyl)propionic acid methyl
599




ester


IIa_14
V_23
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.148
B




{3-[butyryl-(2-chlorophenyl)amino]-
MS[M, M+2]+: 613,




propoxy}phenyl)propionic acid
615




methyl ester


IIa_15
V_23
(S)-3-(4-{3-[Acryloyl-(2-
rt: 9.102
A




chlorophenyl)amino]propoxy}-
MS[M, M+2]+: 597,




phenyl)-2-(2-benzoylphenylamino)-
599




propionic acid methyl ester


IIa_16
V_11
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.961
A




{2-[(2-fluorophenyl)-(thiophene-2-
MS[M+1]+: 623




carbonyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_17
V_11
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.857
A




{2-[(2-fluorophenyl)-(2-
MS[M+1]+: 581




methylacryloyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_18
V_11
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.282
A




{2-[(2-fluorophenyl)-(3-
MS[M+1]+: 597




methylbutyryl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_19
V_11
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.185
A




{2-[cyclobutanecarbonyl-(2-
MS[M+1]+: 595




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_20
V_11
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.412
A




{2-[cyclopentanecarbonyl-(2-
MS[M+1]+: 609




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_21
V_11
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.865
A




{2-[cyclopropanecarbonyl-(2-
MS[M+1]+: 581




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_22
V_11
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.796
A




{2-[(2-fluorophenyl)propionylamino]-
MS[M+1]+: 569




ethoxy}phenyl)propionic acid methyl




ester


IIa_23
V_11
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.04
A




{2-[(2-fluorophenyl)isobutyrylamino]-
MS[M+1]+: 583




ethoxy}phenyl)propionic acid methyl




ester


IIa_24
V_11
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.05
A




{2-[butyryl-(2-fluorophenyl)amino]-
MS[M+1]+: 583




ethoxy}phenyl)propionic acid methyl




ester


IIa_25
V_17
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.408
A




{2-[(2,2-dimethylpropionyl)-(2-
MS[M+1]+: 597




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_26
V_20
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.828
B




{3-[(2-methylacryloyl)-o-tolylamino]-
MS[M+1]+: 591




propoxy}phenyl)propionic acid




methyl ester


IIa_27
V_14
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.684
A




{2-[(2-ethylbutyryl)-o-tolylamino]-
MS[M+1]+: 607




ethoxy}phenyl)propionic acid methyl




ester


IIa_28
V_20
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.165
B




{3-[(3-methylbut-2-(E)-enoyl)-o-
MS[M+1]+: 605




tolylamino]propoxy}phenyl)propionic




acid methyl ester


IIa_29
V_20
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.911
B




[3-(but-2-(E)-enoyl-o-tolylamino)-
MS[M+1]+: 591




propoxy]phenyl}propionic acid




methyl ester


IIa_30
V_14
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.788
A




{2-[(3,3-dimethylbutyryl)-o-
MS[M+1]+: 607




tolylamino]ethoxy}phenyl)propionic




acid methyl ester


IIa_31
V_14
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.465
A




{2-[(3-methylbutyryl)-o-tolylamino]-
MS[M+1]+: 593




ethoxy}phenyl)propionic acid methyl




ester


IIa_32
V_20
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.331
B




{3-[(3-methylbutyryl)-o-tolylamino]-
MS[M+1]+: 607




propoxy}phenyl)propionic acid




methyl ester


IIa_33
V_20
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.129
B




[3-(o-tolylpent-4-enoylamino)-
MS[M+1]+: 605




propoxy]phenyl}propionic acid




methyl ester


IIa_34
V_14
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.378
A




[2-(cyclobutanecarbonyl-o-
MS[M+1]+: 591




tolylamino)ethoxy]phenyl}propionic




acid methyl ester


IIa_35
V_14
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.607
A




[2-(cyclopentanecarbonyl-o-
MS[M+1]+: 605




tolylamino)ethoxy]phenyl}propionic




acid methyl ester


IIa_36
V_20
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.849
B




[3-(propionyl-o-tolylamino)propoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_37
V_14
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.22
A




[2-(isobutyryl-o-tolylamino)ethoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_38
V_20
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.08
B




[3-(isobutyryl-o-tolylamino)propoxy]-
MS[M+1]+: 593




phenyl}propionic acid methyl ester


IIa_39
V_20
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.348
B




[3-(pentanoyl-o-tolylamino)propoxy]-
MS[M+1]+: 607




phenyl}propionic acid methyl ester


IIa_40
V_14
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.233
A




[2-(butyryl-o-tolylamino)ethoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_41
V_20
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.094
B




[3-(butyryl-o-tolylamino)propoxy]-
MS[M+1]+: 593




phenyl}propionic acid methyl ester


IIa_42
V_14
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.077
A




[2-(benzoyl-o-tolylamino)ethoxy]-
MS[M+1]+: 613




phenyl}propionic acid methyl ester


IIa_43
V_14
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.597
A




{2-[(2,2-dimethylpropionyl)-o-
MS[M+1]+: 593




tolylamino]ethoxy}phenyl)propionic




acid methyl ester


IIa_44
V_20
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.435
B




{3-[(2,2-dimethylpropionyl)-o-
MS[M+1]+: 607




tolylamino]propoxy}phenyl)propionic




acid methyl ester


IIa_45
V_20
(S)-3-{4-[3-(Acryloyl-o-tolylamino)-
rt: 9.781
B




propoxy]phenyl}-2-(2-
MS[M+1]+: 577




benzoylphenylamino)propionic acid




methyl ester


IIa_46
V_18
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.126
A




{2-[(3-chlorophenyl)-(2-
MS[M, M+2]+: 597,




methylacryloyl)amino]ethoxy}-
599




phenyl)propionic acid methyl ester


IIa_47
V_18
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.184
A




{2-[but-2-(E)-enoyl-(3-chlorophenyl)-
MS[M, M+2]+: 597,




amino]ethoxy]phenyl}propionic acid
599




methyl ester


IIa_48
V_24
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.348
A




{3-[but-2-(E)-enoyl-(3-chlorophenyl)-
MS[M, M+2]+: 611,




amino]propoxy}phenyl)propionic acid
613




methyl ester


IIa_49
V_18
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.557
A




{2-[(3-chlorophenyl)-(3-
MS[M, M+2]+: 613,




methylbutyryl)amino]ethoxy}phenyl)-
615




propionic acid methyl ester


IIa_50
V_18
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.375
A




{2-[(3-chlorophenyl)-pent-4-
MS[M, M+2]+: 611,




enoylamino]ethoxy}phenyl)propionic
613




acid methyl ester


IIa_51
V_18
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.488
A




{2-[(3-chlorophenyl)-
MS[M, M+2]+: 611,




cyclobutanecarbonylamino]ethoxy}-
613




phenyl)propionic acid methyl ester


IIa_52
V_18
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.708
A




{2-[(3-chlorophenyl)-
MS[M, M+2]+: 625,




cyclopentanecarbonylamino]ethoxy}-
627




phenyl)propionic acid methyl ester


IIa_53
V_18
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.217
A




{2-[(3-chlorophenyl)-
MS[M, M+2]+: 597,




cyclopropanecarbonylamino]ethoxy}-
599




phenyl)propionic acid methyl ester


IIa_54
V_24
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.401
A




{3-[(3-chlorophenyl)-
MS[M, M+2]+: 611,




cyclopropanecarbonylamino]-
613




propoxy}phenyl)propionic acid




methyl ester


IIa_55
V_18
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.097
A




{2-[(3-chlorophenyl)propionylamino]-
MS[M, M+2]+: 585,




ethoxy}phenyl)propionic acid methyl
587




ester


IIa_56
V_24
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.279
A




{3-[(3-chlorophenyl)propionylamino]-
MS[M, M+2]+: 599,




propoxy}phenyl)propionic acid
601




methyl ester


IIa_57
V_18
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.332
A




{2-[(3-chlorophenyl)isobutyrylamino]-
MS[M, M+2]+: 599,




ethoxy}phenyl)propionic acid methyl
601




ester


IIa_58
V_24
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.502
A




{3-[(3-chlorophenyl)isobutyrylamino]-
MS[M, M+2]+: 613,




propoxy}phenyl)propionic acid
615




methyl ester


IIa_59
V_18
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.339
A




{2-[butyryl-(3-chlorophenyl)amino]-
MS[M, M+2]+: 599,




ethoxy}phenyl)propionic acid methyl
601




ester


IIa_60
V_24
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.508
A




{3-[butyryl-(3-chlorophenyl)amino]-
MS[M, M+2]+: 613,




propoxy}phenyl)propionic acid
615




methyl ester


IIa_61
V_18
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.669
A




{2-[(3-chlorophenyl)-(2,2-
MS[M, M+2]+: 613,




dimethylpropionyl)amino]ethoxy)-
615




phenyl)propionic acid methyl ester


IIa_62
V_24
(S)-3-(4-{3-[Acryloyl-(3-
rt: 9.202
A




chlorophenyl)amino]propoxy}-
MS[M, M+2]+: 597,




phenyl)-2-(2-benzoylphenylamino)-
599




propionic acid methyl ester


IIa_63
V_12
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.016
A




{2-[(3-fluorophenyl)-(thiophene-2-
MS[M+1]+: 623




carbonyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_64
V_12
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.86
A




{2-[(3-fluorophenyl)-(2-
MS[M+1]+: 581




methylacryloyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_65
V_12
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.284
A




{2-[(3-fluorophenyl)-(3-
MS[M+1]+: 597




methylbutyryl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_66
V_12
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.198
A




{2-[cyclobutanecarbonyl-(3-
MS[M+1]+: 595




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_67
V_12
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.424
A




{2-[cyclopentanecarbonyl-(3-
MS[M+1]+: 609




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_68
V_12
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.93
A




{2-[cyclopropanecarbonyl-(3-
MS[M+1]+: 581




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_69
V_12
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.805
A




{2-[(3-fluorophenyl)propionylamino]-
MS[M+1]+: 569




ethoxy}phenyl)propionic acid methyl




ester


IIa_70
V_12
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.047
A




{2-[(3-fluorophenyl)isobutyrylamino]-
MS[M+1]+: 583




ethoxy}phenyl)propionic acid methyl




ester


IIa_71
V_12
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.057
A




{2-[butyryl-(3-fluorophenyl)amino]-
MS[M+1]+: 583




ethoxy}phenyl)propionic acid methyl




ester


IIa_72
V_12
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.393
A




{2-[(2,2-dimethylpropionyl)-(3-
MS[M+1]+: 597




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_73
V_8
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.199
A




{3-[(2-methylacryloyl)-(3-
MS[M+1]+: 605




methylbenzyl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_74
V_7
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.678
A




{2-[(2-ethylbutyryl)-(3-methylbenzyl)-
MS[M+1]+: 621




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_75
V_8
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.382
A




{3-[(3-methylbenzyl)-(3-methylbut-2-
MS[M+1]+: 619




(E)-enoyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_76
V_8
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.153
A




{3-[but-2-(E)-enoyl-(3-methylbenzyl)-
MS[M+1]+: 605




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_77
V_7
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.728
A




{2-[(3,3-dimethylbutyryl)-(3-
MS[M+1]+: 621




methylbenzyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_78
V_7
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.471
A




{2-[(3-methylbenzyl)-(3-
MS[M+1]+: 607




methylbutyryl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_79
V_8
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.549
A




{3-[(3-methylbenzyl)-(3-
MS[M+1]+: 621




methylbutyryl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_80
V_7
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.389
A




{2-[cyclobutanecarbonyl-(3-
MS[M+1]+: 605




methylbenzyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_81
V_8
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.464
A




{3-[cyclobutanecarbonyl-(3-
MS[M+1]+: 619




methylbenzyl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_82
V_7
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.588
A




{2-[cyclopentanecarbonyl-(3-
MS[M+1]+: 619




methylbenzyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_83
V_8
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.194
A




{3-[cyclopropanecarbonyl-(3-
MS[M+1]+: 605




methylbenzyl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_84
V_8
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.095
A




{3-[(3-methylbenzyl)propionylamino]-
MS[M+1]+: 593




propoxy}phenyl)propionic acid




methyl ester


IIa_85
V_7
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.23
A




{2-[isobutyryl-(3-methylbenzyl)-
MS[M+1]+: 593




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_86
V_8
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.319
A




{3-[isobutyryl-(3-methylbenzyl)-
MS[M+1]+: 607




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_87
V_7
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.247
A




{2-[butyryl-(3-methylbenzyl)amino]-
MS[M+1]+: 593




ethoxy}phenyl)propionic acid methyl




ester


IIa_88
V_8
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.328
A




{3-[butyryl-(3-methylbenzyl)amino]-
MS[M+1]+: 607




propoxy}phenyl)propionic acid




methyl ester


IIa_89
V_7
(S)-3-(4-{2-[Benzoyl-(3-
rt: 9.28
A




methylbenzyl)amino]ethoxy}phenyl)-
MS[M+1]+: 627




2-(2-benzoylphenylamino)propionic




acid methyl ester


IIa_90
V_7
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.602
A




{2-[(2,2-dimethylpropionyl)-(3-
MS[M+1]+: 607




methylbenzyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_91
V_8
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.635
A




{3-[(2,2-dimethylpropionyl)-(3-
MS[M+1]+: 621




methylbenzyl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_92
V_21
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.906
B




{3-[(2-methylacryloyl)-m-tolylamino]-
MS[M+1]+: 591




propoxy}phenyl)propionic acid




methyl ester


IIa_93
V_15
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.75
A




{2-[(2-ethylbutyryl)-m-tolylamino]-
MS[M+1]+: 607




ethoxy}phenyl)propionic acid methyl




ester


IIa_94
V_21
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.231
B




{3-[(3-methylbut-2-(E)-enoyl)-m-
MS[M+1]+: 605




tolylamino]propoxy}phenyl)propionic




acid methyl ester


IIa_95
V_21
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.985
B




[3-(but-2-(E)-enoyl-m-tolylamino)-
MS[M+1]+: 591




propoxy]phenyl}propionic acid




methyl ester


IIa_96
V_15
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.826
A




{2-[(3,3-dimethylbutyryl)-m-
MS[M+1]+: 607




tolylamino]ethoxy}phenyl)propionic




acid methyl ester


IIa_97
V_15
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.518
A




{2-[(3-methylbutyryl)-m-tolylamino]-
MS[M+1]+: 593




ethoxy}phenyl)propionic acid methyl




ester


IIa_98
V_15
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.46
A




[2-(cyclobutanecarbonyl-m-
MS[M+1]+: 591




tolylamino)ethoxy]phenyl}propionic




acid methyl ester


IIa_99
V_15
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.671
A




[2-(cyclopentanecarbonyl-m-
MS[M+1]+: 605




tolylamino)ethoxy]phenyl}propionic




acid methyl ester


IIa_100
V_21
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.041
B




[3-(cyclopropanecarbonyl-m-
MS[M+1]+: 591




tolylamino)propoxy]phenyl}propionic




acid methyl ester


IIa_101
V_21
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.915
B




[3-(propionyl-m-tolylamino)propoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_102
V_15
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.287
A




[2-(isobutyryl-m-tolylamino)ethoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_103
V_21
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.134
B




[3-(isobutyryl-m-tolylamino)propoxy]-
MS[M+1]+: 593




phenyl}propionic acid methyl ester


IIa_104
V_21
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.398
B




[3-(pentanoyl-m-tolylamino)propoxy]-
MS[M+1]+: 607




phenyl}propionic acid methyl ester


IIa_105
V_15
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.296
A




[2-(butyryl-m-tolylamino)ethoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_106
V_21
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.146
B




[3-(butyryl-m-tolylamino)propoxy]-
MS[M+1]+: 593




phenyl}propionic acid methyl ester


IIa_107
V_15
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.176
A




[2-(benzoyl-m-tolylamino)ethoxy]-
MS[M+1]+: 613




phenyl}propionic acid methyl ester


IIa_108
V_15
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.659
A




{2-[(2,2-dimethylpropionyl)-m-
MS[M+1]+: 593




tolylamino]ethoxy}phenyl)propionic




acid methyl ester


IIa_109
V_21
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.508
B




{3-[(2,2-dimethylpropionyl)-m-
MS[M+1]+: 607




tolylamino]propoxy}phenyl)propionic




acid methyl ester


IIa_110
V_21
(S)-3-{4-[3-(Acryloyl-m-tolylamino)-
rt: 9.85
B




propoxy]phenyl}-2-(2-
MS[M+1]+: 577




benzoylphenylamino)propionic acid




methyl ester


IIa_111
V_19
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.173
A




{2-[(4-chlorophenyl)-(2-
MS[M, M+2]+: 597,




methylacryloyl)amino]ethoxy}-
599




phenyl)propionic acid methyl ester


IIa_112
V_19
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.242
A




{2-[but-2-(E)-enoyl-(4-chlorophenyl)-
MS[M, M+2]+: 597,




amino]ethoxy}phenyl)propionic acid
599




methyl ester


IIa_113
V_19
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.615
A




{2-[(4-chlorophenyl)-(3-
MS[M, M+2]+: 613,




methylbutyryl)amino]ethoxy}phenyl)-
615




propionic acid methyl ester


IIa_114
V_19
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.428
A




{2-[(4-chlorophenyl)-pent-4-
MS[M, M+2]+: 611,




enoylamino]ethoxy}phenyl)propionic
613




acid methyl ester


IIa_115
V_19
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.532
A




{2-[(4-chlorophenyl)-
MS[M, M+2]+: 611,




cyclobutanecarbonylamino]ethoxy}-
613




phenyl)propionic acid methyl ester


IIa_116
V_19
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.763
A




{2-[(4-chlorophenyl)-
MS[M, M+2]+: 625,




cyclopentanecarbonylamino]ethoxy}-
627




phenyl)propionic acid methyl ester


IIa_117
V_19
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.263
A




{2-[(4-chlorophenyl)-
MS[M, M+2]+: 597,




cyclopropanecarbonylamino]ethoxy}-
599




phenyl)propionic acid methyl ester


IIa_118
V_25
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.442
A




{3-[(4-chlorophenyl)-
MS[M, M+2]+: 611,




cyclopropanecarbonylamino]-
613




propoxy}phenyl)propionic acid




methyl ester


IIa_119
V_19
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.146
A




{2-[(4-chlorophenyl)propionylamino]-
MS[M, M+2]+: 585,




ethoxy}phenyl)propionic acid methyl
587




ester


IIa_120
V_25
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.323
A




{3-[(4-chlorophenyl)propionylamino]-
MS[M, M+2]+: 599,




propoxy}phenyl)propionic acid
601




methyl ester


IIa_121
V_19
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.393
A




{2-[(4-chlorophenyl)isobutyrylamino]-
MS[M, M+2]+: 599,




ethoxy}phenyl)propionic acid methyl
601




ester


IIa_122
V_25
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.558
A




{3-[(4-chlorophenyl)isobutyrylamino]-
MS[M, M+2]+: 613,




propoxy}phenyl)propionic acid
615




methyl ester


IIa_123
V_19
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.393
A




{2-[butyryl-(4-chlorophenyl)amino]-
MS[M, M+2]+: 599,




ethoxy}phenyl)propionic acid methyl
601




ester


IIa_124
V_25
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.558
A




{3-[butyryl-(4-chlorophenyl)amino]-
MS[M, M+2]+: 613,




propoxy}phenyl)propionic acid
615




methyl ester


IIa_125
V_19
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.71
A




{2-[(4-chlorophenyl)-(2,2-
MS[M, M+2]+: 613,




dimethylpropionyl)amino]ethoxy}-
615




phenyl)propionic acid methyl ester


IIa_126
V_25
(S)-3-(4-{3-[Acryloyl-(4-
rt: 9.246
A




chlorophenyl)amino]propoxy}-
MS[M, M+2]+: 597,




phenyl)-2-(2-benzoylphenylamino)-
599




propionic acid methyl ester


IIa_127
V_13
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.015
A




{2-[(4-fluorophenyl)-(thiophene-2-
MS[M+1]+: 623




carbonyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_128
V_13
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.828
A




{2-[(4-fluorophenyl)-(2-
MS[M+1]+: 581




methylacryloyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_129
V_13
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.141
A




{2-[(4-fluorophenyl)-(3-methylbut-2-
MS[M+1]+: 595




(E)-enoyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_130
V_13
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.278
A




{2-[(4-fluorophenyl)-(3-
MS[M+1]+: 597




methylbutyryl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_131
V_13
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.184
A




{2-[cyclobutanecarbonyl-(4-
MS[M+1]+: 595




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_132
V_13
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.413
A




{2-[cyclopentanecarbonyl-(4-
MS[M+1]+: 609




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_133
V_13
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.913
A




{2-[cyclopropanecarbonyl-(4-
MS[M+1]+: 581




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_134
V_13
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.794
A




{2-[(4-fluorophenyl)propionylamino]-
MS[M+1]+: 569




ethoxy}phenyl)propionic acid methyl




ester


IIa_135
V_13
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.038
A




{2-[(4-fluorophenyl)isobutyrylamino]-
MS[M+1]+: 583




ethoxy}phenyl)propionic acid methyl




ester


IIa_136
V_13
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.046
A




{2-[butyryl-(4-fluorophenyl)amino]-
MS[M+1]+: 583




ethoxy}phenyl)propionic acid methyl




ester


IIa_137
V_13
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.384
A




{2-[(2,2-dimethylpropionyl)-(4-
MS[M+1]+: 597




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_138
V_22
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.202
A




{3-[(2-methylacryloyl)-p-tolylamino]-
MS[M+1]+: 591




propoxy}phenyl)propionic acid




methyl ester


IIa_139
V_16
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.775
A




{2-[(2-ethylbutyryl)-p-tolylamino]-
MS[M+1]+: 607




ethoxy}phenyl)propionic acid methyl




ester


IIa_140
V_16
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.851
A




{2-[(3,3-dimethylbutyryl)-p-
MS[M+1]+: 607




tolylamino]ethoxy}phenyl)propionic




acid methyl ester


IIa_141
V_16
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.541
A




{2-[(3-methylbutyryl)-p-tolylamino]-
MS[M+1]+: 593




ethoxy}phenyl)propionic acid methyl




ester


IIa_142
V_22
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.674
A




{3-[(3-methylbutyryl)-p-tolylamino]-
MS[M+1]+: 607




propoxy}phenyl)propionic acid




methyl ester


IIa_143
V_16
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.472
A




[2-(cyclobutanecarbonyl-p-
MS[M+1]+: 591




tolylamino)ethoxy]phenyl}propionic




acid methyl ester


IIa_144
V_22
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.605
A




[3-(cyclobutanecarbonyl-p-
MS[M+1]+: 605




tolylamino)propoxy]phenyl}propionic




acid methyl ester


IIa_145
V_16
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.693
A




[2-(cyclopentanecarbonyl-p-
MS[M+1]+: 605




tolylamino)ethoxy]phenyl}propionic




acid methyl ester


IIa_146
V_22
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.208
A




[3-(propionyl-p-tolylamino)propoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_147
V_16
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.307
A




[2-(isobutyryl-p-tolylamino)ethoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_148
V_22
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.443
A




[3-(isobutyryl-p-tolylamino)propoxy]-
MS[M+1]+: 593




phenyl}propionic acid methyl ester


IIa_149
V_16
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.313
A




[2-(butyryl-p-tolylamino)ethoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_150
V_16
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.169
A




[2-(benzoyl-p-tolylamino)ethoxy]-
MS[M+1]+: 613




phenyl}propionic acid methyl ester


IIa_151
V_16
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.671
A




{2-[(2,2-dimethylpropionyl)-p-
MS[M+1]+: 593




tolylamino]ethoxy}phenyl)propionic




acid methyl ester


IIa_152
V_22
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.772
A




{3-[(2,2-dimethylpropionyl)-p-
MS[M+1]+: 607




tolylamino]propoxy}phenyl)propionic




acid methyl ester


IIa_153
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.4
A




{2-[benzyl(naphthalene-1-carbonyl)-
MS[M+1]+: 663




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_154
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.42
A




{2-[benzyl(naphthalene-2-carbonyl)-
MS[M+1]+: 663




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_155
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.532
A




{2-[benzyl(pyrazine-2-carbonyl)-
MS[M+1]+: 615




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_156
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.642
A




{3-[benzyl(pyrazine-2-carbonyl)-
MS[M+1]+: 629




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_157
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.693
A




{2-[benzyl(pyridine-2-carbonyl)-
MS[M+1]+: 614




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_158
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.90(d, 1H), 8.55,
A




{3-[benzyl(pyridine-2-carbonyl)-
8.45(2×d, 1H,




amino]propoxy}phenyl)propionic acid
rotamers mixture),




methyl ester
7.77-7.12(ca, 17H),





6.81-6.55(ca, 4H),





4.80, 4.69(2×s, 2H,





rotamers mixture),





4.39(q, 1H), 3.39,





3.76(2×t, 2H,





rotamers mixture),





3.70, 3.69(2×s, 3H,





rotamers mixture),





3.62, 3.58(2×t, 2H,





rotamers mixture),





3.20(dd, 1H), 3.10(m,





1H), 2.15-1.97(ca,





2H)


IIa_159
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.294
A




{2-[benzyl(quinoline-2-carbonyl)-
MS[M+1]+: 664




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_160
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.90(t, 1H), 8.21,
A




{3-[benzyl(quinoline-2-carbonyl)-
8.13(2×d, 1H, rotamers




amino]propoxy}phenyl)propionic acid
mixture), 8.04,




methyl ester
7.80(2×t, 2H, rotamers





mixture),





7.73-7.25(ca, 14H), 7.18,





7.06(2×d, 2H, rotamers





mixture), 6.82,





6.47(2×d, 2H, rotamers





mixture),





6.70-6.55(ca, 2H), 4.86,





4.79(2×s, 2H, rotamers





mixture), 4.37(q, 1H),





4.02, 3.77(2×t, 2H,





rotamers mixture),





3.69-3.64(ca, 5H),





3.25-3.05(ca, 2H),





2.20-2.04(ca, 2H)


IIa_161
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.119
A




{2-[benzyl(quinoxaline-2-carbonyl)-
MS[M+1]+: 665




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_162
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.211
A




{3-[benzyl(quinoxaline-2-carbonyl)-
MS[M+1]+: 679




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_163
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.07
A




{2-[benzyl(thiophene-2-carbonyl)-
MS[M+1]+: 619




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_164
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.193
A




{3-[benzyl(thiophene-2-carbonyl)-
MS[M+1]+: 633




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_165
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.815
A




{2-[benzyl(furan-3-carbonyl)amino]-
MS[M+1]+: 603




ethoxy}phenyl)propionic acid methyl




ester


IIa_166
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.907
A




{3-[benzyl(furan-3-carbonyl)amino]-
MS[M+1]+: 617




propoxy}phenyl)propionic acid




methyl ester


IIa_167
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.1
A




{2-[benzyl(isoquinoline-3-carbonyl)-
MS[M+1]+: 664




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_168
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
9.19, 9.10(2×s, 1H,
A




{3-[benzyl(isoquinoline-3-carbonyl)-
rotamers mixture),




amino]propoxy}phenyl)propionic acid
8.90(t, 1H), 8.07,




methyl ester
7.99(2×s, 1H, rotamers





mixture),





7.64-7.25(ca, 16H), 7.18,





7.05(2×d, 2H, rotamers





mixture), 6.82,





6.50(2×d, 2H, rotamers





mixture),





6.65-6.55(ca, 2H), 4.86,





4.76(2×s, 2H, rotamers





mixture), 4.37(m, 1H),





4.02, 3.77(2×t, 2H,





rotamers mixture),





3.69-3.60(ca, 5H),





3.25-3.05(ca, 2H),





2.20-2.04(ca, 2H)


IIa_169
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.90(d, 1H),
A




{2-benzyl(pyridine-3-carbonyl)-
8.78-8.62(ca, 2H), 7.83-7.73(m




amino]ethoxy}phenyl)propionic acid
1H), 7.59(d, 2H),




methyl ester
7.51-7.41(ca, 4H),





7.37-7.20(m, 9H),





6.85-6.72(ca, 2H),





6.65-6.56(ca, 2H),





4.87, 4.69(2×s, 2H,





rotamers mixture),





4.40(q, 1H),





4.25-3.58(ca, 7H), 3.25(dd,





1H), 3.10(dd, 1H)


IIa_170
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.90(d, 1H),
A




{3-[benzyl(pyridine-3-carbonyl)-
8.67-8.59(ca, 2H), 7.67-7.10(m




amino]propoxy}phenyl)propionic acid
16H), 6.81-6.55(ca,




methyl ester
4H), 4.80, 4.51(2×s,





2H, rotamers mixture),





4.39(q, 1H),





4.02-3.39(ca, 7H), 3.25(dd,





1H), 3.10(dd, 1H),





1.92-1.71(ca, 2H)


IIa_171
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
8.91(d, 1H), 7.59(d,
A




[2-(benzylphenylacetylamino)-
2H), 7.51-7.41(ca,




ethoxy]phenyl}propionic acid methyl
4H), 7.33-7.09(ca,




ester
13H), 6.78-6.70(ca,





2H), 6.65-6.55(ca,





2H), 4.71, 4.67(2×s,





2H, rotamers mixture),





4.39(q, 1H), 4.14,





3.88(2×t, 2H,





rotamers mixture),





3.92-3.60(ca, 7H),





3.26-3.08(ca, 2H)


IIa_172
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.26
A




[3-(benzylphenylacetylamino)-
MS[M+1]+: 641




propoxy]phenyl}propionic acid




methyl ester


IIa_173
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.865
A




{2-[benzyl-(2-methylacryloyl)amino]-
MS[M+1]+: 577




ethoxy}phenyl)propionic acid methyl




ester


IIa_174
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.948
A




{3-[benzyl-(2-methylacryloyl)amino]-
MS[M+1]+: 591




propoxy}phenyl)propionic acid




methyl ester


IIa_175
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.367
A




{2-[benzyl-(3-phenylpropynoyl)-
MS[M+1]+: 637




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_176
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.454
A




{3-[benzyl-(3-phenylpropynoyl)-
MS[M+1]+: 651




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_177
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.45
A




{2-[benzyl-(2-ethylbutyryl)amino]-
MS[M+1]+: 607




ethoxy}phenyl)propionic acid methyl




ester


IIa_178
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.511
A




{3-[benzyl-(2-ethylbutyryl)amino]-
MS[M+1]+: 621




propoxy}phenyl)propionic acid




methyl ester


IIa_179
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.087
A




{2-[benzyl-(3-methylbut-2-(E)-enoyl)-
MS[M+1]+: 591




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_180
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.187
A




{3-[benzyl-(3-methylbut-2-(E)-enoyl)-
MS[M+1]+: 605




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_181
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.027
A




{2-[benzyl-(3-furan-2-ylacryloyl)-
MS[M+1]+: 629




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_182
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.12
A




{3-[benzyl-(3-furan-2-ylacryloyl)-
MS[M+1]+: 643




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_183
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.19
A




{2-[benzyl-(3-thiophen-2-ylacryloyl)-
MS[M+1]+: 645




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_184
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.304
A




{3-[benzyl-(3-thiophen-2-ylacryloyl)-
MS[M+1]+: 659




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_185
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.889
A




{2-[benzyl-(3-furan-3-yl-(E)-acryloyl)-
MS[M+1]+: 629




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_186
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.005
A




{3-[benzyl-(3-furan-3-yl-(E)-acryloyl)-
MS[M+1]+: 643




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_187
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.097
A




{2-[benzyl-(3-pyridin-3-yl-(E)-
MS[M+1]+: 640




acryloyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_188
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.245
A




{3-[benzyl-(3-pyridin-3-yl-(E)-
MS[M+1]+: 654




acryloyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_189
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.105
A




{2-[benzyl-(3-thiophen-3-yl-(E)-
MS[M+1]+: 645




acryloyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_190
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.214
A




{3-[benzyl-(3-thiophen-3-yl-(E)-
MS[M+1]+: 659




acryloyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_191
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.808
A




[2-(benzylbut-2-(E)-enoylamino)-
MS[M+1]+: 577




ethoxy]phenyl}propionic acid methyl




ester


IIa_192
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.336
A




[3-(benzylbut-2-(E)-enoylamino)-
MS[M+1]+: 607




propoxy]phenyl}propionic acid




methyl ester


IIa_193
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.093
A




{2-[benzyl-(2-thiophen-2-ylacetyl)-
MS[M+1]+: 633




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_194
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.90(d, 1H), 7.59(d,
A




{3-[benzyl-(2-thiophen-2-ylacetyl)-
2H), 7.50-7.43(m 4H),




amino]propoxy}phenyl)propionic acid
7.36-7.10(m, 9H),




methyl ester
6.91-6.74(ca, 4H),





6.64-6.58(ca, 2H),





4.63, 4.56(2×s, 2H,





rotamers mixture),





4.38(q, 1H), 3.98,





3.86(2×s, 2H,





rotamers mixture),





3.92-3.85(ca, 2H),





3.69(s, 3H), 3.56,





3.47(2×t, 2H,





rotamers mixture),





3.25-3.06(ca, 2H),





2.06-1.90(ca, 2H)


IIa_195
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.90(d, 1H),
A




{2-[benzyl-(2-pyridin-3-ylacetyl)-
8.52-8.34(ca, 2H), 7.61-7.14(m




amino]ethoxy}phenyl)propionic acid
16H), 6.83-6.74(ca,




methyl ester
2H), 6.65-6.56(ca,





2H), 4.74, 4.70(2×s,





2H, rotamers mixture),





4.40(q, 1H), 4.15,





3.98(2×t, 2H,





rotamers mixture),





3.93-3.66(ca, 7H),





3.26-3.00(ca, 2H)


IIa_196
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.90(d, 1H),
A




{3-[benzyl-(2-pyridin-3-ylacetyl)-
8.48-8.37(ca, 2H),




amino]propoxy}phenyl)propionic acid
7.61-7.13(m 16H),




methyl ester
6.81-6.74(ca, 2H),





6.64-6.55(ca, 2H), 4.63,





4.57(2×s, 2H,





rotamers mixture),





4.38(q, 1H),





3.92-3.88(ca, 2H),





3.78-3.65(ca, 5H), 3.58,





3.48(2×t, 2H, rotamers





mixture),





3.25-3.06(ca, 2H),





2.06-1.94(ca, 2H)


IIa_197
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.076
A




{2-[benzyl-(2-thiophen-3-ylacetyl)-
MS[M+1]+: 633




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_198
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.90(d, 1H), 7.59(d,
A




{3-[benzyl-(2-thiophen-3-ylacetyl)-
2H), 7.51-7.43(m 4H),




amino]propoxy}phenyl)propionic acid
7.36-6.97(ca, 11H),




methyl ester
6.79-6.73(ca, 2H),





6.64-6.55(ca, 2H),





4.62, 4.52(2×s, 2H,





rotamers mixture),





4.38(q, 1H),





3.91-3.85(ca, 2H),





3.80-3.69(ca, 5H), 3.54,





3.45(2×t, 2H, rotamers





mixture),





3.25-3.12(ca, 2H),





2.05-1.89(ca, 2H)


IIa_199
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.502
A




{2-[benzyl-(3,3-dimethylbutyryl)-
MS[M+1]+: 607




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_200
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.594
A




{3-[benzyl-(3,3-dimethylbutyryl)-
MS[M+1]+: 621




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_201
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.243
A




{2-[benzyl-(3-methylbutyryl)-amino]-
MS[M+1]+: 593




ethoxy}phenyl)propionic acid methyl




ester


IIa_202
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.324
A




{3-[benzyl-(3-methylbutyryl)amino]-
MS[M+1]+: 607




propoxy}phenyl)propionic acid




methyl ester


IIa_203
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.90(d, 1H),
A




{2-[benzyl-(3-pyridin-3-ylpropionyl)-
8.58-8.39(ca, 2H), 7.59(d, 2H),




amino]ethoxy}phenyl)propionic acid
7.49-7.05(ca, 14H),




methyl ester
6.79-6.56(ca, 4H),





4.68, 4.63(2×s, 2H,





rotamers mixture),





4.39(q, 1H), 4.11,





3.90(2×t, 2H,





rotamers mixture),





3.75-3.57(ca, 5H),





3.21(dd, 1H), 3.10(m,





1H), 3.96, 2.95(2×t,





2H, rotamers mixture),





2.84, 2.62(2×t, 2H,





rotamers mixture)


IIa_204
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.131
A




{3-[benzyl-(3-pyridin-3-ylpropionyl)-
MS[M+1]+: 656




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_205
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.064
A




[2-(benzylpent-4-enoylamino)-
MS[M+1]+: 591




ethoxy]phenyl}propionic acid methyl




ester


IIa_206
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.159
A




[3-(benzylpent-4-enoylamino)-
MS[M+1]+: 605




propoxy]phenyl}propionic acid




methyl ester


IIa_207
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.368
A




{2-[benzyl-(3-phenylpropionyl)-
MS[M+1]+: 641




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_208
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.90(d, 1H), 7.59(d,
A




{3-[benzyl-(3-phenylpropionyl)-
2H), 7.50-7.04(ca,




amino]propoxy}phenyl)propionic acid
14H), 6.78-6.71(ca,




methyl ester
2H), 6.64-6.55(ca,





2H), 4.61, 4.43(2×s,





2H, rotamers mixture),





4.38(q, 1H), 3.88,





3.82(2×t, 2H,





rotamers mixture),





3.69(s, 3H), 3.52,





3.36(2×t, 2H,





rotamers mixture),





3.21(dd, 1H),





3.10(dd, 1H),





3.02-2.90(ca, 2H), 2.72,





2.61(2×t, 2H, rotamers





mixture), 2.03,





1.88(2×t, 2H, rotamers





mixture)


IIa_209
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.19
A




[2-
MS[M+1]+: 591




(benzylcyclobutanecarbonylamino)-




ethoxy]phenyl}propionic acid methyl




ester


IIa_210
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.596
A




[3-
MS[M+1]+: 621




(benzylcyclobutanecarbonylamino)-




propoxy]phenyl}propionic acid




methyl ester


IIa_211
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.536
A




[2-
MS[M+1]+: 619




(benzylcyclohexanecarbonylamino)-




ethoxy]phenyl}propionic acid methyl




ester


IIa_212
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.624
A




[3-
MS[M+1]+: 633




(benzylcyclohexanecarbonylamino)-




propoxy]phenyl}propionic acid




methyl ester


IIa_213
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.056
A




{2-[benzyl-(3-cyclohexylpropionyl)-
MS[M+1]+: 647




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_214
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.90(d, 1H), 7.59(d,
A




{3-[benzyl-(3-cyclohexylpropionyl)-
2H), 7.51-7.41(ca,




amino]propoxy}phenyl)propionic acid
4H), 7.31-7.13(ca,




methyl ester
8H), 6.78(d, 2H),





6.64-6.55(ca, 2H),





4.60, 4.52(2×s, 2H,





rotamers mixture),





4.38(q, 1H),





3.93-3.86(ca, 2H), 3.69(s, 3H),





3.52, 3.42(2×t, 2H,





rotamers mixture),





3.25-3.08(ca, 2H),





2.43-2.29(ca, 2H),





2.04-1.92(ca, 2H),





1.69-1.48(ca, 13H)


IIa_215
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.828
A




{2-[benzyl-(2-cyclohexylacetyl)-
MS[M+1]+: 633




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_216
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.90(d, 1H), 7.59(d,
A




{3-[benzyl-(2-cyclohexylacetyl)-
2H), 7.51-7.41(ca,




amino]propoxy}phenyl)propionic acid
4H), 7.33-7.12(ca,




methyl ester
8H), 6.77(d, 2H),





6.64-6.55(ca, 2H),





4.61, 4.53(2×s, 2H,





rotamers mixture),





4.38(q, 1H),





3.93-3.85(ca, 2H), 3.69(s, 3H),





3.51, 3.44(2×t, 2H,





rotamers mixture),





3.25-3.08(ca, 2H),





2.26, 2.18(2×d, 2H,





rotamers mixture),





2.04-1.92(ca, 3H),





1.80-1.64(ca, 10H)


IIa_217
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
8.90(d, 1H), 7.59(d,
A




[2-
2H), 7.51-7.44(ca,




(benzylcyclopentanecarbonylamino)-
4H), 7.36-7.14(ca,




ethoxy]phenyl}propionic acid methyl
8H), 6.79-6.73(ca,




ester
2H), 6.64-6.55(ca,





2H), 4.75, 4.69(2×s,





2H, rotamers mixture),





4.38(q, 1H), 4.11,





3.96(2×t, 2H,





rotamers mixture),





3.75-3.65(ca, 5H),





3.24-3.08(ca, 2H),





2.75(m, 1H),





1.87-1.74(ca, 8H)


IIa_218
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
8.90(d, 1H), 7.59(d,
A




[3-
2H), 7.51-7.41(ca,




(benzylcyclopentanecarbonylamino)-
4H), 7.33-7.13(ca,




propoxy]phenyl}propionic acid
8H), 6.77(d, 2H),




methyl ester
6.64-6.55(ca, 2H),





4.61, 4.59(2×s, 2H,





rotamers mixture),





4.38(q, 1H),





3.93-3.87(ca, 2H), 3.69(s,





3H), 3.53-3.44(ca,





2H), 3.25-3.10(ca,





2H), 2.75(m, 1H),





1.99-1.74(ca, 10H)


IIa_219
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.814
A




{2-[benzyl-(3-cyclopentylpropionyl)-
MS[M+1]+: 633




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_220
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.246
A




{3-[benzyl-(3-cyclopentylpropionyl)-
MS[M+1]+: 605




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_221
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.885
A




[2-
MS[M+1]+: 577




(benzylcyclopropanecarbonylamino)-




ethoxy]phenyl}propionic acid methyl




ester


IIa_222
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.969
A




[3-
MS[M+1]+: 591




(benzylcyclopropanecarbonylamino)-




propoxy]phenyl}propionic acid




methyl ester


IIa_223
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.784
A




[2-(benzylpropionylamino)ethoxy]-
MS[M+1]+: 565




phenyl}propionic acid methyl ester


IIa_224
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.858
A




[3-(benzylpropionylamino)propoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_225
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.02
A




[2-(benzylisobutyrylamino)ethoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_226
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.091
A




[3-(benzylisobutyrylamino)propoxy]-
MS[M+1]+: 593




phenyl}propionic acid methyl ester


IIa_227
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.511
A




[2-(benzylhexanoylamino)ethoxy]-
MS[M+1]+: 607




phenyl}propionic acid methyl ester


IIa_228
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.108
A




[3-(benzylhexanoylamino)propoxy]-
MS[M+]+: 593




phenyl}propionic acid methyl ester


IIa_229
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.261
A




[2-(benzylpentanoylamino)ethoxy]-
MS[M+1]+: 593




phenyl}propionic acid methyl ester


IIa_230
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.337
A




[3-(benzylpentanoylamino)propoxy]-
MS[M+1]+: 607




phenyl}propionic acid methyl ester


IIa_231
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.027
A




[2-(benzyloctanoylamino)ethoxy]-
MS[M+1]+: 635




phenyl}propionic acid methyl ester


IIa_232
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.092
A




[3-(benzyloctanoylamino)propoxy]-
MS[M+1]+: 649




phenyl}propionic acid methyl ester


IIa_233
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.763
A




[2-(benzylheptanoylamino)ethoxy]-
MS[M+1]+: 621




phenyl}propionic acid methyl ester


IIa_234
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.829
A




[3-(benzylheptanoylamino)propoxy]-
MS[M+1]+: 635




phenyl}propionic acid methyl ester


IIa_235
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.341
A




[2-(benzylnonanoylamino)ethoxy]-
MS[M+1]+: 649




phenyl}propionic acid methyl ester


IIa_236
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.403
A




[3-(benzylnonanoylamino)propoxy]-
MS[M+1]+: 663




phenyl}propionic acid methyl ester


IIa_237
V_1
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.045
A




[2-(benzylbutyrylamino)ethoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_238
V_2
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.873
A




[3-(benzylbutyrylamino)propoxy]-
MS[M+1]+: 647




phenyl}propionic acid methyl ester


IIa_239
V_1
(S)-3-{4-[2-(Benzoylbenzylamino)-
8.90(d, 1H), 7.59(d,
A




ethoxy]phenyl}-2-(2-
2H), 7.51-7.15(ca,




benzoylphenylamino)propionic acid
17H), 6.85-6.56(ca,




methyl ester
4H), 4.87, 4.67(2×s,





2H, rotamers mixture),





4.39(q, 1H),





4.24-3.56(ca, 7H),





3.25-3.08(ca, 2H)


IIa_240
V_2
(S)-3-{4-[3-(Benzoylbenzylamino)-
8.90(bs, 1H), 7.59(d,
A




propoxy]phenyl}-2-(2-
2H), 7.51-7.14(ca,




benzoylphenylamino)propionic acid
17H), 6.83-6.55(ca,




methyl ester
4H), 4.80, 4.51(2×s,





2H, rotamers mixture),





4.38(m, 1H),





4.00-3.38(ca, 7H),





3.23(dd, 1H), 3.11(dd, 1H)


IIa_241
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.90(d, 1H), 7.77(m,
A




{2-[benzyl-(3-phenylacryloyl)amino]-
1H), 7.59(d, 2H),




ethoxy}phenyl)propionic acid methyl
7.50-7.05(ca, 18H),




ester
6.85-6.73(ca, 2H),





6.64-6.55(ca, 2H),





4.86, 4.81(2×s, 2H,





rotamers mixture),





4.38(q, 1H), 4.20,





4.03(2×t, 2H,





rotamers mixture),





3.85-3.68(ca, 5H),





3.23-3.08(ca, 2H)


IIa_242
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.91(d, 1H), 7.75(m,
A




{3-[benzyl-(3-phenylactyloyl)amino]-
1H), 7.59-7.16(ca,




propoxy}phenyl)propionic acid
19H), 7.03-6.79(ca,




methyl ester
2H), 6.64-6.55(ca,





2H), 4.73, 4.69(2×s,





2H, rotamers mixture),





4.38(q, 1H),





3.98-3.91(ca, 2H),





3.69-3.59(ca, 5H),





3.23-3.08(ca, 2H),





2.12-2.01(ca, 2H)


IIa_243
V_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.363
A




{2-[benzyl-(2,2-dimethylpropionyl)-
MS[M+1]+: 593




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_244
V_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.411
A




{3-[benzyl-(2,2-dimethylpropionyl)-
MS[M+1]+: 607




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_245
V_3
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.408
A




{2-[cyclohexyl-(3-furan-2-ylacryloyl)-
MS[M+1]+: 621




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_246
V_3
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.655
A




[2-
MS[M+1]+: 583




(cyclobutanecarbonylcyclohexylamino)




ethoxy]phenyl}propionic acid




methyl ester


IIa_247
V_3
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.336
A




{2-[cyclohexyl-(3-
MS[M+1]+: 625




cyclopentylpropionyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_248
V_3
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.459
A




[2-(butyrylcyclohexylamino)ethoxy]-
MS[M+1]+: 571




phenyl}propionic acid methyl ester


IIa_249
V_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.272
A




{2-[cyclopropylmethyl(naphthalene-
MS[M+1]+: 627




2-carbonyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_250
V_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.351
A




{3-[cyclopropylmethyl(naphthalene-
MS[M+1]+: 641




2-carbonyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_251
V_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.005
A




{2-[cyclopropylmethyl(quinoline-2-
MS[M+1]+: 628




carbonyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_252
V_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.065
A




{3-[cyclopropylmethyl(quinoline-2-
MS[M+1]+: 642




carbonyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_253
V_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.896
A




{2-[cyclopropylmethyl(quinoxaline-2-
MS[M+1]+: 629




carbonyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_254
V_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.003
A




{3-[cyclopropylmethyl(quinoxaline-2-
MS[M+1]+: 643




carbonyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_255
V_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.871
A




{2-[cyclopropylmethyl(thiophene-2-
MS[M+1]+: 583




carbonyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_256
V_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.976
A




{3-[cyclopropylmethyl(thiophene-2-
MS[M+1]+: 597




carbonyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_257
V_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.92
A




{2-[cyclopropylmethyl(pyridine-3-
MS[M+1]+: 578




carbonyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_258
V_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.062
A




{3-[cyclopropylmethyl(pyridine-3-
MS[M+1]+: 592




carbonyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_259
V_5
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.958
A




[2-
MS[M+1]+: 591




(cyclopropylmethylphenylacetylamino)




ethoxy]phenyl}propionic acid




methyl ester


IIa_260
V_6
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.053
A




[3-
MS[M+1]+: 605




(cyclopropylmethylphenylacetylamino)




propoxy]phenyl}propionic acid




methyl ester


IIa_261
V_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.833
A




{2-[cyclopropylmethyl-(3-furan-2-
MS[M+1]+: 593




ylacryloyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_262
V_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.934
A




{3-[cyclopropylmethyl-(3-furan-2-
MS[M+1]+: 607




ylacryloyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_263
V_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.003
A




{2-[cyclopropylmethyl-(3-thiophen-2-
MS[M+1]+: 609




ylacryloyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_264
V_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.11
A




{3-[cyclopropylmethyl-(3-thiophen-2-
MS[M+1]+: 623




ylacryloyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_265
V_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.864
A




{2-[cyclopropylmethyl-(2-thiophen-2-
MS[M+1]+: 597




ylacetyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_266
V_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.96
A




{3-[cyclopropylmethyl-(2-thiophen-2-
MS[M+1]+: 611




ylacetyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_267
V_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.836
A




{2-[cyclopropylmethyl-(2-thiophen-3-
MS[M+1]+: 597




ylacetyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_268
V_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.929
A




{3-[cyclopropylmethyl-(2-thiophen-3-
MS[M+1]+: 611




ylacetyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_269
V_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 6.894
A




{2-[cyclopropylmethyl-(3-pyridin-3-
MS[M+1]+: 606




ylpropionyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_270
V_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 6.961
A




{3-[cyclopropylmethyl-(3-pyridin-3-
MS[M+1]+: 620




ylpropionyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_271
V_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.169
A




{2-[cyclopropylmethyl-(3-
MS[M+1]+: 605




phenylpropionyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_272
V_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.244
A




{3-[cyclopropylmethyl-(3-
MS[M+1]+: 619




phenylpropionyl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_273
V_5
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.977
A




[2-
MS[M+1]+: 555




(cyclobutanecarbonylcyclopropylmethylamino)




ethoxy]phenyl}propionic




acid methyl ester


IIa_274
V_6
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.059
A




[3-
MS[M+1]+: 569




(cyclobutanecarbonylcyclopropylmethylamino)




propoxy]phenyl}propionic




acid methyl ester


IIa_275
V_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.641
A




{2-[(2-cyclohexylacetyl)-
MS[M+1]+: 597




cyclopropylmethylamino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_276
V_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.707
A




{3-[(2-cyclohexylacetyl)-
MS[M+1]+: 611




cyclopropylmethylamino]propoxy}-




phenyl)propionic acid methyl ester


IIa_277
V_5
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.201
A




[2-
MS[M+1]+: 569




(cyclopentanecarbonylcyclopropylmethylamino)




ethoxy]phenyl}propionic




acid methyl ester


IIa_278
V_6
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.285
A




[3-
MS[M+1]+: 583




(cyclopentanecarbonylcyclopropylmethylamino)




propoxy]phenyl}propionic




acid methyl ester


IIa_279
V_5
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.641
A




[2-
MS[M+1]+: 541




(cyclopropanecarbonylcyclopropylmethylamino)




ethoxy]phenyl}propaonic




acid methyl ester


IIa_280
V_6
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.747
A




[3-
MS[M+1]+: 555




(cyclopropanecarbonylcyclopropylmethylamino)




propoxy]phenyl}propaonic




acid methyl ester


IIa_281
V_5
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.525
A




[2-
MS[M+1]+: 529




(cyclopropylmethylpropionylamino)-




ethoxy]phenyl}propionic acid methyl




ester


IIa_282
V_6
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.626
A




[3-
MS[M+1]+: 543




(cyclopropylmethylpropionylamino)-




propoxy]phenyl}propionic acid




methyl ester


IIa_283
V_5
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.791
A




[2-
MS[M+1]+: 543




(cyclopropylmethylisobutyrylamino)-




ethoxy]phenyh}propionic acid methyl




ester


IIa_284
V_6
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.895
A




[3
MS[M+1]+: 557




(cyclopropylmethylisobutyrylamino)-




propoxy]phenyl}propionic acid




methyl ester


IIa_285
V_5
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.813
A




[2-(butyrylcyclopropylmethylamino)-
MS[M+1]+: 543




ethoxy]phenyl}propionic acid methyl




ester


IIa_286
V_6
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.903
A




[3-(butyrylcyclopropylmethylamino)-
MS[M+1]+: 557




propoxy]phenyl}propionic acid




methyl ester


IIa_287
V_5
(S)-3-{4-[2-
rt: 8.858
A




(Benzoylcyclopropylmethylamino)-
MS[M+1]+: 577




ethoxy]phenyl}-2-(2-




benzoylphenylamino)propionic acid




methyl ester


IIa_288
V_6
(S)-3-{4-[3-
rt: 8.958
A




(Benzoylcyclopropylmethylamino)-
MS[M+1]+: 591




propoxy]phenyl}-2-(2-




benzoylphenylamino)propionic acid




methyl ester


IIa_289
V_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.085
A




{2-[cyclopropylmethyl-(3-
MS[M+1]+: 602




phenylacryloyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_290
V_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.182
A




{3-[cyclopropylmethyl-(3-
MS[M+1]+: 617




phenylacryloyl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_291
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.13
A




{2-[(naphthalene-1-carbonyl)-
MS[M+1]+: 649




phenylamino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_292
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.283
A




{3-[(naphthalene-1-carbonyl)-
MS[M+1]+: 663




phenylamino]propoxy}phenyl)-




propionic acid methyl ester


IIa_293
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.315
A




{2-[(naphthalene-2-carbonyl)-
MS[M+1]+: 649




phenylamino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_294
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.429
A




{3-[(naphthalene-2-carbonyl)-
MS[M+1]+: 663




phenylamino]propoxy}phenyl)-




propionic acid methyl ester


IIa_295
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.904
A




{2-[phenyl(quinoline-2-carbonyl)-
MS[M+1]+: 650




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_296
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.023
A




{3-[phenyl(quinoline-2-carbonyl)-
MS[M+1]+: 664




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_297
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.817
A




{2-[phenyl(quinoxaline-2-carbonyl)-
MS[M+1]+: 651




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_298
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.976
A




{3-[phenyl(quinoxaline-2-carbonyl)-
MS[M+1]+: 665




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_299
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.049
A




{2-[phenyl(thiophene-2-carbonyl)-
MS[M+1]+: 605




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_300
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.155
A




{3-[phenyl(thiophene-2-carbonyl)-
MS[M+1]+: 619




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_301
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.746
A




{2-[(isoquinoline-3-carbonyl)-
MS[M+1]+: 650




phenylamino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_302
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.086
A




{2-[phenyl(pyridine-3-carbonyl)-
MS[M+1]+: 600




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_303
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.264
A




{3-[phenyl(pyridine-3-carbonyl)-
MS[M+1]+: 614




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_304
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.934
A




{2-[phenyl(pyridine-4-carbonyl)-
MS[M+1]+: 600




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_305
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.124
A




{3-[phenyl(pyridine-4-carbonyl)-
MS[M+1]+: 614




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_306
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.22
A




[2-(phenylphenylacetylamino)-
MS[M+1]+: 613




ethoxy]phenyl}propionic acid methyl




ester


IIa_307
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.363
A




[3-(phenylphenylacetylamino)-
MS[M+1]+: 627




propoxy]phenyl}propionic acid




methyl ester


IIa_308
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.799
A




{2-[(2-methylacryloyl)phenylamino]-
MS[M+1]+: 563




ethoxy}phenyl)propionic acid methyl




ester


IIa_309
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.943
A




{3-[(2-methylacryloyl)phenylamino]-
MS[M+1]+: 577




propoxy}phenyl)propionic acid




methyl ester


IIa_310
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.245
A




{2-[phenyl-(3-phenylpropynoyl)-
MS[M+1]+: 615




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_311
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.5
A




{2-[(2-ethylbutyryl)phenylamino]-
MS[M+1]+: 593




ethoxy}phenyl)propionic acid methyl




ester


IIa_312
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.628
A




{3-[(2-ethylbutyryl)phenylamino]-
MS[M+1]+: 607




propoxy}phenyl)propionic acid




methyl ester


IIa_313
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.025
A




{2-[(3-furan-2-ylacryloyl)-
MS[M+1]+: 615




phenylamino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_314
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.164
A




{3-[(3-furan-2-ylacryloyl)-
MS[M+1]+: 629




phenylamino]propoxy}phenyl)-




propionic acid methyl ester


IIa_315
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.267
A




{2-[phenyl-(3-thiophen-2-ylacryloyl)-
MS[M+1]+: 631




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_316
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.394
A




{3-[phenyl-(3-thiophen-2-ylacryloyl)-
MS[M+1]+: 645




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_317
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.954
A




{2-[(3-furan-3-yl-(E)-acryloyl)-
MS[M+1]+: 615




phenylamino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_318
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.091
A




{3-[(3-furan-3-yl-(E)-acryloyl)-
MS[M+1]+: 629




phenylamino]propoxy}-phenyl)-




propionic acid methyl ester


IIa_319
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.103
A




{2-[phenyl-(3-pyridin-3-yl-(E)-
MS[M+1]+: 626




acryloyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_320
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.293
A




{3-[phenyl-(3-pyridin-3-yl-(E)-
MS[M+1]+: 640




acryloyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_321
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.213
A




{2-[phenyl-(3-thiophen-3-yl-(E)-
MS[M+1]+: 631




acryloyl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_322
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.334
A




{3-[phenyl-(3-thiophen-3-yl-(E)-
MS[M+1]+: 645




acryloyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_323
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9
A




[3-(but-2-(E)-enoylphenylamino)-
MS[M+1]+: 577




propoxy]phenyl}propionic acid




methyl ester


IIa_324
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.132




{2-[phenyl-(2-thiophen-2-ylacetyl)-
MS[M+1]+: 619




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_325
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.295
A




{3-[phenyl-(2-thiophen-2-ylacetyl)-
MS[M+1]+: 633




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_326
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.23
A




{3-[phenyl-(2-thiophen-3-ylacetyl)-
MS[M+1]+: 633




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_327
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.587
A




{2-[(3,3-dimethylbutyryl)-
MS[M+1]+: 593




phenylamino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_328
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.706
A




{3[(3,3-dimethylbutryl)-
MS[M+1]+: 607




phenylamino]propoxy}phenyl)-




propionic acid methyl ester


IIa_329
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.271
A




{2-[(3-methylbutyryl)phenylamino]-
MS[M+1]+: 579




ethoxy}phenyl)propionic acid methyl




ester


IIa_330
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.401
A




{3-[(3-methylbutyryl)phenylamino]-
MS[M+1]+: 593




propoxy}phenyl)propionic acid




methyl ester


IIa_331
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.038
A




{2-[phenyl-(3-pyridin-3-ylpropionyl)-
MS[M+1]+: 627




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_332
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.229
A




{3-[phenyl-(3-pyridin-3-ylpropionyl)-
MS[M+1]+: 641




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_333
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.078
A




[2-(pent-4-enoylphenylamino)-
MS[M+1]+: 577




ethoxy]phenyl}propionic acid methyl




ester


IIa_334
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.212
A




[3-(pent-4-enoylphenylamino)-
MS[M+1]+: 591




propoxy]phenyl}propionic acid




methyl ester


IIa_335
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.369
A




{2-[phenyl-(3-phenylpropionyl)-
MS[M+1]+: 627




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_336
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.494
A




{3-[phenyl-(3-phenylpropionyl)-
MS[M+1]+: 641




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_337
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.203
A




[2-
MS[M+1]+: 577




(cyclobutanecarbonylphenylamino)-




ethoxy]phenyl}propionic acid methyl




ester


IIa_338
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.333
A




[3-
MS[M+1]+: 591




(cyclobutanecarbonylphenylamino)-




propoxy]phenyl}propionic acid




methyl ester


IIa_339
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.602
A




[2-
MS[M+1]+: 605




(cyclohexanecarbonylphenylamino)-




ethoxy]phenyl}propionic acid methyl




ester


IIa_340
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.708
A




[3-
MS[M+1]+: 619




(cyclohexanecarbonylphenylamino)-




propoxy]phenyl}propionic acid




methyl ester


IIa_341
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.166
A




{2-[(3-cyclohexylpropionyl)-
MS[M+1]+: 633




phenylamino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_342
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.282
A




{3-[(3-cyclohexylpropionyl)-
MS[M+1]+: 647




phenylamino]propoxy}phenyl)-




propionic acid methyl ester


IIa_343
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.883
A




{2-[(2-cyclohexylacetyl)-
MS[M+1]+: 619




phenylamino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_344
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10
A




{3-[(2-cyclohexylacetyl)-
MS[M+1]+: 633




phenylamino]propoxy}phenyl)-




propionic acid methyl ester


IIa_345
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.463
A




[2-
MS[M+1]+: 591




(cyclopentanecarbonylphenylamino)-




ethoxy]phenyl}propionic acid methyl




ester


IIa_346
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.582
A




[3-
MS[M+1]+: 605




(cyclopentanecarbonylphenylamino)-




propoxy]phenyl}propionic acid




methyl ester


IIa_347
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.87
A




{2-[(3-cyclopentylpropionyl)-
MS[M+1]+: 619




phenylamino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_348
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.98
A




{3-[(3-cyclopentylpropionyl)-
MS[M+1]+: 633




phenylamino]propoxy}phenyl)-




propionic acid methyl ester


IIa_349
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.91
A




[2-
MS[M+1]+: 563




(cyclopropanecarbonylphenylamino)-




ethoxy]phenyl}propionic acid methyl




ester


IIa_350
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.06
A




[3-
MS[M+1]+: 577




(cyclopropanecarbonylphenylamino)-




propoxy]phenyl}propionic acid




methyl ester


IIa_351
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.78
A




[2-(phenylpropionylamino)ethoxy]-
MS[M+1]+: 551




phenyl}propionic acid methyl ester


IIa_352
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.925
A




[3-(phenylpropionylamino)propoxy]-
MS[M+1]+: 565




phenyl}propionic acid methyl ester


IIa_353
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.033
A




[2-(isobutyrylphenylamino)ethoxy]-
MS[M+1]+: 565




phenyl}propionic acid methyl ester


IIa_354
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.168
A




[3-(isobutyrylphenylamino)propoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_355
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.56
A




[2-(hexanoylphenylamino)ethoxy]-
MS[M+1]+: 593




phenyl}propionic acid methyl ester


IIa_356
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.671
A




[3-(hexanoylphenylamino)propoxy]-
MS[M+1]+: 607




phenyl}propionic acid methyl ester


IIa_357
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.298
A




[2-(pentanoylphenylamino)ethoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_358
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.421
A




[3-(pentanoylphenylamino)propoxy]-
MS[M+1]+: 593




phenyl}propionic acid methyl ester


IIa_359
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.11
A




[2-(octanoylphenylamino)ethoxy]-
MS[M+1]+: 621




phenyl}propionic acid methyl ester


IIa_360
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.224
A




[3-(octanoylphenylamino)propoxy]-
MS[M+1]+: 635




phenyl}propionic acid methyl ester


IIa_361
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.825
A




[2-(heptanoylphenylamino)ethoxy]-
MS[M+1]+: 607




phenyl}propionic acid methyl ester


IIa_362
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.933
A




[3-(heptanoylphenylamino)propoxy]-
MS[M+1]+: 621




phenyl}propionic acid methyl ester


IIa_363
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.455
A




[2-(nonanoylphenylamino)ethoxy]-
MS[M+1]+: 635




phenyl}propionic acid methyl ester


IIa_364
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 10.588
A




[3-(nonanoylphenylamino)propoxy]-
MS[M+1]+: 649




phenyl}propionic acid methyl ester


IIa_365
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.043
A




[2-(butyrylphenylamino)ethoxy]-
MS[M+1]+: 565




phenyl}propionic acid methyl ester


IIa_366
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.18
A




[3-(butyrylphenylamino)propoxy]-
MS[M+1]+: 579




phenyl}propionic acid methyl ester


IIa_367
V_9
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.97
A




[2-(benzoylphenylamino)ethoxy]-
MS[M+1]+: 599




phenyl}propionic acid methyl ester


IIa_368
V_10
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.121
A




[3-(benzoylphenylamino)propoxy]-
MS[M+1]+: 613




phenyl}propionic acid methyl ester


IIa_369
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.383
A




{2-[phenyl-(3-phenylacryloyl)amino]-
MS[M+1]+: 625




ethoxy}phenyl)propionic acid methyl




ester


IIa_370
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.51
A




{3-[phenyl-(3-phenylacryloyl)amino]-
MS[M+1]+: 639




propoxy}phenyl)propionic acid




methyl ester


IIa_371
V_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.402
A




{2-[(2,2-dimethylpropionyl)-
MS[M+1]+: 579




phenylamino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_372
V_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.5
A




{3-[(2,2-dimethylpropionyl)-
MS[M+1]+: 593




phenylamino]propoxy}phenyl)-




propionic acid methyl ester


IIa_373
V_4
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.256
A




[2-(tert-
MS[M+1]+: 557




butylcyclobutanecarbonylamino)-




ethoxy]phenyl}propionic acid methyl




ester


IIa_374
V_4
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.917
A




{2-[tert-butyl-(3-
MS[M+1]+: 599




cyclopentylpropionyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_375
V_26
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.214
A




{2-[(2-methylacryloyl)naphthalen-1-
MS[M+1]+: 613




ylamino]ethoxy}phenyl)propionic




acid methyl ester


IIa_376
V_26
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.276
A




[2-(but-2-(E)-enoylnaphthalen-1-
MS[M+1]+: 613




ylamino)ethoxy]phenyl}propionic




acid methyl ester


IIa_377
V_26
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.336
A




[2-
MS[M+1]+: 613




(cyclopropanecarbonylnaphthalen-1-




ylamino)ethoxy]phenyl}propionic




acid methyl ester


IIa_378
V_26
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.273
A




[2-(naphthalen-1-ylpropionylamino)-
MS[M+1]+: 601




ethoxy]phenyl}propionic acid methyl




ester


IIa_379
V_30
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.261
A




{2-[(2-methylacryloyl)naphthalen-2-
MS[M+1]+: 613




ylamino]ethoxy}phenyl)propionic




acid methyl ester


IIa_380
V_30
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.355
A




[2-(but-2-(E)-enoylnaphthalen-2-
MS[M+1]+: 613




ylamino)ethoxy]phenyl}propionic




acid methyl ester


IIa_381
V_30
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.269
A




[2-(naphthalen-2-ylpropionylamino)-
MS[M+1]+: 601




ethoxy]phenyl}propionic acid methyl




ester


IIa_382
V_30
(S)-3-{4-[2-(Acetylnaphthalen-2-
rt: 8.914
A




ylamino)ethoxy]phenyl}-2-(2-
MS[M+1]+: 587




benzoylphenylamino)propionic acid




methyl ester


IIa_383
V_27
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.054
A




{2-[(2-methylacryloyl)-(3-
MS[M+1]+: 609




methylsulfanylphenyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_384
V_27
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.126
A




{2-[but-2-(E)-enoyl-(3-
MS[M+1]+: 609




methylsulfanylphenyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_385
V_27
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.28
A




{2-[butyryl-(3-methylsulfanylphenyl)-
MS[M+1]+: 611




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_386
V_28
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.051
A




{2-[(2-methylacryloyl)-(4-
MS[M+1]+: 609




methylsulfanylphenyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_387
V_28
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.134
A




{2-[but-2-(E)-enoyl-(4-
MS[M+1]+: 609




methylsulfanylphenyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_388
V_28
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.284
A




{2-[isobutyryl-(4-
MS[M+1]+: 611




methylsulfanylphenyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_389
V_28
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.284
A




{2-[butyryl-(4-methylsulfanylphenyl)-
MS[M+1]+: 611




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_390
V_26
(S)-3-{4-[2-(Acetylnaphthalen-1-
rt: 8.903
A




ylamino)ethoxy]phenyl}-2-(2-
MS[M+1]+: 587




benzoylphenylamino)propionic acid




methyl ester


IIa_391
V_30
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.387
A




[2-
MS[M+1]+: 613




(cyclopropanecarbonylnaphthalen-2-




ylamino)ethoxy]phenyl}propionic




acid methyl ester


IIa_392
V_31
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.23
A




{3-[butyryl-(2-fluorophenyl)amino]-
MS[M+1]+: 597




propoxy}phenyl)propionic acid




methyl ester


IIa_393
V_31
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.355
A




{3-[cyclobutanecarbonyl-(2-
MS[M+1]+: 609




fluorophenyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_394
V_31
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.056
A




{3-[cyclopropanecarbonyl-(2-
MS[M+1]+: 595




fluorophenyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_395
V_31
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.219
A




{3-[(2-fluorophenyl)isobutyrylamino]-
MS[M+1]+: 597




propoxy}phenyl)propionic acid




methyl ester


IIa_396
V_1
(S)-3-{4-[2-(Acryloylbenzylamino)-
rt: 8.639
A




ethoxy]phenyl}-2-(2-
MS[M+1]+: 563




benzoylphenylamino)propionic acid




methyl ester


IIa_397
V_2
(S)-3-{4-[3-(Acryloylbenzylamino)-
rt: 8.747
A




propoxy]phenyl}-2-(2-
MS[M+1]+: 577




benzoylphenylamino)propionic acid




methyl ester


IIa_398
V_9
(S)-3-{4-[2-(Acryloylphenylamino)-
rt: 8.693
A




ethoxy]phenyl}-2-(2-
MS[M+1]+: 549




benzoylphenylamino)propionic acid




methyl ester


IIa_399
V_10
(S)-3-{4-[2-(Acryloylphenylamino)-
rt: 8.842
A




propoxy]phenyl}-2-(2-
MS[M+1]+: 563




benzoylphenylamino)propionic acid




methyl ester


IIa_400
V_31
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.986
A




{3-[(2-fluorophenyl)propionylamino]-
MS[M+1]+: 583




propoxy}phenyl)propionic acid




methyl ester


IIa_401
V_31
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.279
A




{3-[(2-fluorophenyl)pent-4-
MS[M+1]+: 609




enoylamino]propoxy}phenyl)-




propionic acid methyl ester


IIa_402
V_31
(S)-3-(4-{3-[Acryloyl-(2-
rt: 8.87
A




fluorophenyl)amino]propoxy}phenyl)-
MS[M+1]+: 581




2-(2-benzoylphenylamino)propionic




acid methyl ester


IIa_403
V_31
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.009
A




{3-[but-2-(E)-enoyl-(2-fluorophenyl)-
MS[M+1]+: 595




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_404
V_31
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.45
A




{3-[(2-fluorophenyl)-(3-
MS[M+1]+: 611




methylbutyryl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_405
V_29
(R)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.023
A




{2-[phenyl(thiophene-2-carbonyl)-
MS[M+1]+: 605




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_406
V_31
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.048
A




{3-[(2-fluorophenyl)-(2-
MS[M+1]+: 595




methylacryloyl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_407
V_32
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.025
A




{3-[(3-fluorophenyl)-(2-
MS[M+1]+: 595




methylacryloyl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_408
V_34
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.84
A




{2-[but-2-(E)-enoyl-(2-
MS[M+1]+: 593




methoxyphenyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_409
V_35
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.852
A




{2-[but-2-(E)-enoyl-(3-
MS[M+1]+: 593




methoxyphenyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_410
V_34
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.303
A




{2-[(2-methoxyphenyl)-(3-
MS[M+1]+: 609




methylbutyryl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_411
V_32
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.436
A




{3-[(3-fluorophenyl)-(3-
MS[M+1]+: 611




methylbutyryl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_412
V_35
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.243
A




{2-[(3-methoxyphenyl)-(3-
MS[M+1]+: 609




methylbutyryl)amino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_413
V_32
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.262
A




{3-[(3-fluorophenyl)pent-4-
MS[M+1]+: 609




enoylamino]propoxy}phenyl)-




propionic acid methyl ester


IIa_414
V_32
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.353
A




{3-[cyclobutanecarbonyl-(3-
MS[M+1]+: 609




fluorophenyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_415
V_33
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.338
A




{3-[cyclobutanecarbonyl-(4-
MS[M+1]+: 609




fluorophenyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_416
V_29
(R)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.207
A




[2-
MS[M+1]+: 577




(cyclobutanecarbonylphenylamino)-




ethoxy]phenyl}propionic acid methyl




ester


IIa_417
V_34
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.891
A




{2-[cyclopropanecarbonyl-(2-
MS[M+1]+: 593




methoxyphenyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_418
V_32
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.103
A




{3-[cyclopropanecarbonyl-(3-
MS[M+1]+: 595




fluorophenyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_419
V_33
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.082
A




{3-[cyclopropanecarbonyl-(4-
MS[M+1]+: 595




fluorophenyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_420
V_34
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.817
A




{2-[(2-methoxyphenyl)-
MS[M+1]+: 581




propionylamino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_421
V_32
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.976
A




{3-[(3-fluorophenyl)propionylamino]-
MS[M+1]+: 583




propoxy}phenyl)propionic acid




methyl ester


IIa_422
V_35
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.766
A




{2-[(3-methoxyphenyl)-
MS[M+1]+: 581




propionylamino]ethoxy}phenyl)-




propionic acid methyl ester


IIa_423
V_33
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.958
A




{3-[(4-fluorophenyl)propionylamino]-
MS[M+1]+: 583




propoxy}phenyl)propionic acid




methyl ester


IIa_424
V_29
(R)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.783
A




[2-(phenylpropionylamino)ethoxy]-
MS[M+1]+: 551




phenyl}propionic acid methyl ester


IIa_425
V_32
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.206
A




{3-[(3-fluorophenyl)isobutyrylamino]-
MS[M+1]+: 597




propoxy}phenyl)propionic acid




methyl ester


IIa_426
V_35
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.011
A




{2-[isobutyryl-(3-methoxyphenyl)-
MS[M+1]+: 595




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_427
V_33
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.187
A




{3-[(4-fluorophenyl)isobutyrylamino]-
MS[M+1]+: 597




propoxy}phenyl)propionic acid




methyl ester


IIa_428
V_31
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.473
A




{3-[(2-fluorophenyl)pentanoylamino]-
MS[M+1]+: 611




propoxy}phenyl)propionic acid




methyl ester


IIa_429
V_32
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.455
A




{3-[(3-fluorophenyl)pentanoylamino]-
MS[M+1]+: 611




propoxy}phenyl)propionic acid




methyl ester


IIa_430
V_34
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.069
A




{2-[butyryl-(2-methoxyphenyl)amino]-
MS[M+1]+: 595




ethoxy}phenyl)propionic acid methyl




ester


IIa_431
V_32
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.227
A




{3-[butyryl-(3-fluorophenyl)amino]-
MS[M+1]+: 597




propoxy}phenyl)propionic acid




methyl ester


IIa_432
V_35
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.014
A




{2-[butyryl-(3-methoxyphenyl)amino]-
MS[M+1]+: 595




ethoxy}phenyl)propionic acid methyl




ester


IIa_433
V_33
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.202
A




{3-[butyryl-(4-fluorophenyl)amino]-
MS[M+1]+: 597




propoxy}phenyl)propionic acid




methyl ester


IIa_434
V_31
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.539
A




{3-[(2,2-dimethylpropionyl)-(2-
MS[M+1]+: 611




fluorophenyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_435
V_34
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.411
A




{2-[(2,2-dimethylpropionyl)-(2-
MS[M+1]+: 609




methoxyphenyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_436
V_32
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.518
A




{3-[(2,2-dimethylpropionyl)-(3-
MS[M+1]+: 611




fluorophenyl)amino]propoxy}phenyl)-




propionic acid methyl ester


IIa_437
V_35
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.367
A




{2-[(2,2-dimethylpropionyl)-(3-
MS[M+1]+: 609




methoxyphenyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_438
V_27
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.277
A




{2-[isobutyryl-(3-
MS[M+1]+: 611




methylsulfanylphenyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_439
V_37
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.92
A




{3-[(2-methoxyphenyl)-
MS[M+1]+: 595




propionylamino]propoxy}phenyl)-




propionic acid methyl ester


IIa_440
V_37
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.154
A




{3-[cyclopropanecarbonyl-(2-
MS[M+1]+: 609




methoxyphenyl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_441
V_37
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.999
A




{3-[isobutyryl-(2-methoxyphenyl)-
MS[M+1]+: 607




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_442
V_37
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.942
A




{3-[but-2-(E)-(enoyl-(2-
MS[M+1]+: 607




methoxyphenyl)amino]propoxy)-




phenyl)propionic acid methyl ester


IIa_443
V_37
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.954
A




{3-[(2-methoxyphenyl)-(2-
MS[M+1]+: 607




methylacryloyl)amino]propoxy)-




phenyl)propionic acid methyl ester


IIa_444
V_37
(S)-3-(4-{3-[Acryloyl-(2-
rt: 8.82
A




methoxyphenyl)amino]propoxy}-
MS[M+1]+: 593




phenyl)-2-(2-benzoylphenylamino)-




propionic acid methyl ester


IIa_445
V_37
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.161
A




{3-[butyryl-(2-methoxyphenyl)amino]-
MS[M+1]+: 609




propoxy}phenyl)propionic acid




methyl ester


IIa_446
V_38
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.904
A




{3-[(3-methoxyphenyl)-
MS[M+1]+: 595




propionylamino]propoxy}phenyl)-




propionic acid methyl ester


IIa_447
V_38
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.029
A




{3-[cyclopropanecarbonyl-(3-
MS[M+1]+: 607




methoxyphenyl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_448
V_38
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.137
A




{3-[isobutyryl-(3-methoxyphenyl)-
MS[M+1]+: 609




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_449
V_38
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.98
A




{3-[but-2-(E)-enoyl-(3-
MS[M+1]+: 607




methoxyphenyl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_450
V_38
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.923
A




{3-[(3-methoxyphenyl)-(2-
MS[M+1]+: 607




methylacryloyl)amino]propoxy}-




phenyl)propionic acid methyl ester


IIa_451
V_38
(S)-3-(4-{3-[Acryloyl-(3-
rt: 8.845
A




methoxyphenyl)amino]propoxy}-
MS[M+1]+: 593




phenyl)-2-(2-benzoylphenylamino)-




propionic acid methyl ester


IIa_452
V_38
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.143
A




{3-[butyryl-(3-methoxyphenyl)amino]-
MS[M+1]+: 609




propoxy}phenyl)propionic acid




methyl ester


IIa_453
V_34
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.202
A




{2-[cyclobutanecarbonyl-(2-
MS[M+1]+: 607




methoxyphenyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_454
V_34
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.066
A




{2-[isobutyryl-(2-methoxyphenyl)-
MS[M+1]+: 595




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_455
V_26
(S)-3-{4-[2-(Acryloylnaphthalen-1-
rt: 9.145
A




ylamino)ethoxy]phenyl}-2-(2-
MS[M+1]+: 599




benzoylphenylamino)propionic acid




methyl ester


IIa_456
V_30
(S)-3-{4-[2-(Acryloylnaphthalen-2-
rt: 9.201
A




ylamino)ethoxy]phenyl}-2-(2-
MS[M+1]+: 599




benzoylphenylamino)propionic acid




methyl ester


IIa_457
V_27
(S)-3-(4-{2-[Acryloyl-(3-
rt: 8.979
A




methylsulfanylphenyl)amino]ethoxy}-
MS[M+1]+: 595




phenyl)-2-(2-benzoylphenylamino)-




propionic acid methyl ester


IIa_458
V_28
(S)-3-(4-{2-[Acryloyl-(4-
rt: 8.982
A




methylsulfanylphenyl)amino]ethoxy}-
MS[M+1]+: 595




phenyl)-2-(2-benzoylphenylamino)-




propionic acid methyl ester


IIa_459
V_32
(S)-3-(4-{3-[Acryloyl-(3-
rt: 8.908
A




fluorophenyl)amino]propoxy}phenyl)-
MS[M+1]+: 581




2-(2-benzoylphenylamino)propionic




acid methyl ester


IIa_460
V_32
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.06
A




{3-[but-2-(E)-enoyl-(3-fluorophenyl)-
MS[M+1]+: 595




amino]propoxy}phenyl)propionic acid




methyl ester


IIa_461
V_34
(S)-3-(4-{2-[Acryloyl-(2-
rt: 8.709
A




methoxyphenyl)amino]ethoxy}-
MS[M+1]+: 579




phenyl)-2-(2-benzoylphenylamino)-




propionic acid methyl ester


IIa_462
V_34
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.85
A




{2-[(2-methoxyphenyl)-(2-
MS[M+1]+: 593




methylacryloyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_463
V_35
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.887
A




{2-[cyclopropanecarbonyl-(3-
MS[M+1]+: 593




methoxyphenyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_464
V_35
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.164
A




{2-[cyclobutanecarbonyl-(3-
MS[M+1]+: 607




methoxyphenyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_465
V_35
(S)-3-(4-{2-[Acryloyl-(3-
rt: 8.703
A




methoxyphenyl)amino]ethoxy}-
MS[M+1]+: 579




phenyl)-2-(2-benzoylphenylamino)-




propionic acid methyl ester


IIa_466
V_35
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.786
A




{2-[(3-methoxyphenyl)-(2-
MS[M+1]+: 593




methylacryloyl)amino]ethoxy}-




phenyl)propionic acid methyl ester


IIa_467
V_36
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.001
A




{2-[ethyl(naphthalene-2-carbonyl)-
MS[M+1]+: 601




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_468
V_39
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.244
A




{2-[(naphthalene-2-carbonyl)-
MS[M+1]+: 615




propylamino]ethoxy}phenyl)propionic




acid methyl ester


IIa_469
V_36
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.712
A




{2-[ethyl(quinoline-2-carbonyl)-
MS[M+1]+: 602




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_470
V_39
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.999
A




{2-[propyl(quinoline-2-carbonyl)-
MS[M+1]+: 616




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_471
V_36
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.595
A




{2-[ethyl(quinoxaline-2-carbonyl)-
MS[M+1]+: 603




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_472
V_39
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.888
A




{2-[propyl(quinoxaline-2-carbonyl)-
MS[M+1]+: 617




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_473
V_36
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.558
A




{2-[ethyl(thiophene-2-carbonyl)-
MS[M+1]+: 557




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_474
V_39
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.841
A




{2-[propyl(thiophene-2-carbonyl)-
MS[M+1]+: 571




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_475
V_36
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.545
A




{2-[ethyl(pyridine-3-carbonyl)amino]-
MS[M+1]+: 552




ethoxy}phenyl)propionic acid methyl




ester


IIa_476
V_39
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.863
A




{2-[propyl(pyridine-3-carbonyl)-
MS[M+1]+: 566




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_477
V_36
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.711
A




{2-[ethyl-(3-thiophen-2-ylacryloyl)-
MS[M+1]+: 583




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_478
V_39
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.993
A




{2-[propyl-(3-thiophen-2-ylacryloyl)-
MS[M+1]+: 597




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_479
V_39
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.34
A




{2-[(3,3-dimethylbutyryl)-
MS[M+1]+: 559




propylamino]ethoxy}phenyl)propionic




acid methyl ester


IIa_480
V_36
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 6.512
A




{2-[ethyl-(3-pyridin-3-ylpropionyl)-
MS[M+1]+: 580




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_481
V_39
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 6.767
A




{2-[propyl-(3-pyridin-3-ylpropionyl)-
MS[M+1]+: 594




amino]ethoxy}phenyl)propionic acid




methyl ester


IIa_482
V_39
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.955
A




[2-
MS[M+1]+: 543




(cyclobutanecarbonylpropylamino)-




ethoxy]phenyl}propionic acid methyl




ester


IIa_483
V_39
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.789
A




[2-(isobutyrylpropylamino)ethoxy]-
MS[M+1]+: 531




phenyl}propionic acid methyl ester


IIa_484
V_39
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.775
A




[2-(butyrylpropylamino)ethoxy]-
MS[M+1]+: 531




phenyl}propionic acid methyl ester


IIa_485
V_36
(S)-3-{4-[2-(Benzoylethylamino)-
rt: 8.547
A




ethoxy]phenyl}-2-(2-
MS[M+1]+: 551




benzoylphenylamino)propionic acid




methyl ester


IIa_486
V_39
(S)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.829
A




[2-(benzoylpropylamino)ethoxy]-
MS[M+1]+: 565




phenyl}propionic acid methyl ester


IIa_487
V_36
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.806
A




{2-[ethyl-(3-phenylacryloyl)amino]-
MS[M+1]+: 577




ethoxy}phenyl)propionic acid methyl




ester


IIa_488
V_36
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.931
A




{2-[(2,2-dimethylpropionyl)-
MS[M+1]+: 531




ethylamino]ethoxy}phenyl)propionic




acid methyl ester


IIa_489
V_39
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.233
A




{2-[(2,2-dimethylpropionyl)-
MS[M+1]+: 545




propylamino]ethoxy}phenyl)propionic




acid methyl ester


IIa_490
V_24
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.298
A




{3-[(3-chlorophenyl)-(2-
MS[M, M+2]+: 611,




methylacryloyl)amino]propoxy}-
613




phenyl)propionic acid methyl ester


IIa_491
V_25
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.347
A




{3-[(3-chlorophenyl)-(2-
MS[M, M+2]+: 611,




methylacryloyl)amino]propoxy}-
613




phenyl)propionic acid methyl ester









Compounds I:

Compounds I described shown in Table 6 were obtained starting from the corresponding ester derivative of formula II following any of the procedures J or K described below.
PROCEDURE J: To a 0.02 M solution of compound II (1 eq) in a mixture of THF:methanol (3:1) or THF, a 1 M aqueous solution of lithium hydroxide (1.5 eq) was added. The resulting mixture was stirred at room temperature for 18 h, then treated with HCl 1 N until pH=56, and extracted twice with EtOAc. The organic layers were dried over anhydrous sodium sulfate and filtered. The solvent was distilled off under reduced pressure.
PROCEDURE K: To a solution 0.03 M of compound II (1 eq) in methanol, potassium hydroxide (10 eq) was added. The resulting solution was stirred at room temperature for 18 h, then treated with HCl 1 N until acid pH=4-5. To the resulting suspension, water and EtOAc were added. The organic layer was separated and the aqueous layer was extracted once with EtOAc. The combined organic layers were dried over anhydrous sodium sulfate and filtered. The solvent was distilled off under reduced pressure.











TABLE 6





Example
Starting


HPLC


Number
product
Compound name
1H-NMR/LC-MS
Method







I_1
IIa_1
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.327
A




{2-[(2-chlorophenyl)-(2-
MS[M, M+2]+: 583, 585




methylacryloyl)amino]ethoxy}phenyl)-




propionic acid


I_2
IIa_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.476
A




{3-[(2-chlorophenyl)-(2-
MS[M, M+2]+: 597, 599




methylacryloyl)amino]propoxy)-




phenyl)propionic acid


I_3
IIa_3
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.295
A




{2-[but-2-(E)-enoyl-(2-chlorophenyl)-
MS[M, M+2]+: 583, 585




amino]ethoxy}phenyl)propionic acid


I_4
IIa_4
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.855
A




{2-[(2-chlorophenyl)-(3-methylbutyryl)-
MS[M, M+2]+: 599, 601




amino]ethoxy}phenyl)propionic acid


I_5
IIa_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.728
A




{2-[(2-chlorophenyl)-
MS[M, M+2]+: 597, 599




cyclobutanecarbonylamino]ethoxy}-




phenyl)propionic acid


I_6
IIa_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.989
A




{2-[(2-chlorophenyl)-
MS[M, M+2]+: 611, 613




cyclopentanecarbonylamino]ethoxy}-




phenyl)propionic acid


I_7
IIa_7
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.353; MS[M, M+2]+:
A




{2-[(2-chlorophenyl)-
583, 585




cyclopropanecarbonylamino]ethoxy}-




phenyl)propionic acid


I_8
IIa_8
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.508
A




{3-[(2-chlorophenyl)-
MS[M, M+2]+: 597, 599




cyclopropanecarbonylamino]propoxy}-




phenyl)propionic acid


I_9
IIa_9
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.298
A




{2-[(2-chlorophenyl)propionylamino]-
MS[M, M+2]+: 571, 573




ethoxy}phenyl)propionic acid


I_10
IIa_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.446
A




{3-[(2-chlorophenyl)propionylamino]-
MS[M, M+2]+: 585, 587




propoxy}phenyl)propionic acid


I_11
IIa_11
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.561
A




{2-[(2-chlorophenyl)isobutyrylamino]-
MS[M, M+2]+: 585, 587




ethoxy}phenyl)propionic acid


I_12
IIa_12
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.701
A




{3-[(2-chlorophenyl)isobutyrylamino]-
MS[M, M+2]+: 599, 601




propoxy}phenyl)propionic acid


I_13
IIa_13
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.588
A




{2-[butyryl-(2-chlorophenyl)amino]-
MS[M, M+2]+: 585, 587




ethoxy}phenyl)propionic acid


I_14
IIa_14
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.726
A




{3-[butyryl-(2-chlorophenyl)amino]-
MS[M, M+2]+: 599, 601




propoxy}phenyl)propionic acid


I_15
IIa_15
(S)-3-(4-{3-[Acryloyl-(2-chlorophenyl)-
rt: 8.293
A




amino]propoxy}phenyl)-2-(2-
MS[M, M+2]+: 583, 585




benzoylphenylamino)propionic acid


I_16
IIa_16
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.19
A




{2-[(2-fluorophenyl)-(thiophene-2-
MS[M+1]+: 609




carbonyl)amino]ethoxy}phenyl)-




propionic acid


I_17
IIa_17
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.054
A




{2-[(2-fluorophenyl)-(2-
MS[M+1]+: 567




methylacryloyl)amino]ethoxy}phenyl)-




propionic acid


I_18
IIa_18
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.534
A




{2-[(2-fluorophenyl)-(3-methylbutyryl)-
MS[M+1]+: 583




amino]ethoxy}phenyl)propionic acid


I_19
IIa_19
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.414
A




{2-[cyclobutanecarbonyl-(2-
MS[M+1]+: 581




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid


I_20
IIa_20
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.674
A




{2-[cyclopentanecarbonyl-(2-
MS[M+1]+: 595




fluorophenyl)amino]ethoxyl}phenyl)-




propionic acid


I_21
IIa_21
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.061
A




{2-[cyclopropanecarbonyl-(2-
MS[M+1]+: 567




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid


I_22
IIa_22
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.981
A




{2-[(2-fluorophenyl)propionylamino]-
MS[M+1]+: 555




ethoxy}phenyl)propionic acid


I_23
IIa_23
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.256
A




{2-[(2-fluorophenyl)isobutyrylamino]-
MS[M+1]+: 569




ethoxy}phenyl)propionic acid


I_24
IIa_24
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.269
A




{2-[butyryl-(2-fluorophenyl)amino]-
MS[M+1]+: 569




ethoxy}phenyl)propionic acid


I_25
IIa_25
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.665
A




{2-[(2,2-dimethylpropionyl)-(2-
MS[M+1]+: 583




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid


I_26
IIa_26
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.369
A




{3-[(2-methylacryloyl)-o-tolylamino]-
MS[M+1]+: 577




propoxy}phenyl)propionic acid


I_27
IIa_27
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.99
A




{2-[(2-ethylbutyryl)-o-tolylamino]-
MS[M+1]+: 593




ethoxy}phenyl)propionic acid


I_28
IIa_28
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.758
A




{3-[(3-methylbut-2-(E)-enoyl)-o-
MS[M+1]+: 591




tolylamino]propoxy}phenyl)propionic




acid


I_29
IIa_29
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.471
A




(but-2-(E)-enoyl-o-tolylamino)-
MS[M+1]+: 577




propoxy]phenyl}propionic acid


I_30
IIa_30
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.101
A




{2-[(3,3-dimethylbutyryl)-o-tolylamino]-
MS[M+1]+: 593




ethoxy}phenyl)propionic acid


I_31
IIa_31
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.75
A




{2-[(3-methylbutyryl)-o-tolylamino]-
MS[M+1]+: 579




ethoxy}phenyl)propionic acid


I_32
IIa_32
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.945
A




{3-[(3-methylbutyryl)-o-tolylamino]-
MS[M+1]+: 593




propoxy}phenyl)propionic acid


I_33
IIa_33
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.742
A




(o-tolylpent-4-enoylamino)propoxy]-
MS[M+1]+: 591




phenyl}propionic acid


I_34
IIa_34
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.634
A




(cyclobutanecarbonyl-o-tolylamino)-
MS[M+1]+: 577




ethoxy]phenyl}propionic acid


I_35
IIa_35
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.898
A




(cyclopentanecarbonyl-o-tolylamino)-
MS[M+1]+: 591




ethoxy]phenyl}propionic acid


I_36
IIa_36
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.387
A




(propionyl-o-tolylamino)propoxy]-
MS[M+1]+: 565




phenyl}propionic acid


I_37
IIa_37
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.458
A




(isobutyryl-o-tolylamino)ethoxy]-
MS[M+1]+: 565




phenyl}propionic acid


I_38
IIa_38
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.66
A




(isobutyryl-o-tolylamino)propoxy]-
MS[M+1]+: 579




phenyl}propionic acid


I_39
IIa_39
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.968
A




(pentanoyl-o-tolylamino)propoxy]-
MS[M+1]+: 593




phenyl}propionic acid


I_40
IIa_40
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.474
A




(butyryl-o-tolylamino)ethoxy]phenyl}-
MS[M+1]+: 565




propionic acid


I_41
IIa_41
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.677
A




(butyryl-o-tolylamino)propoxy]phenyl)-
MS[M+1]+: 579




propionic acid


I_42
IIa_42
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.324
A




(benzoyl-o-tolylamino)ethoxy]phenyl}-
MS[M+1]+: 599




propionic acid


I_43
IIa_43
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.884
A




{2-[(2,2-dimethylpropionyl)-o-
MS[M+1]+: 579




tolylamino]ethoxy}phenyl)propionic




acid


I_44
IIa_44
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.028
A




{3-[(2,2-dimethylpropionyl)-o-
MS[M+1]+: 593




tolylamino]propoxy}phenyl)propionic




acid


I_45
IIa_45
(S)-3-{4-[3-(Acryloyl-o-tolylamino)-
rt: 8.31
A




propoxy]phenyl}-2-(2-
MS[M+1]+: 563




benzoylphenylamino)propionic acid


I_46
IIa_46
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.385
A




{2-[(3-chlorophenyl)-(2-
MS[M, M+2]+: 583, 586




methylacryloyl)amino]ethoxy}phenyl)-




propionic acid


I_47
IIa_490
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.54
A




{3-[(3-chlorophenyl)-(2-
MS[M, M+2]+: 597, 599




methylacryloyl)amino]propoxy}-




phenyl)propionic acid


I_48
IIa_47
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.45
A




{2-[but-2-(E)-enoyl-(3-chlorophenyl)-
MS[M, M+2]+: 583, 585




amino]ethoxy}phenyl)propionic acid


I_49
IIa_48
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.596
A




{3-[but-2-(E)-enoyl-(3-chlorophenyl)-
MS[M, M+2]+: 597, 599




amino]propoxy}phenyl)propionic acid


I_50
IIa_49
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.877
A




{2-[(3-chlorophenyl)-(3-methylbutyryl)-
MS[M, M+2]+: 599, 601




amino]ethoxy}phenyl)propionic acid


I_51
IIa_50
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.68
A




{2-[(3-chlorophenyl)-pent-4-
MS[M, M+2]+: 597, 599




enoylamino]ethoxy}phenyl)propionic




acid


I_52
IIa_51
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.787
A




{2-[(3-chlorophenyl)-
MS[M, M+2]+: 597, 599




cyclobutanecarbonylamino]ethoxy}-




phenyl)propionic acid


I_53
IIa_52
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.040
A




{2-[(3-chlorophenyl)-
MS[M, M+2]+: 611, 613




cyclopentanecarbonylamino]ethoxy}-




phenyl)propionic acid


I_54
IIa_53
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.481
A




{2-[(3-chlorophenyl)-
MS[M, M+2]+: 583, 585




cyclopropanecarbonylamino]ethoxy}-




phenyl)propionic acid


I_55
IIa_54
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.645; MS[M, M+2]+:
A




{3-[(3-chlorophenyl)-
597, 599




cyclopropanecarbonylamino]propoxy}-




phenyl)propionic acid


I_56
IIa_55
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.345
A




{2-[(3-chlorophenyl)propioylamino]-
MS[M, M+2]+: 571, 573




ethoxy}phenyl)propionic acid


I_57
IIa_56
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.509
A




{3-[(3-chlorophenyl)propionylamino]-
MS[M, M+2]+: 585, 587




propoxy}phenyl)propionic acid


I_58
IIa_57
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.613
A




{2-[(3-chlorophenyl)isobutyrylamino]-
MS[M, M+2]+: 585, 587




ethoxy}phenyl)propionic acid


I_59
IIa_58
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.768
A




{3-[(3-chlorophenyl)isobutyrylamino]-
MS[M, M+2]+: 599, 601




propoxy}phenyl)propionic acid


I_60
IIa_59
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.623
A




{2-[butyryl-(3-chlorophenyl)amino]-
MS[M, M+2]+: 585, 587




ethoxy}phenyl)propionic acid


I_61
IIa_60
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.779; MS[M, M+2]+:
A




{3-[butyryl-(3-chlorophenyl)amino]-
599, 601




propoxy}phenyl)propionic acid


I_62
IIa_61
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.995
A




{2-[(3-chlorophenyl)-(2,2-
MS[M, M+2]+: 599, 601




dimethylpropionyl)amino]ethoxy}-




phenyl)propionic acid


I_63
IIa_62
(S)-3-(4-{3-[Acryloyl-(3-chlorophenyl)-
rt: 8.419
A




amino]propoxy}phenyl)-2-(2-
MS[M, M+2]+: 583, 585




benzoylphenylamino)propionic acid


I_64
IIa_63
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.250
A




{2-[(3-fluorophenyl)-(thiophene-2-
MS[M+1]+: 609




carbonyl)amino]ethoxy}phenyl)-




propionic acid


I_65
IIa_64
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.062
A




{2-[(3-fluorophenyl)-(2-
MS[M+1]+: 567




methylacryloyl)amino]ethoxy}phenyl)-




propionic acid


I_66
IIa_65
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.538
A




{2-[(3-fluorophenyl)-(3-methylbutyryl)-
MS[M+1]+: 583




amino]ethoxy}phenyl)propionic acid


I_67
IIa_66
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.431
A




{2-[cyclobutanecarbonyl-(3-
MS[M+1]+: 581




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid


I_68
IIa_67
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.688
A




{2-[cyclopentanecarbonyl-(3-
MS[M+1]+: 595




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid


I_69
IIa_68
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.134
A




{2-[cyclopropanecarbonyl-(3-
MS[M+1]+: 567




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid


I_70
IIa_69
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.998
A




{2-[(3-fluorophenyl)propionylamino]-
MS[M+1]+: 555




ethoxy}phenyl)propionic acid


I_71
IIa_70
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.267
A




{2-[(3-fluorophenyl)isobutyrylamino]-
MS[M+1]+: 569




ethoxy}phenyl)propionic acid


I_72
IIa_71
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.278
A




{2-[butyryl-(3-fluorophenyl)amino]-
MS[M+1]+: 569




ethoxy}phenyl)propionic acid


I_73
IIa_72
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.65
A




{2-[(2,2-dimethylpropionyl)-(3-
MS[M+1]+: 583




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid


I_74
IIa_73
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.439
A




{3-[(2-methylacryloyl)-(3-
MS[M+1]+: 591




methylbenzyl)amino]propoxy}phenyl)-




propionic acid


I_75
IIa_74
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.973
A




{2-[(2-ethylbutyryl)-(3-methylbenzyl)-
MS[M+1]+: 607




amino]ethoxy}phenyl)propionic acid


I_76
IIa_75
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.634
A




{3-[(3-methylbenzyl)-(3-methylbut-2-
MS[M+1]+: 605




(E)-enoyl)amino]propoxy}phenyl)-




propionic acid


I_77
IIa_76
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.381
A




{3-[but-2-(E)-enoyl-(3-methylbenzyl)-
MS[M+1]+: 591




amino]propoxy}phenyl)propionic acid


I_78
IIa_77
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.041
A




{2-[(3,3-dimethylbutyryl)-(3-
MS[M+1]+: 607




methylbenzyl)amino]ethoxy}phenyl)-




propionic acid


I_79
IIa_78
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.745
A




{2-[(3-methylbenzyl)-(3-
MS[M+1]+: 593




methylbutyryl)amino]ethoxy}phenyl)-




propionic acid


I_80
IIa_79
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.828
A




{3-[(3-methylbenzyl)-(3-
MS[M+1]+: 607




methylbutyryl)amino]propoxy}phenyl)-




propionic acid


I_81
IIa_80
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.645
A




{2-[cyclobutanecarbonyl-(3-
MS[M+1]+: 591




methylbenzyl)amino]ethoxy}phenyl)-




propionic acid


I_82
IIa_81
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.722
A




{3-[cyclobutanecarbonyl-(3-
MS[M+1]+: 605




methylbenzyl)amino]propoxy}phenyl)-




propionic acid


I_83
IIa_82
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.874
A




{2-[cyclopentanecarbonyl-(3-
MS[M+1]+: 605




methylbenzyl)amino]ethoxy}phenyl)-




propionic acid


I_84
IIa_83
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.422
A




{3[cyclopropanecarbonyl-(3-
MS[M+1]+: 591




methylbenzyl)amino]propoxy}phenyl)-




propionic acid


I_85
IIa_84
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.31
A




{3-[(3-methylbenzyl)propionylamino]-
MS[M+1]+: 579




propoxy}phenyl)propionic acid


I_86
IIa_85
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.468
A




{2-[isobutyryl-(3-methylbenzyl)amino]-
MS[M+1]+: 579




ethoxy}phenyl)propionic acid


I_87
IIa_86
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.56
A




{3-[isobutyryl-(3-methylbenzyl)amino]-
MS[M+1]+: 593




propoxy}phenyl)propionic acid


I_88
IIa_87
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.489
A




{2-[butyryl-(3-methylbenzyl)amino]-
MS[M+1]+: 579




ethoxy}phenyl)propionic acid


I_89
IIa_88
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.574
A




{3-[butyryl-(3-methylbenzl)amino]-
MS[M+1]+: 593




propoxy}phenyl)propionic acid


I_90
IIa_89
(S)-3-(4-{2-[Benzoyl-(3-methylbenzyl)-
rt: 8.545
A




amino]ethoxy}phenyl)-2-(2-
MS[M+1]+: 613




benzoylphenylamino)propionic acid


I_91
IIa_90
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.886
A




{2-[(2,2-dimethylpropionyl)-(3-
MS[M+1]+: 593




methylbenzyl)amino]ethoxy}phenyl)-




propionic acid


I_92
IIa_91
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.909
A




{3-[(2,2-dimethylpropionyl)-(3-
MS[M+1]+: 607




methylbenzyl)amino]propoxy}phenyl)-




propionic acid


I_93
IIa_92
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.472
A




{3-[(2-methylacryloyl)-m-tolylamino]-
MS[M+1]+: 577




propoxy}phenyl)propionic acid


I_94
IIa_93
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.062
A




{2-[(2-ethylbutyryl)-m-tolylamino]-
MS[M+1]+: 593




ethoxy}phenyl)propionic acid


I_95
IIa_94
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.826
A




{3-[(3-methylbut-2-(E)-enoyl)-m-
MS[M+1]+: 591




tolylamino]propoxy}phenyl)propionic




acid


I_96
IIa_95
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.554
A




(but-2-(E)-enoyl-m-tolylamino)-
MS[M+1]+: 577




propoxy]phenyl}propionic acid


I_97
IIa_96
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.152
A




{2-[(3,3-dimethylbutyryl)-m-
MS[M+1]+: 593




tolylamino]ethoxy}phenyl)propionic




acid


I_98
IIa_97
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.802
A




{2-[(3-methylbutyryl)-m-tolylamino]-
MS[M+1]+: 579




ethoxy}phenyl)propionic acid


I_99
IIa_98
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.724
A




(cyclobutanecarbonyl-m-tolyamino)-
MS[M+1]+: 577




ethoxy]phenyl}propionic acid


I_100
IIa_99
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.958
A




(cyclopentanecabonyl-m-tolylamino)-
MS[M+1]+: 591




ethoxy]phenyl}propionic acid


I_101
IIa_100
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.607
A




(cyclopropanecarbonyl-m-tolylamino)-
MS[M+1]+: 577




propoxy]phenyl}propionic acid


I_102
IIa_101
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.468
A




(propionyl-m-tolylamino)propoxy]-
MS[M+1]+: 565




phenyl}propionic acid


I_103
IIa_102
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.532
A




(isobutyryl-m-tolyamino)ethoxy]-
MS[M+1]+: 565




phenyl}propionic acid


I_104
IIa_103
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.731
A




(isobutyryl-m-tolylamino)propoxy]-
MS[M+1]+: 579




phenyl}propionic acid


I_105
IIa_104
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 9.025
A




(pentanoyl-m-tolylamino)propoxy]-
MS[M+1]+: 593




phenyl}propionic acid


I_106
IIa_105
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.543
A




(butyryl-m-tolylamino)ethoxy]phenyl}-
MS[M+1]+: 565




propionic acid


I_107
IIa_106
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.741
A




(butyryl-m-tolylamino)propoxy]-
MS[M+1]+: 579




phenyl}propionic acid


I_108
IIa_107
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.436
A




(benzoyl-m-tolylamino)ethoxy]phenyl}-
MS[M+1]+: 599




propionic acid


I_109
IIa_108
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.953
A




{2-[(2,2-dimethylpropionyl)-m-
MS[M+1]+: 579




tolylamino]ethoxy}phenyl)propionic




acid


I_110
IIa_109
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.109
A




{3-[(2,2-dimethylpropionyl)-m-
MS[M+1]+: 593




tolylamino]propoxy}phenyl)propionic




acid


I_111
IIa_110
(S)-3-{4-[3-(Acryloyl-m-tolylamino)-
rt: 8.388
A




propoxy]phenyl}-2-(2-
MS[M+1]+: 563




benzoylphenylamino)propionic acid


I_112
IIa_111
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.437
A




{2-[(4-chlorophenyl)-(2-
MS[M, M+2]+: 583, 586




methylacryloyl)amino]ethoxy}phenyl)-




propionic acid


I_113
IIa_491
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.595
A




{3-[(4-chlorophenyl)-(2-
MS[M, M+2]+: 597, 599




methylacryloyl)amino]propoxy}-




phenyl)propionic acid


I_114
IIa_112
(S)-2-(2-Benzoylphenyamino)-3-(4-
rt: 8.517
A




{2-[but-2-(E)-enoyl-(4-chlorophenyl)-
MS[M, M+2]+: 583, 585




amino]ethoxy}phenyl)propionic acid


I_115
IIa_113
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.942
A




{2-[(4-chlorophenyl)-(3-methylbutyryl)-
MS[M, M+2]+: 599, 601




amino]ethoxy}phenyl)propionic acid


I_116
IIa_114
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.739
A




{2-[(4-chlorophenyl)-pent-4-
MS[M, M+2]+: 597, 599




enoylamino]ethoxy}phenyl)propionic




acid


I_117
IIa_115
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.839
A




{2-[(4-chlorophenyl)-
MS[M, M+2]+: 597, 599




cyclobutanecarbonylamino]ethoxy}-




phenyl)propionic acid


I_118
IIa_116
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.103
A




{2-[(4-chlorophenyl)-
MS[M, M+2]+: 611, 613




cyclopentanecarbonylamino]ethoxy}-




phenyl)propionic acid


I_119
IIa_117
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.533
A




{2-[(4-chlorophenyl)-
MS[M, M+2]+: 583, 585




cyclopropanecarbonylamino]ethoxy}-




phenyl)propionic acid


I_120
IIa_118
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.696
A




{3-[(4-chlorophenyl)-
MS[M, M+2]+: 597, 599




cyclopropanecarbonylamino]propoxy}-




phenyl)propionic acid


I_121
IIa_119
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.399
A




{2-[(4-chlorophenyl)propionylamino]-
MS[M, M+2]+: 571, 573




ethoxy}phenyl)propionic acid


I_122
IIa_120
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.562
A




{3-[(4-chlorophenyl)propionylamino]-
MS[M, M+2]+: 585, 587




propoxy}phenyl)propionic acid


I_123
IIa_121
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.682
A




{2-[(4-chlorophenyl)isobutyrylamino]-
MS[M, M+2]+: 585, 587




ethoxy}phenyl)propionic acid


I_124
IIa_122
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.835
A




{3-[(4-chlorophenyl)isobutyrylamino]-
MS[M, M+2]+: 599, 601




propoxy}phenyl)propionic acid


I_125
IIa_123
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.684
A




{2-[butyryl-(4-chlorophenyl)amino]-
MS[M, M+2]+: 585, 587




ethoxy}phenyl)propionic acid


I_126
IIa_124
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.836
A




{3-[butyryl-(4-chlorophenyl)amino]-
MS[M, M+2]+: 599, 601




propoxy}phenyl)propionic acid


I_127
IIa_125
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.043
A




{2-[(4-chlorophenyl)-(2,2-
MS[M, M+2]+: 599, 601




dimethylpropionyl)amino]ethoxy}-




phenyl)propionic acid


I_128
IIa_126
(S)-3-(4-{3-[Acryloyl-(4-chlorophenyl)-
rt: 8.475
A




amino]propoxy}phenyl)-2-(2-
MS[M, M+2]+: 583, 585




benzoylphenylamino)propionic acid


I_129
IIa_127
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.247
A




{2-[(4-fluorophenyl)-(thiophene-2-
MS[M+1]+: 609




carbonyl)amino]ethoxy}phenyl)-




propionic acid


I_130
IIa_128
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.026
A




{2-[(4-fluorophenyl)-(2-
MS[M+1]+: 567




methylacryloyl)amino]ethoxy}phenyl)-




propionic acid


I_131
IIa_129
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.365
A




{2-[(4-fluorophenyl)-(3-methylbut-2-
MS[M+1]+: 581




(E)-enoyl)amino]ethoxy}phenyl)-




propionic acid


I_132
IIa_130
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.528
A




{2-[(4-fluorophenyl)-(3-methylbutyryl)-
MS[M+1]+: 583




amino]ethoxy}phenyl)propionic acid


I_133
IIa_131
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.421
A




{2-[cyclobutanecarbonyl-(4-
MS[M+1]+: 581




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid


I_134
IIa_132
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.675
A




{2-[cyclopentanecarbonyl-(4-
MS[M+1]+: 595




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid


I_135
IIa_133
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.117
A




{2-[cyclopropanecarbonyl-(4-
MS[M+1]+: 567




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid


I_136
IIa_134
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.987
A




{2-[(4-fluorophenyl)propionylamino]-
MS[M+1]+: 555




ethoxy}phenyl)propionic acid


I_137
IIa_135
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.253
A




{2-[(4-fluorophenyl)isobutyrylamino]-
MS[M+1]+: 569




ethoxy}phenyl)propionic acid


I_138
IIa_136
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.266
A




{2-[butyryl-(4-fluorophenyl)amino]-
MS[M+1]+: 569




ethoxy}phenyl)propionic acid


I_139
IIa_137
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.64
A




{2-[(2,2-dimethylpropionyl)-(4-
MS[M+1]+: 583




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid


I_140
IIa_138
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.483
A




{3-[(2-methylacryloyl)-p-tolylamino]-
MS[M+1]+: 577




propoxy}phenyl)propionic acid


I_141
IIa_139
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.088
A




{2-[(2-ethylbutyryl)-p-tolylamino]-
MS[M+1]+: 593




ethoxy}phenyl)propionic acid


I_142
IIa_140
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.178
A




{2-[(3,3-dimethylbutyryl)-p-tolylamino]-
MS[M+1]+: 593




ethoxy}phenyl)propionic acid


I_143
IIa_141
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.827
A




{2-[(3-methylbutyryl)-p-tolylamino]-
MS[M+1]+: 579




ethoxy}phenyl)propionic acid


I_144
IIa_142
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.025
A




{3-[(3-methylbutyryl)-p-tolylamino]-
MS[M+1]+: 593




propoxy}phenyl)propionic acid


I_145
IIa_143
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.737
A




(cyclobutanecarbonyl-p-tolylamino)-
MS[M+1]+: 577




ethoxy]phenyl}propionic acid


I_146
IIa_144
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.936
A




(cyclobutanecarbonyl-p-tolylamino)-
MS[M+1]+: 591




propoxy]phenyl}propionic acid


I_147
IIa_145
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.992
A




(cyclopentanecarbonyl-p-tolylamino)-
MS[M+1]+: 591




ethoxy]phenyl}propionic acid


I_148
IIa_146
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.486
A




(propionyl-p-tolylamino)propoxy]-
MS[M+1]+: 565




phenyl}propionic acid


I_149
IIa_147
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.554
A




(isobutyryl-p-tolylamino)ethoxy]-
MS[M+1]+: 565




phenyl}propionic acid


I_150
IIa_148
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.758
A




(isobutyryl-p-tolylamino)propoxy]-
MS[M+1]+: 579




phenyl}propionic acid


I_151
IIa_149
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.561
A




(butyryl-p-tolylamino)ethoxy]phenyl}-
MS[M+1]+: 565




propionic acid


I_152
IIa_150
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.431
A




(benzoyl-p-tolylamino)ethoxy]phenyl}-
MS[M+1]+: 599




propionic acid


I_153
IIa_151
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.967
A




{2-[(2,2-dimethylpropionyl)-p-
MS[M+1]+: 579




tolylamino]ethoxy}phenyl)propionic




acid


I_154
IIa_152
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.126
A




{3-[(2,2-dimethylpropionyl)-p-
MS[M+1]+: 593




tolylamino]propoxy}phenyl)propionic




acid


I_155
IIa_153
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.702
A




{2-[benzyl(naphthalene-1-carbonyl)-
MS[M+1]+: 649




amino]ethoxy}phenyl)propionic acid


I_156
IIa_154
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.744
A




{2-[benzyl(naphthalene-2-carbonyl)-
MS[M+1]+: 649




amino]ethoxy}phenyl)propionic acid


I_157
IIa_155
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.713
A




{2-[benzyl(pyrazine-2-carbonyl)-
MS[M+1]+: 601




amino]ethoxy}phenyl)propionic acid


I_158
IIa_156
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.813
A




{3-[benzyl(pyrazine-2-carbonyl)-
MS[M+1]+: 615




amino]propoxy}phenyl)propionic acid


I_159
IIa_157
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.866
A




{2-[benzyl(pyridine-2-carbonyl)amino]-
MS[M+1]+: 600




ethoxy}phenyl)propionic acid


I_160
IIa_158
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.978
A




{3-[benzyl(pyridine-2-carbonyl)amino]-
MS[M+1]+: 614




propoxy}phenyl)propionic acid


I_161
IIa_159
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.538
A




{2-[benzyl(quinoline-2-carbonyl)-
MS[M+1]+: 650




amino]ethoxy}phenyl)propionic acid


I_162
IIa_160
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.602
A




{3-[benzyl(quinoline-2-carbonyl)-
MS[M+1]+: 664




amino]propoxy}phenyl)propionic acid


I_163
IIa_161
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.374
A




{2-[benzyl(quinoxaline-2-carbonyl)-
MS[M+1]+: 651




amino]ethoxy}phenyl)propionic acid


I_164
IIa_162
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.455
A




{3-[benzyl(quinoxaline-2-carbonyl)-
MS[M+1]+: 665




amino]propoxy}phenyl)propionic acid


I_165
IIa_163
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.331
A




{2-[benzyl(thiophene-2-carbonyl)-
MS[M+1]+: 605




amino]ethoxy}phenyl)propionic acid


I_166
IIa_164
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.415
A




{3-[benzyl(thiophene-2-carbonyl)-
MS[M+1]+: 619




amino]propoxy}phenyl)propionic acid


I_167
IIa_165
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.026
A




{2-[benzyl(furan-3-carbonyl)amino]-
MS[M+1]+: 589




ethoxy}phenyl)propionic acid


I_168
IIa_166
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.105
A




{3-[benzyl(furan-3-carbonyl)amino]-
MS[M+1]+: 603




propoxy}phenyl)propionic acid


I_169
IIa_167
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.318
A




{2-[benzyl(isoquinoline-3-carbonyl)-
MS[M+1]+: 650




amino]ethoxy}phenyl)propionic acid


I_170
IIa_168
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.383
A




{3-[benzyl(isoquinoline-3-carbonyl)-
MS[M+1]+: 664




amino]propoxy}phenyl)propionic acid


I_171
IIa_169
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.448
A




{2-[benzyl(pyridine-3-carbonyl)amino]-
MS[M+1]+: 600




ethoxy}phenyl)propionic acid


I_172
IIa_170
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.584
A




{3-[benzyl(pyridine-3-carbonyl)amino]-
MS[M+1]+: 614




propoxy}phenyl)propionic acid


I_173
IIa_171
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.461
A




(benzylphenylacetylamino)ethoxy]-
MS[M+1]+: 613




phenyl}propionic acid


I_174
IIa_172
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.489
A




(benzylphenylacetylamino)propoxy]-
MS[M+1]+: 627




phenyl}propionic acid


I_175
IIa_173
(S)-2.(2-Benzoylphenylamino)-3-(4-
rt: 8.057
A




{2-[benzyl-(2-methylacryloyl)amino]-
MS[M+1]+: 563




ethoxy}phenyl)propionic acid


I_176
IIa_174
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.14
A




{3-[benzyl-(2-methylacryloyl)amino]-
MS[M+1]+: 577




propoxy}phenyl)propionic acid


I_177
IIa_175
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.675
A




{2-[benzyl-(3-phenylpropynoyl)amino]-
MS[M+1]+: 623




ethoxy}phenyl)propionic acid


I_178
IIa_176
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.762
A




{3-[benzyl-(3-phenylpropynoyl)amino]-
MS[M+1]+: 637




propoxy}phenyl)propionic acid


I_179
IIa_177
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.711
A




{2-[benzyl-(2-ethylbutyryl)amino]-
MS[M+1]+: 593




ethoxy}phenyl)propionic acid


I_180
IIa_178
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.766
A




{3-[benzyl-(2-ethylbutyryl)amino]-
MS[M+1]+: 607




propoxy}phenyl)propionic acid


I_181
IIa_179
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.278
A




{2-[benzyl-(3-methylbut-2-(E)-enoyl)-
MS[M+1]+: 577




amino]ethoxy}phenyl)propionic acid


I_182
IIa_180
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.381
A




{3-[benzyl-(3-methylbut-2-(E)-enoyl)-
MS[M+1]+: 591




amino]propoxy}phenyl)propionic acid


I_183
IIa_181
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.279
A




{2-[benzyl-(3-furan-2-ylacryloyl)-
MS[M+1]+: 615




amino]ethoxy}phenyl)propionic acid


I_184
IIa_182
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.386
A




{3-[benzyl-(3-furan-2-ylacryloyl)-
MS[M+1]+: 629




amino]propoxy}phenyl)propionic acid


I_185
IIa_183
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.436
A




{2-[benzyl-(3-thiophen-2-ylacryloyl)-
MS[M+1]+: 631




amino]ethoxy}phenyl)propionic acid


I_186
IIa_184
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.551
A




{3-[benzyl-(3-thiophen-2-ylacryloyl)-
MS[M+1]+: 645




amino]propoxy}phenyl)propionic acid


I_187
IIa_185
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.158
A




{2-[benzyl-(3-furan-3-yl-(E)-acryloyl)-
MS[M+1]+: 615




amino]ethoxy}phenyl)propionic acid


I_188
IIa_186
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.266
A




{3-[beznyl-(3-furan-3-yl-(E)-acryloyl)-
MS[M+1]+: 629




amino]propoxy}phenyl)propionic acid


I_189
IIa_187
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.303
A




{2-[benzyl-(3-pyridin-3-yl-(E)-acryloyl)-
MS[M+1]+: 626




amino]ethoxy}phenyl)propionic acid


I_190
IIa_188
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.428
A




{3-[benzyl-(3-pyridin-3-yl-(E)-acryloyl)-
MS[M+1]+: 640




amino]propoxy}phenyl)propionic acid


I_191
IIa_189
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.388
A




{2-[benzyl-(3-thiophen-3-yl-(E)-
MS[M+1]+: 631




acryloyl)amino]ethoxy}phenyl)-




propionic acid


I_192
IIa_190
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.489
A




{3-[benzyl-(3-thiophen-3-yl-(E)-
MS[M+1]+: 645




acryloyl)amino]propoxy}phenyl)-




propionic acid


I_193
IIa_191
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.008
A




(benzylbut-2-(E)-enoylamino)ethoxy]-
MS[M+1]+: 563




phenyl}propionic acid


I_194
IIa_192
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.114
A




(benzylbut-2-(E)-enoylamino)-
MS[M+1]+: 577




propoxy]phenyl}propionic acid


I_195
IIa_193
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.325
A




{2-[benzyl-(2-thiophen-2-ylacetyl)-
MS[M+1]+: 619




amino]ethoxy}phenyl)propionic acid


I_196
IIa_194
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.441
A




{3-[benzyl-(2-thiophe-2-ylacetyl)-
MS[M+1]+: 633




amino]propoxy}phenyl)propionic acid


I_197
IIa_195
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 6.546
A




{2-[benzyl-(2-pyridin-3-ylacetyl)-
MS[M+1]+: 614




amino]ethoxy}phenyl)propionic acid


I_198
IIa_196
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 6.683
A




{3-[benzyl-(2-pyridin-3-ylacetyl)-
MS[M+1]+: 628




amino]propoxy}phenyl)propionic acid


I_199
IIa_197
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.32
A




{2-[benzyl-(2-thiophen-3-ylacetyl)-
MS[M+1]+: 619




amino]ethoxy}phenyl)propionic acid


I_200
IIa_198
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.417
A




{3-[benzyl-(2-thiophen-3-ylacetyl)-
MS[M+1]+: 633




amino]propoxy}phenyl)propionic acid


I_201
IIa_199
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.803
A




{2-[benzyl(3,3-dimethylbutyryl)amino]-
MS[M+1]+: 593




ethoxy}phenyl)propionic acid


I_202
IIa_200
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.88
A




{3-[benzyl(3,3-dimethylbutyryl)amino]-
MS[M+1]+: 607




propoxy}phenyl)propionic acid


I_203
IIa_201
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.483
A




{2-[benzyl-(3-methylbutyryl)amino]-
MS[M+1]+: 579




ethoxy}phenyl)propionic acid


I_204
IIa_202
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.562
A




{3-[benzyl-(3-methylbutyryl)amino]-
MS[M+1]+: 593




propoxy}phenyl)propionic acid


I_205
IIa_203
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 6.329
A




{2-[benzyl-(3-pyridin-3-ylpropionyl)-
MS[M+1]+: 628




amino]ethoxy}phenyl)propionic acid


I_206
IIa_204
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 6.584
A




{3-[benzyl-(3-pyridin-3-ylpropionyl)-
MS[M+1]+: 642




amino]propoxy}phenyl)propionic acid


I_207
IIa_205
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.32
A




(benzylpent-4-enoylamino)ethoxy]-
MS[M+1]+: 577




phenyl}propionic acid


I_208
IIa_206
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.401
A




(benzylpent-4-enoylamino)propoxy]-
MS[M+1]+: 591




phenyl}propionic acid


I_209
IIa_207
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.628
A




{2-[benzyl-(3-phenylpropionyl)amino]-
MS[M+1]+: 627




ethoxy}phenyl)propionic acid


I_210
IIa_208
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.732
A




{3-[benzyl-(3-phenylpropionyl)amino]-
MS[M+1]+: 641




propoxy}phenyl)propionic acid


I_211
IIa_209
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.41
A




(benzylcyclobutanecarbonylamino)-
MS[M+1]+: 577




ethoxy]phenyl}propionic acid


I_212
IIa_210
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.481
A




(benzylcyclobutanecarbonylamino)-
MS[M+1]+: 591




propoxy]phenyl}propionic acid


I_213
IIa_211
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.786
A




(benzylcyclohexanecarbonylamino)-
MS[M+1]+: 605




ethoxy]phenyl}propionic acid


I_214
IIa_212
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.865
A




(benzylcyclohexanecarbonylamino)-
MS[M+1]+: 619




propoxy]phenyl}propionic acid


I_215
IIa_213
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.382
A




{2-[benzyl-(3-cyclohexylpropionyl)-
MS[M+1]+: 633




amino]ethoxy}phenyl)propionic acid


I_216
IIa_214
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.479
A




{3-[benzyl-(3-cyclohexylpropionyl)-
MS[M+1]+: 647




amino]propoxy}phenyl)propionic acid


I_217
IIa_215
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.109
A




{2-[benzyl-(2-cyclohexylacetyl)amino]-
MS[M+1]+: 619




ethoxy}phenyl)propionic acid


I_218
IIa_216
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.207
A




{3-[benzyl-(2-cyclohexylacetyl)amino]-
MS[M+1]+: 633




propoxy}phenyl)propionic acid


I_219
IIa_217
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.663
A




(benzylcyclopentanecarbonylamino)-
MS[M+1]+: 591




ethoxy]phenyl}propionic acid


I_220
IIa_218
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.84
A




benzylcyclopentanecarbonylamino)-
MS[M+1]+: 605




propoxy]phenyl}propionic acid


I_221
IIa_219
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.16
A




{2-[benzyl-(3-cyclopentylpropionyl)-
MS[M+1]+: 619




amino]ethoxy}phenyl)propionic acid


I_222
IIa_220
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.208
A




{3-[benzyl-(3-cyclopentylpropionyl)-
MS[M+1]+: 633




amino]propoxy}phenyl)propionic acid


I_223
IIa_221
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.08
A




(benzylcyclopropanecarbonylamino)-
MS[M+1]+: 563




ethoxy]phenyl}propionic acid


I_224
IIa_222
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.181
A




(benzylcyclopropanecarbonylamino)-
MS[M+1]+: 577




propoxy]phenyl}propionic acid


I_225
IIa_223
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 7.968
A




(benzylpropionylamino)ethoxyl-
MS[M+1]+: 551




phenyl}propionic acid


I_226
IIa_224
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.054
A




(benzylpropionylamino)propoxy]-
MS[M+1]+: 565




phenyl}propionic acid


I_227
IIa_225
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.225
A




(benzylisobutyrylamino)ethoxy]-
MS[M+1]+: 565




phenyl}propionic acid


I_228
IIa_226
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.311
A




(benzylisobutyrylamino)propoxy]-
MS[M+1]+: 579




phenyl}propionic acid


I_229
IIa_227
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.843
A




(benzylhexanoylamino)ethoxy]-
MS[M+1]+: 593




phenyl}propionic acid


I_230
IIa_228
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.898
A




(benzylhexanoylamino)propoxy]-
MS[M+1]+: 607




phenyl}propionic acid


I_231
IIa_229
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.507
A




(benzylpentanoylamino)ethoxy]-
MS[M+1]+: 579




phenyl}propionic acid


I_232
IIa_230
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.581
A




(benzylpentanoylamino)propoxy]-
MS[M+1]+: 593




phenyl}propionic acid


I_233
IIa_231
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 9.396
A




(benzyloctanoylamino)ethoxy]phenyl}-
MS[M+1]+: 621




propionic acid


I_234
IIa_232
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 9.432
A




(benzyloctanoylamino)propoxy]-
MS[M+1]+: 635




phenyl}propionic acid


I_235
IIa_233
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 9.112
A




(benzylheptanoylamino)ethoxy]-
MS[M+1]+: 607




phenyl}propionic acid


I_236
IIa_234
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 9.158
A




(benzylheptanoylamino)propoxy]-
MS[M+1]+: 621




phenyl}propionic acid


I_237
IIa_235
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 9.653
A




(benzylnonanoylamino)ethoxy]-
MS[M+1]+: 635




phenyl}propionic acid


I_238
IIa_236
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 9.69
A




(benzylnonanoylamino)propoxy]-
MS[M+1]+: 649




phenyl}propionic acid


I_239
IIa_237
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.256
A




(benzylbutyrylamino)ethoxy]phenyl}-
MS[M+1]+: 565




propionic acid


I_240
IIa_238
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.332
A




(benzylbutyrylamino)propoxy]phenyl}-
MS[M+1]+: 579




propionic acid


I_241
IIa_239
(S)-3-{4-12-(Benzoylbenzylamino)-
rt: 8.333
A




ethoxy]phenyl}-2-(2-
MS[M+1]+: 599




(benzoylphenylamino)propionic acid


I_242
IIa_240
(S)-3-{4-13-(Benzoylbenzylamino)-
rt: 8.378
A




propoxy]phenyl}-2-(2-
MS[M+1]+: 613




benzoylphenylamino)propionic acid


I_243
IIa_241
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.579
A




{2-[benzyl-(3-phenylacryloyl)amino]-
MS[M+1]+: 625




ethoxy}phenyl)propionic acid


I_244
IIa_242
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.68
A




{3-[benzyl-(3-phenylacryloyl)amino]-
MS[M+1]+: 639




propoxy}phenyl)propionic acid


I_245
IIa_243
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.628
A




{2-[benzyl-(2,2-dimethylpropionyl)-
MS[M+1]+: 579




amino]ethoxy}phenyl)propionic acid


I_246
IIa_244
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.656
A




{3-[benzyl-(2,2-dimethylpropionyl)-
MS[M+1]+: 593




amino]propoxy}phenyl)propionic acid


I_247
IIa_245
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.676
A




{2-[cyclohexyl-(3-furan-2-ylacryloyl)-
MS[M+1]+: 607




amino]ethoxy}phenyl)propionic acid


I_248
IIa_246
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.913
A




(cyclobutanecarbonylcyclohexylamino)
MS[M+1]+: 569




ethoxy]phenyl}propionic acid


I_249
IIa_247
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.607
A




{2-[cyclohexyl-(3-
MS[M+1]+: 611




cyclopentylpropionyl)amino]ethoxy}-




phenyl)propionic acid


I_250
IIa_248
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.691
A




(butyrylcyclohexylamino)ethoxy]-
MS[M+1]+: 557




phenyl}propionic acid


I_251
IIa_249
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.536
A




{2-[cyclopropylmethyl(naphthalene-2-
MS[M+1]+: 613




carbonyl)amino]ethoxy}phenyl)-




propionic acid


I_252
IIa_250
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.609
A




{3-[cyclopropylmethyl(naphthalene-2-
MS[M+1]+: 627




carbonyl)amino]propoxy}phenyl)-




propionic acid


I_253
IIa_251
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.206
A




{2-[cyclopropylmethyl(quinoline-2-
MS[M+1]+: 614




carbonyl)amino]ethoxy}phenyl)-




propionic acid


I_254
IIa_252
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.267
A




{3-[cyclopropylmethyl(quinoline-2-
MS[M+1]+: 628




carbonyl)amino]propoxy}phenyl)-




propionic acid


I_255
IIa_253
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.084
A




{2-[cyclopropylmethyl(quinoxaline-2-
MS[M+1]+: 615




carbonyl)amino]ethoxy}phenyl)-




propionic acid


I_256
IIa_254
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.192
A




{3-[cyclopropylmethy(quinoxaline-2-
MS[M+1]+: 629




carbonyl)amino]propoxy}phenyl)-




propionic acid


I_257
IIa_255
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.068
A




{2-[cyclopropylmethyl(thiophene-2-
MS[M+1]+: 569




carbonyl)amino]ethoxy}phenyl)-




propionic acid


I_258
IIa_256
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.17
A




{3-[cyclopropylmethyl(thiophene-2-
MS[M+1]+: 583




carbonyl)amino]propoxy}phenyl)-




propionic acid


I_259
IIa_257
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.1
A




{2-[cyclopropylmethyl(pyridine-3-
MS[M+1]+: 564




carbonyl)amino]ethoxy}phenyl)-




propionic acid


I_260
IIa_258
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.299
A




{3-[cyclopropylmethyl(pyridine-3-
MS[M+1]+: 578




carbonyl)amino]propoxy}phenyl)-




propionic acid


I_261
IIa_259
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.179
A




(cyclopropylmethylphenylacetylamino)
MS[M+1]+: 577




ethoxy]phenyl}propionic acid


I_262
IIa_260
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.268
A




(cyclopropylmethylphenylacetylamino)
MS[M+1]+: 591




propoxy]phenyl}propionic acid


I_263
IIa_261
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.056
A




{2-[cyclopropylmethyl-(3-furan-2-
MS[M+1]+: 579




ylacryloyl)amino]ethoxy}phenyl)-




propionic acid


I_264
IIa_262
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.149
A




{3-[cyclopropylmethyl-(3-furan-2-
MS[M+1]+: 593




ylacryloyl)amino]propoxy}phenyl)-




propionic acid


I_265
IIa_263
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.239
A




{2-[cyclopropylmethyl-(3-thiophen-2-
MS[M+1]+: 595




ylacryloyl)amino]ethoxy}phenyl)-




propionic acid


I_266
IIa_264
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.342
A




{3-[cyclopropylmethyl-(3-thiophen-2-
MS[M+1]+: 609




ylacryloyl)amino]propoxy}phenyl)-




propionic acid


I_267
IIa_265
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.085
A




{2-[cyclopropylmethyl-(2-thiophen-2-
MS[M+1]+: 583




ylacetyl)amino]ethoxy}phenyl)-




propionic acid


I_268
IIa_266
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.175
A




{3-[cyclopropylmethyl-(2-thiophen-2-
MS[M+1]+: 597




ylacetyl)amino]propoxy}phenyl)-




propionic acid


I_269
IIa_267
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.056
A




{2-[cyclopropylmethyl-(2-thiophen-3-
MS[M+1]+: 583




ylacetyl)amino]ethoxy}phenyl)-




propionic acid


I_270
IIa_268
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.142
A




{3-[cyclopropylmethyl-(2-thiophen-3-
MS[M+1]+: 597




ylacetyl)amino]propoxy}phenyl)-




propionic acid


I_271
IIa_269
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 6.234
A




{2-[cyclopropylmethyl-(3-pyridin-3-
MS[M+1]+: 592




ylpropionyl)amino]ethoxy}phenyl)-




propionic acid


I_272
IIa_270
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 6.385
A




{3-[cyclopropylmethyl-(3-pyridin-3-
MS[M+1]+: 606




ylpropionyl)amino]propoxy}phenyl)-




popionic acid


I_273
IIa_271
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.413
A




{2-[cyclopropylmethyl-(3-
MS[M+1]+: 591




phenylpropionyl)amino]ethoxy}-




phenyl)propionic acid


I_274
IIa_272
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.488
A




{3-[cyclopropylmethyl-(3-
MS[M+1]+: 605




phenylpropionyl)amino]propoxy}-




phenyl)propionic acid


I_275
IIa_273
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.16
A




(cyclobutanecarbonylcyclopropylmethylamino)
MS[M+1]+: 541




ethoxy]phenyl}propionic acid


I_276
IIa_274
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.24
A




(cyclobutanecarbonylcyclopropylmethylamino)
MS[M+1]+: 555




propoxy]phenyl}propionic




acid


I_277
IIa_275
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.907
A




{2-[(2-cyclohexylacetyl)-
MS[M+1]+: 583




cyclopropylmethylamino]ethoxy}-




phenyl)propionic acid


I_278
IIa_276
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.975
A




{3-[(2-cyclohexylacetyl)-
MS[M+1]+: 597




cyclopropylmethylamino]propoxy}-




phenyl)propionic acid


I_279
IIa_277
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.405
A




(cyclopentanecarbonylcyclopropylmethylamino)
MS[M+1]+: 555




ethoxy]phenyl}propionic




acid


I_280
IIa_278
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.486
A




(cyclopentanecarbonylcyclopropylmethylamino)
MS[M+1]+: 569




propoxy]phenyl}propionic




acid


I_281
IIa_279
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 7.808
A




(cyclopropanecarbonylcyclopropylmethylamino)
MS[M+1]+: 527




ethoxy]phenyl}propionic




acid


I_282
IIa_280
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 7.905
A




(cyclopropanecarbonylcyclopropylmethylamino)
MS[M+1]+: 541




propoxy]phenyl}propionic




acid


I_283
IIa_281
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 7.682
A




(cyclopropylmethylpropionylamino)-
MS[M+1]+: 515




ethoxy]phenyl}propionic acid


I_284
IIa_282
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 7.776
A




(cyclopropylmethylpropionylamino)-
MS[M+1]+: 529




propoxy]phenyl}propionic acid


I_285
IIa_283
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 7.966
A




(cyclopropylmethylisobutyrylamino)-
MS[M+1]+: 529




ethoxy]phenyl}propionic acid


I_286
IIa_284
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.056
A




(cyclopropylmethylisobutyrylamino)-
MS[M+1]+: 543




propoxy]phenyl}propionic acid


I_287
IIa_285
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 7.99
A




(butyrylcyclopropylmethylamino)-
MS[M+1]+: 529




ethoxy]phenyl}propionic acid


I_288
IIa_286
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.071
A




(butyrylcyclopropylmethylamino)-
MS[M+1]+: 543




propoxy]phenyl}propionic acid


I_289
IIa_287
(S)-3-{4-[2-
rt: 8.06
A




(Benzoylcyclopropylmethylamino)-
MS[M+1]+: 563




ethoxy]phenyl}-2-(2-




benzoylphenylamino)propionic acid


I_290
IIa_288
(S)-3-{4-[3-
rt: 8.161
A




(Benzoylcyclopropylmethylamino)-
MS[M+1]+: 577




propoxy]phenyl}-2-(2-




benzoylphenylamino)propionic acid


I_291
IIa_289
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.338
A




{2-[cyclopropylmethyl-(3-
MS[M+1]+: 589




phenylacryloyl)amino]ethoxy}phenyl)-




propionic acid


I_292
IIa_290
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.424
A




{3-[cyclopropylmethyl-(3-
MS[M+1]+: 603




phenylacryloyl)amino]propoxy}-




phenyl)propionic acid


I_293
IIa_291
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.404
A




{2-[(naphthalene-1-carbonyl)-
MS[M+1]+: 635




phenylamino]ethoxy}phenyl)propionic




acid


I_294
IIa_292
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.588
A




{3-[(naphthalene-1-carbonyl)-
MS[M+1]+: 649




phenylamino]propoxy}phenyl)-




propionic acid


I_295
IIa_293
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.618
A




{2-[(naphthalene-2-carbonyl)-
MS[M+1]+: 635




phenylamino]ethoxy}phenyl)propionic




acid


I_296
IIa_294
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.762
A




{3-[(naphthalene-2-carbonyl)-
MS[M+1]+: 649




phenylamino]propoxy}phenyl)-




propionic acid


I_297
IIa_295
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.095
A




{2-[(quinoline-2-carbonyl)-
MS[M+1]+: 636




phenylamino]ethoxy}phenyl)propionic




acid


I_298
IIa_296
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.241
A




{3-[phenyl(quinoline-2-carbonyl)-
MS[M+1]+: 650




amino]propoxy}phenyl)propionic acid


I_299
IIa_297
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: —
A




{2-[phenyl(quinoxaline-2-carbonyl)-
MS[M+1]+: 637




amino]ethoxy}phenyl)propionic acid


I_300
IIa_298
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.214
A




{3-[phenyl(quinoxaline-2-carbonyl)-
MS[M+1]+: 651




amino]propoxy}phenyl)propionic acid


I_301
IIa_299
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.259
A




{2-[phenyl(thiophene-2-carbonyl)-
MS[M+1]+: 591




amino]ethoxy}phenyl)propionic acid


I_302
IIa_300
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.416
A




{3-[phenyl(thiophene-2-carbonyl)-
MS[M+1]+: 605




amino]propoxy}phenyl)propionic acid


I_303
IIa_301
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.925
A




{2-[(isoquinoline-3-carbonyl)-
MS[M+1]+: 636




phenylamino]ethoxy}phenyl)propionic




acid


I_304
IIa_302
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.253
A




{2-[phenyl(pyridine-3-carbonyl)amino]-
MS[M+1]+: 586




ethoxy}phenyl)propionic acid


I_305
IIa_303
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.434
A




{3-[phenyl(pyridine-3-carbonyl)amino]-
MS[M+1]+: 600




propoxy}phenyl)propionic acid


I_306
IIa_304
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.061
A




{2-[phenyl(pyridine-4-carbonyl)amino]-
MS[M+1]+: 586




ethoxy}phenyl)propionic acid


I_307
IIa_305
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.261
A




{3-[phenyl(pyridine-4-carbonyl)amino]-
MS[M+1]+: 600




propoxy}phenyl)propionic acid


I_308
IIa_306
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.439
A




(phenylphenylacetylamino)ethoxy]-
MS[M+1]+: 599




phenyl}propionic acid


I_309
IIa_307
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.619
A




(phenylphenylacetylamino)propoxy]-
MS[M+1]+: 613




phenyl}propionic acid


I_310
IIa_308
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.98
A




{2-[(2-methylacryloyl)phenylamino]-
MS[M+1]+: 549




ethoxy}phenyl)propionic acid


I_311
IIa_309
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.146
A




{2-[(2-methylacryloyl)phenylamino]-
MS[M+1]+: 563




propoxy}phenyl)propionic acid


I_312
IIa_310
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.511
A




{2-[phenyl-(3-phenylpropynoyl)amino]-
MS[M+1]+: 609




ethoxy}phenyl)propionic acid


I_313
IIa_311
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.759
A




{2-[(2-ethylbutyryl)phenylamino]-
MS[M+1]+: 579




ethoxy}phenyl)propionic acid


I_314
IIa_312
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.917
A




{3-[(2-ethylbutyryl)phenylamino]-
MS[M+1]+: 593




propoxy}phenyl)propionic acid


I_315
IIa_313
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.259
A




{2-[(3-furan-2-ylacryloyl)phenylamino]-
MS[M+1]+: 601




ethoxy}phenyl)propionic acid


I_316
IIa_314
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.422
A




{3-[(3-furan-2-ylacryloyl)phenylamino]-
MS[M+1]+: 615




propoxy}phenyl)propionic acid


I_317
IIa_315
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.521
A




{2-[phenyl-(3-thiophen-2-ylacryloyl)-
MS[M+1]+: 617




amino]ethoxy}phenyl)propionic acid


I_318
IIa_316
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.677
A




{3-[phenyl-(3-thiophen-2-ylacryloyl)-
MS[M+1]+: 631




amino]propoxy}phenyl)propionic acid


I_319
IIa_317
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.191
A




{2-[(3-furan-3-yl-(E)-acryloyl)-
MS[M+1]+: 601




phenylamino]ethoxy}phenyl)propionic




acid


I_320
IIa_318
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.348
A




{3-[(3-furan-3-yl-(E)-acryloyl)-
MS[M+1]+: 615




phenylamino]propoxy}phenyl)-




propionic acid


I_321
IIa_319
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.217
A




{2-[phenyl-(3-pyridin-3-yl-(E)-acryloyl)-
MS[M+1]+: 612




amino]ethoxy}phenyl)propionic acid


I_322
IIa_320
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.417
A




{3-[phenyl-(3-pyridin-3-yl-(E)-acryloyl)-
MS[M+1]+: 626




amino]propoxy}phenyl)propionic acid


I_323
IIa_321
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.471
A




{2-[phenyl-(3-thiophen-3-yl-(E)-
MS[M+1]+: 617




acryloyl)amino]ethoxy}phenyl)-




propionic acid


I_324
IIa_322
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.616
A




{3-[phenyl-(3-thiophen-3-yl-(E)-
MS[M+1]+: 631




acryloyl)amino]propoxy}phenyl)-




propionic acid


I_325
IIa_323
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.213
A




(but-2-(E)-enoylphenylamino)-
MS[M+1]+: 563




propoxy]phenyl}propionic acid


I_326
IIa_324
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.348
A




{2-[phenyl-(2-thiophen-2-ylacetyl)-
MS[M+1]+: —




amino]ethoxy}phenyl)propionic acid


I_327
IIa_325
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.506
A




{3-[phenyl-(2-thiophen-2-ylacetyl)-
MS[M+1]+: 619




amino]propoxy}phenyl)propionic acid


I_328
IIa_326
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.478
A




{3-[phenyl-(2-thiophen-3-ylacetyl)-
MS[M+1]+: 619




amino]propoxy}phenyl)propionic acid


I_329
IIa_327
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.882
A




{2-[(3,3-dimethylbutyryl)phenylamino]-
MS[M+1]+: 579




ethoxy}phenyl)propionic acid


I_330
IIa_328
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.037
A




{3-[(3,3-dimethylbutyryl)phenylamino]-
MS[M+1]+: 593




propoxy}phenyl)propionic acid


I_331
IIa_329
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.503
A




{2-[(3-methylbutyryl)phenylamino]-
MS[M+1]+: 565




ethoxy}phenyl)propionic acid


I_332
IIa_330
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.663
A




{3-[(3-methylbutyryl)phenylamino]-
MS[M+1]+: 579




propoxy}phenyl)propionic acid


I_333
IIa_331
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 6.373
A




{2-[phenyl-(3-pyridin-3-ylpropionyl)-
MS[M+1]+: 614




amino]ethoxy}phenyl)propionic acid


I_334
IIa_332
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 6.561
A




{3-[phenyl-(3-pyridin-3-ylpropionyl)-
MS[M+1]+: 628




amino]propoxy}phenyl)propionic acid


I_335
IIa_333
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.317
A




(pent-4-enoylphenylamino)ethoxy]-
MS[M+1]+: 563




phenyl}propionic acid


I_336
IIa_334
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.482
A




(pent-4-enoylphenylamino)propoxy]-
MS[M+1]+: 577




phenyl}propionic acid


I_337
IIa_335
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.631
A




{2-[phenyl-(3-phenylpropionyl)amino]-
MS[M+1]+: 613




ethoxy}phenyl)propionic acid


I_338
IIa_336
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.791
A




{3-[phenyl-(3-phenylpropionyl)amino]-
MS[M+1]+: 627




propoxy}phenyl)propionic acid


I_339
IIa_337
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.432
A




(cyclobutanecarbonylphenylamino)-
MS[M+1]+: 563




ethoxy]phenyl}propionic acid


I_340
IIa_338
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.594
A




(cyclobutanecarbonylphenylamino)-
MS[M+1]+: 577




propoxy]phenyl}propionic acid


I_341
IIa_339
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: —
A




(cyclohexanecarbonylphenylamino)-
MS[M+1]+: —




ethoxy]phenyl}propionic acid


I_342
IIa_340
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.986
A




(cyclohexanecarbonylphenylamino)-
MS[M+1]+: 605




propoxy]phenyl}propionic acid


I_343
IIa_341
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.466
A




{2-[(3-cyclohexylpropionyl)-
MS[M+1]+: 619




phenylamino]ethoxy}phenyl)propionic




acid


I_344
IIa_342
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.587
A




{3-[(3-cyclohexylpropionyl)-
MS[M+1]+: 633




phenylamino]propoxy}phenyl)-




propionic acid


I_345
IIa_343
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.175
A




{2-[(2-cyclohexylacetyl)phenylamino]-
MS[M+1]+: 605




ethoxy}phenyl)propionic


I_346
IIa_344
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.316
A




{3-[(2-cyclohexylacetyl)phenylamino]-
MS[M+1]+: 619




propoxy}phenyl)propionic acid


I_347
IIa_345
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.68
A




(cyclopentanecarbonylphenylamino)-
MS[M+1]+: 577




ethoxy]phenyl}propionic acid


I_348
IIa_346
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.839
A




(cyclopentanecarbonylphenylamino)-
MS[M+1]+: 591




propoxy]phenyl}propionic acid


I_349
IIa_347
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.207
A




{2-[(3-cyclopentylpropionyl)-
MS[M+1]+: 605




phenylamino]ethoxy}phenyl)propionic




acid


I_350
IIa_348
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.339
A




{3-[(3-cyclopentylpropionyl)-
MS[M+1]+: 619




phenylamino]propoxy}phenyl)-




propionic acid


I_351
IIa_349
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.11
A




(cyclopropanecarbonylphenylamino)-
MS[M+1]+: 549




ethoxy]phenyl}propionic acid


I_352
IIa_350
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.284
A




(cyclopropanecarbonylphenylamino)-
MS[M+1]+: 563




propoxy]phenyl}propionic acid


I_353
IIa_351
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 7.965
A




(phenylpropionylamino)ethoxy]-
MS[M+1]+: 537




phenyl}propionic acid


I_354
IIa_352
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.138
A




(phenylpropionylamino)propoxy]-
MS[M+1]+: 551




phenyl}propionic acid


I_355
IIa_353
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.246
A




(isobutyrylphenylamino)ethoxy]-
MS[M+1]+: 551




phenyl}propionic acid


I_356
IIa_354
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.411
A




(isobutyrylphenylamino)propoxy]-
MS[M+1]+: 656




phenyl}propionic acid


I_357
IIa_355
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.850
A




(hexanoylphenylamino)ethoxy]-
MS[M+1]+: 579




phenyl}propionic acid


I_358
IIa_356
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.996
A




(hexanoylphenylamino)propoxy]-
MS[M+1]+: 593




phenyl}propionic acid


I_359
IIa_357
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.535
A




(pentanoylphenylamino)ethoxy]-
MS[M+1]+: 565




phenyl}propionic acid


I_360
IIa_358
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.691
A




(pentanoylphenylamino)propoxy]-
MS[M+1]+: 579




phenyl}propionic acid


I_361
IIa_359
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 9.465
A




(octanoylphenylamino)ethoxy]phenyl}-
MS[M+1]+: 607




propionic acid


I_362
IIa_360
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 9.587
A




(octanoylphenylamino)propoxy]-
MS[M+1]+: 621




phenyl}propionic acid


I_363
IIa_361
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 9.168
A




(heptanoylphenylamino)ethoxy]-
MS[M+1]+: 593




phenyl}propionic acid


I_364
IIa_362
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 9.302
A




(heptanoylphenylamino)propoxy]-
MS[M+1]+: 607




phenyl}propionic acid


I_365
IIa_363
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 9.736
A




(nonanoylphenylamino)ethoxy]-
MS[M+1]+: 621




phenyl}propionic acid


I_366
IIa_364
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 9.85
A




(nonanoylphenylamino)propoxy]-
MS[M+1]+: 635




phenyl}propionic acid


I_367
IIa_365
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.259
A




(butyrylphenylamino)ethoxy]phenyl}-
MS[M+1]+: 551




propionic acid


I_368
IIa_366
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.426
A




(butylylphenylamino)propoxy]phenyl}-
MS[M+1]+: 565




propionic acid


I_369
IIa_367
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.172
A




(benzoylphenylamino)ethoxy]phenyl}-
MS[M+1]+: 585




propionic acid


I_370
IIa_368
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.348
A




(benzoylphenylamino)propoxy]-
MS[M+1]+: 599




phenyl}propionic acid


I_371
IIa_369
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.647
A




{2-[phenyl-(3-phenylacryloyl)amino]-
MS[M+1]+: 611




ethoxy}phenyl)propionic acid


I_372
IIa_370
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.81
A




{3-[phenyl-(3-phenylacryloyl)amino]-
MS[M+1]+: 625




propoxy}phenyl)propionic acid


I_373
IIa_371
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.661
A




{2-[(2,2-dimethylpropionyl)-
MS[M+1]+: 565




phenylamino]ethoxy}phenyl)propionic




acid


I_374
IIa_372
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.79
A




{3-[(2,2-dimethylpropionyl)-
MS[M+1]+: 579




phenylamino]propoxy}phenyl)-




propionic acid


I_375
IIa_373
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.443
A




(tert-butylcyclobutanecarbonylamino)-
MS[M+1]+: 543




ethoxy]phenyl}propionic acid


I_376
IIa_374
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.194
A




{2-[tert-butyl-(3-cyclopentylpropionyl)-
MS[M+1]+: 585




amino]ethoxy}phenyl)propionic acid


I_377
II_1
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
8.98(bs, 1H), 7.56(d,
A




(benzylindan-5-ylamino)ethoxy]-
2H), 7.45-7.37(ca, 5H),




phenyl}propionic acid
7.27-7.19(ca, 8H),





7.01(t, 1H), 6.71-6.65(ca,





3H), 6.54-6.41(ca, 2H),





4.60(s, 2H), 4.27(m,





1H), 4.07(t, 2H),





3.76(t, 2H), 3.27(dd, 1H),





3.08(m, 1H), 2.80(ca,





4H), 2.01(ca, 2H)


I_378
II_2
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.342
A




{2-[benzyl(2,6-difluorophenyl)amino]-
MS[M+1]+: 607




ethoxy}phenyl)propionic acid


I_379
II_3
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.516
A




{2-[(2-chlorophenyl)-(2-fluorobenzyl)-
MS[M+1]+: 624




amino]ethoxy}phenyl)propionic acid


I_380
II_4
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.98(bs, 1H), 7.56(d,
A




{2-[benzyl-(2-fluorophenyl)amino]-
2H), 7.46-7.37(ca, 5H),




ethoxy}phenyl)propionic acid
7.32-7.18(m, 9H),





6.98-6.91(ca, 2H),





6.70-6.65(ca, 3H), 6.44(t, 1H),





4.46(s, 2H), 4.27(m,





1H), 3.99(t, 2H),





3.56(t, 2H), 3.27(m, 1H),





3.08(m, 1H)


I_381
II_5
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.88(bs, 1H), 7.57(d,
A




{2-[(2-methylbenzyl)phenylamino]-
2H), 7.55-7.32(ca, 6H),




ethoxy}phenyl)propionic acid
7.24-7.09(ca, 8H),





6.75-6.64(ca, 5H),





6.58(t, 1H), 4.55(s, 2H),





4.33(m, 1H), 4.11(t,





2H), 3.80(t, 2H),





3.25(m, 1H), 3.09(m, 1H),





2.34(s, 3H)


I_382
II_6
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.546
A




{2-[(3-chlorophenyl)-(2-
MS[M+1]+: 636




methoxybenzyl)amino]ethoxy}phenyl)-




propionic acid


I_383
II_7
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.461
A




{2-[(2-methoxybenzyl)-m-tolylamino]-
MS[M+1]+: 615




ethoxy}phenyl)propionic acid


I_384
II_8
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.292
A




{3-[(2-methoxybenzyl)phenylamino]-
MS[M+1]+: 615




propoxy}phenyl)propionic acid


I_385
II_9
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 9.523
A




(benzyl-o-tolylamino)ethoxy]phenyl}-
MS[M+1]+: 585




propionic acid


I_386
II_10
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.98(bs, 1H), 7.56(d,
A




{2-[benzyl-(3-ethylphenyl)amino]-
2H), 7.45-7.37(ca, 5H),




ethoxy}phenyl)propionic acid
7.28-7.20(m, 9H),





7.08(t, 1H), 6.70(d, 2H),





6.58-6.52(ca, 2H),





6.43(t, 1H), 4.62(s, 2H),





4.27(m, 1H), 4.09(t,





2H), 3.78(t, 2H),





3.27(m, 1H), 3.08(m, 1H),





2.53(q, 2H), 1.14(t,





3H)


I_387
II_11
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.98(bs, 1H), 7.56(d,
A




{2-[benzyl-(3-fluorophenyl)amino]-
2H), 7.46-7.37(ca, 5H),




ethoxy}phenyl)propionic acid
7.31-7.17(ca, 8H),





7.08(m, 1H), 6.70(ca, 3H),





6.48-6.32(ca, 3H),





4.62(s, 2H), 4.27(m, 1H),





4.08(t, 2H), 3.78(t,





2H), 3.27(dd, 1H),





3.08(m, 1H)


I_388
II_12
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.428
A




{2-[(2-chlorophenyl)-(3-
MS[M+1]+: 636




methoxybenzyl)amino]ethoxy}phenyl)-




propionic acid


I_389
II_13
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.375
A




{2-[(3-chlorophenyl)-(3-
MS[M+1]+: 636




methoxybenzyl)amino]ethoxy}phenyl)-




propionic acid


I_390
II_14
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.354
A




{2-[(3-methoxybenzyl)-m-tolylamino]-
MS[M+1]+: 615




ethoxy}phenyl)propionic acid


I_391
II_15
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.259
A




{3-[(3-methoxybenzyl)phenylamino]-
MS[M+1]+: 615




propoxy}phenyl)propionic acid


I_392
II_16
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
8.98(bs, 1H), 7.56(d,
A




(benzyl-m-tolylamino)ethoxy]phenyl}-
2H), 7.45-7.37(ca, 5H),




propionic acid
7.27-7.19(ca, 7H),





7.05(t, 1H), 6.71-6.68(ca,





3H), 6.56-6.42(ca, 4H),





4.61(s, 2H), 4.28(m,





1H), 4.07(t, 2H),





3.77(t, 2H), 3.26(dd, 1H),





3.06(m, 1H), 2.25(s,





3H)


I_393
II_17
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.98(bs, 1H), 7.56(d,
A




{2-[benzyl-(4-chlorophenyl)amino]-
2H), 7.47-7.39(ca, 5H),




ethoxy}phenyl)propionic acid
7.30-7.16(ca, 8H),





7.08(d, 2H), 6.72-6.61(ca,





4H), 6.44(t, 1H),





4.60(s, 2H), 4.27(m, 1H),





4.07(t, 2H), 3.77(t,





2H), 3.26(dd, 1H),





3.08(m, 1H)


I_394
II_18
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.98(bs, 1H), 7.56(d,
A




{2-[benzyl-(4-fluorophenyl)amino]-
2H), 7.46-7.37(ca, 5H),




ethoxy}phenyl)propionic acid
7.32-7.19(ca, 8H),





6.89-6.84(ca, 2H),





6.72-6.61(ca, 4H),





6.44(t, 1H), 4.57(s, 2H),





4.28(m, 1H), 4.06(t,





2H), 3.75(t, 2H),





3.27(dd, 1H), 3.08(m, 1H)


I_395
II_19
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.96(bs, 1H), 7.55(d,
A




{2-[(4-methylbenzyl)phenylamino]-
2H), 7.46-7.37(ca, 5H),




ethoxy}phenyl)propionic acid
7.24-7.09(m, 9H),





6.72-6.64(ca, 5H), 6.45(t,





1H), 4.58(s, 2H),





4.27(m, 1H), 4.06(t, 2H),





3.77(t, 2H), 3.27(dd,





1H), 3.08(m, 1H),





2.30(s, 3H)


I_396
II_20
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.178
A




{3-[(4-methoxybenzyl)phenylamino]-
MS[M+1]+: 615




propoxy}phenyl)propionic acid


I_397
II_21
(S)-2-(Benzoylphenylamino)-3-{4-[2-
8.96(bs, 1H), 7.53(d,
A




(di-p-tolylamino)ethoxy]phenyl}-
2H), 7.48-7.35(ca, 5H),




propionic acid
7.22-7.15(m, 9H),





7.03(d, 1H), 6.89(d, 1H),





6.69-6.65(ca, 3H),





6.43(t, 1H), 4.23(m, 1H),





4.02(bs, 4H), 3.25(m,





1H), 3.05(m, 1H),





2.27(s, 6H)..


I_398
II_22
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
8.83(bs, 1H),
A




(benzyl-p-tolylamino)ethoxy]phenyl}-
7.50-6.93(ca, 17H),




propionic acid
6.60-6.55(ca, 4H), 6.34(t, 1H),





4.53(s, 2H), 4.21(m,





1H), 3.93(t, 2H),





3.62(t, 2H), 3.17(dd, 1H),





2.98(m, 1H), 2.19(s,





3H)


I_399
II_23
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 9.736
A




(benzylindan-5-ylamino)propoxy]-
MS[M+1]+: 625




phenyl}propionic acid


I_400
II_24
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.747
A




{3-[benzyl-(3-ethylphenyl)amino]-
MS[M+1]+: 613




propoxy}phenyl)propionic acid


I_401
II_25
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 9.549
A




(benzyl-m-tolylamino)propoxy]-
MS[M+1]+: 599




phenyl}propionic acid


I_402
II_26
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 9.526
A




(benzyl-p-tolylamino)propoxy]phenyl}-
MS[M+1]+: 599




propionic acid


I_403
II_27
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 6.67
A




(benzylcyclohexylamino)propoxy]-
MS[M+1]+: 591




phenyl}propionic acid methyl ester


I_404
II_28
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
8.92(bs, 1H), 7.56(d,
A




(benzyphenylamino)propoxy]phenyl}-
2H), 7.46-7.37(ca, 5H),




propionic acid
7.30-7.10(ca, 10H),





6.76-6.61(ca, 5H),





6.44(t, 1H), 4.53(s, 2H),





4.28(m, 1H), 3.92(t,





2H), 3.62(t, 2H),





3.22(dd, 1H), 3.10(m, 1H),





2.09-1.98(ca, 2H)


I_405
II_29
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.565
A




{2-[(2-fluorophenyl)isobutylamino]-
MS[M+1]+: 555




ethoxy}phenyl)propionic acid


I_406
II_30
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 9.729
A




(isobutyl-o-tolylamino)ethoxy]phenyl}-
MS[M+1]+: 551




propionic acid


I_407
II_31
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 9.443
A




(isobutyl-o-tolylamino)propoxy]-
MS[M+1]+: 565




phenyl}propionic acid


I_408
II_32
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.445
A




{2-[(3-fluorophenyl)isobutylamino]-
MS[M+1]+: 555




ethoxy}phenyl)propionic acid


I_409
II_33
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.65
A




{2-[isobutyl-m-tolylamino]ethoxy}-
MS[M+1]+: 551




phenyl)propionic acid


I_410
II_34
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.573
A




{3-[isobutyl-m-tolylamino]propoxy}-
MS[M+1]+: 565




phenyl)propionic acid


I_411
II_35
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
8.99(bs, 1H), 7.57(d,
A




(benzylphenethylamino)ethoxy]-
2H), 7.46-7.36(ca, 4H),




phenyl}propionic acid
7.32-7.21(ca, 11H),





7.13(d, 2H),





6.73-6.69(ca, 3H), 6.44(t, 1H),





4.23(m, 1H), 3.94(t,





2H), 3.76(s, 2H),





3.27(m, 1H), 3.07(m, 1H),





2.93(t, 2H), 2.81(bs,





4H)


I_412
II_36
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 9.089
A




(cyclobutylmethyl-o-tolylamino)-
MS[M+1]+: 563




ethoxy]phenyl}propionic acid


I_413
II_37
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 6.418
A




(benzylcyclopentylamino)ethoxy]-
MS[M+1]+: 563




phenyl}propionic acid


I_414
II_38
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 6.97
A




(cyclopentylphenylamino)propoxy]-
MS[M+1]+: 563




phenyl}propionic acid


I_415
II_39
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.937
A




{2-[cyclopentylmethyl-(2-
MS[M+1]+: 581




fluorophenyl)amino]ethoxy}phenyl)-




propionic acid


I_416
II_40
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
8.84(bs, 1H),
A




(cyclopentylmethylphenylamino)-
7.57-7.41(ca, 7H), 7.22-7.16(ca,




ethoxy]phenyl}propionic acid
4H), 6.75-6.55(ca, 7H),





4.31(ca, 3H), 3.98(t,





1H), 3.71(t, 2H),





3.30-3.20(ca, 3H), 3.09(m,





1H), 2.29(m, 1H),





1.75-1.54(ca, 8H)


I_417
II_41
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 6.432
A




(benzylcyclopropylmethylamino)-
MS[M+1]+: 549




ethoxy]phenyl}propionic acid


I_418
II_42
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 6.47
A




(benzylcyclopropylmethylamino)-
MS[M+1]+: 563




propoxy]phenyl}propionic acid


I_419
II_43
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.98(bs, 1H), 7.57(d,
A




{2-[(2-methoxybenzyl)phenylamino]-
2H), 7.48-7.39(ca, 5H),




ethoxy}phenyl)propionic acid
7.27-7.13(ca, 6H),





7.05(d, 1H), 6.88-6.80(ca,





2H), 6.73-6.60(ca, 5H),





6.44(t, 1H), 4.59(s,





2H), 4.27(m, 1H),





4.10(t, 2H), 3.85(s, 3H),





3.79(t, 2H), 3.27(dd,





1H), 3.08(m, 1H)


I_420
II_44
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.98(bs, 1H), 7.57(d,
A




{2-[(3-methoxybenzyl)phenylamino]-
2H), 7.48-7.39(ca, 5H),




ethoxy}phenyl)propionic acid
7.27-7.13(ca, 6H),





6.85-6.62(ca, 8H),





6.44(t, 1H), 4.60(s, 2H),





4.27(m, 1H), 4.10(t,





2H), 3.85(s, 3H),





3.79(t, 2H), 3.27(m, 1H),





3.08(m, 1H)


I_421
II_45
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.97(bs, 1H),
A




{2-[(3-methoxyphenyl)phenylamino]-
7.55-7.3(ca, 6H), 7.28-6.95(ca,




ethoxy}phenyl)propionic acid
11H), 6.68-6.40(ca,





5H), 4.23(m, 1H),





4.05(bs, 4H), 3.71(s, 3H),





3.25(m, 1H), 3.05(m,





1H)


I_422
II_46
(S)-2-(2-Benzoylphenylamino)-3-(4-
8.98(bs, 1H), 7.57(d,
A




{2-[(4-methoxybenzoyl)phenylamino]-
2H), 7.48-7.39(ca, 5H),




ethoxy}phenyl)propionic acid
7.27-7.13(ca, 7H),





6.85(d, 2H), 6.75-6.60(ca,





5H), 6.42(t, 1H),





4.59(s, 2H), 4.27(m, 1H),





4.10(t, 2H), 3.79(ca,





2H), 3.76(s, 3H),





3.27(m, 1H), 3.08(m, 1H)


I_423
II_47
(S)-2-(2-Benzoylphenylamino)-3-(4-
t: 9.939
A




{2-[(4-tert-butylbenzyl)phenylamino]-
MS[M+1]+: 627




ethoxy}phenyl)propionic acid


I_424
II_48
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
8.70(d, 1H),
A




(benzylphenylamino)ethoxy]phenyl}-
7.60-7.40(ca, 4H), 7.40-7.10(m,




propionic acid
9H), 7.10-7.00(ca, 4H),





6.80-6.60(ca, 4H),





7.60-7.45(ca, 2H),





4.60(s, 2H), 4.31(bs, 1H)





4.07(t, 2H), 3.77(t,





2H), 3.13(dd, 1H),





2.96(dd, 1H).


I_425
II_49
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
8.98(d, 1H), 7.56(d,
A




(cyclobutylmethylphenylamino)-
2H), 7.46-7.38(ca, 4H),




ethoxy]phenyl}propionic acid
7.21-7.15(ca, 5H),





6.73-6.63(ca, 6H),





6.45(t, 1H), 4.27(m, 1H),





3.97(t, 2H), 3.68(t,





2H), 3.37(d, 2H),





3.26(dd, 1H), 2.68(m, 1H),





2.03-1.70(ca, 6H)


I_426
II_50
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 9.029
A




(cyclohexylphenylamino)ethoxy]-
MS[M+1]+: 563




phenyl}propionic acid


I_427
II_51
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
8.98(d, 1H), 7.57(d,
A




(cyclohexylmethylphenylamino)-
2H), 7.46-7.38(ca, 4H),




ethoxy]phenyl}propionic acid
7.21-7.15(ca, 6H),





6.67-6.63(ca, 5H),





6.44(t, 1H), 4.27(m, 1H),





3.98(t, 2H), 3.70(t,





2H), 3.26(dd, 1H),





3.17(d, 2H), 3.06(m, 1H),





1.80-1.50(ca, 11H)


I_428
II_52
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 7.669
A




(cyclopentylphenylamino)ethoxy]-
MS[M+1]+: 549




phenyl}propionic acid


I_429
II_53
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
8.98(bs, 1H), 7.56(d,
A




(cyclopropylmethylphenylamino)-
2H), 7.44-7.40(ca, 4H),




ethoxy]phenyl}propionic acid
7.23-7.18(ca, 6H),





6.78-6.66(ca, 5H),





6.44(t, 1H), 4.27(m, 1H),





4.04(t, 2H), 3.76(t,





2H), 3.29-3.24(ca, 3H),





3.06(m, 1H),





1.00-0.80(m, 1H), 0.54-0.40(ca,





2H), 0.26-0.21(ca, 2H)


I_430
II_54
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
8.62(d, 1H),
A




(diphenylamino)ethoxy]phenyl}-
7.60-7.44(ca, 4H), 7.38(t, 1H),




propionic acid
7.32(dd, 2H), 7.24(td,





4H), 7.07(d, 2H),





6.99(d, 4H), 6.91(t, 2H),





6.82(d, 1H), 6.73(d,





2H), 6.57(t, 1H),





4.50(m, 1H), 4.05(s, 4H),





3.25-2.95(ca, 2H).


I_431
IIa_375
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.502
A




{2-[(2-methylacryloyl)naphthalen-1-
MS[M+1]+: 599




ylamino]ethoxy}phenyl)propionic acid


I_432
IIa_376
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.432
A




(but-2-(E)-enoylnaphthalen-1-
MS[M+1]+: 599




ylamino)ethoxy]phenyl}propionic acid


I_433
IIa_377
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.485
A




(cyclopropanecarbonylnaphthalen-1-
MS[M+1]+: 587




ylamino)ethoxy]phenyl}propionic acid


I_434
IIa_378
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.563
A




(naphthalen-1-ylpropionylamino)-
MS[M+1]+: 599




ethoxy]phenyl}propionic acid


I_435
IIa_379
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.599
A




{2-[(2-methylacryloyl)naphthalen-2-
MS[M+1]+: 599




ylamino]ethoxy}phenyl)propionic acid


I_436
IIa_380
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.491
A




(but-2-(E)-enoylnaphthalen-2-
MS[M+1]+: 599




ylamino)ethoxy]phenyl}propionic acid


I_437
IIa_381
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.494
A




(naphthalen-2-ylpropionylamino)-
MS[M+1]+: 587




ethoxy]phenyl}propionic acid


I_438
IIa_382
(S)-3-{4-[2-(Acetylnaphthalen-2-
rt: 8.099
A




ylamino)ethoxy]phenyl}-2-(2-
MS[M+1]+: 573




benzoylphenylamino)propionic acid


I_439
IIa_383
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.343
A




{2-[(2-methylacryloyl)-(3-
MS[M+1]+: 595




methylsulfanylphenyl)amino]ethoxy}-




phenyl)propionic acid


I_440
IIa_334
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.261
A




{2-[but-2-(E)-enoyl-(3-
MS[M+1]+: 595




methylsulfanylphenyl)amino]ethoxy}-




phenyl)propionic acid


I_441
IIa_385
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.51
A




{2-[butyryl-(3-methylsulfanylphenyl)-
MS[M+1]+: 597




amino]ethoxy}phenyl)propionic acid


I_442
IIa_386
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.36
A




{2-[(2-methylacryloyl)-(4-
MS[M+1]+: 595




methylsulfanylphenyl)amino]ethoxy}-




phenyl)propionic acid


I_443
IIa_387
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.262
A




{2-[but-2-(E)-enoyl-(4-
MS[M+1]+: 595




methylsulfanylphenyl)amino]ethoxy}-




phenyl)propionic acid


I_444
IIa_388
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.519
A




{2-[isobutyryl-(4-
MS[M+1]+: 597




methylsulfanylphenyl)amino]ethoxy}-




phenyl)propionic acid


I_445
IIa_389
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.522
A




{2-[butyryl-(4-methylsulfanylphenyl)-
MS[M+1]+: 597




amino]ethoxy}phenyl)propionic acid


I_446
IIa_390
(S)-3-{4-[2-Acetylnaphthalen-1-
rt: 8.599
A




ylamino)ethoxy]phenyl}-2-(2-
MS[M+1]+: —




benzoylphenylamino)propionic acid


I_447
IIa_391
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.627
A




(cyclopropanecarbonylnaphthalen-2-
MS[M+1]+: —




ylamino)ethoxy]phenyl}propionic acid


I_448
IIa_392
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.464
A




{3-[butyryl-(2-fluorophenyl)amino]-
MS[M+1]+: 583




propoxy}phenyl)propionic acid


I_449
IIa_393
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.603
A




{3-[cyclobutanecarbonyl-(2-
MS[M+1]+: 595




fluorophenyl)amino]propoxy}phenyl)-




propionic acid


I_450
IIa_394
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.269
A




{3-[cyclopropanecarbonyl-(2-
MS[M+1]+: 581




fluorophenyl)amino]propoxy}phenyl)-




propionic acid


I_451
IIa_395
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.451
A




{3-[(2-fluorophenyl)isobutyrylamino]-
MS[M+1]+: 583




propoxy}phenyl)propionic acid


I_452
II_55
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.216
A




{2-[cyclohexylmethyl-(2-fluorophenyl)-
MS[M+1]+: 595




amino]ethoxy}phenyl)propionic acid


I_453
II_56
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.146
A




{2-[(3-chlorophenyl)-
MS[M+1]+: 597, 599




cyclopentylmethylamino]ethoxy}-




phenyl)propionic acid


I_454
II_57
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.757
A




{3-[cyclobutylmethyl-(3-fluorophenyl)-
MS[M+1]+: 581




amino]propoxy}phenyl)propionic acid


I_455
II_58
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.973
A




(cyclobutylmethyl-m-tolylamino)-
MS[M+1]+: 577




propoxy]phenyl}propionic acid


I_456
II_59
(R)-2-(2-Benzoylphenylamino)-3-{4-
rt: 9.268
A




[2-(benzylphenylamino)ethoxy]-
MS[M+1]+: 571




phenyl}propionic acid


I_457
II_60
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.276
A




{2-[(2-chlorophenyl)-
MS[M+1]+: 597, 599




cyclopentylmethylamino]ethoxy}-




phenyl)propionic acid


I_458
II_61
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.166
A




{2-[(2-fluorophenyl)thiophen-2-
MS[M+1]+: 595




ylmethylamino]ethoxy}phenyl)-




propionic acid


I_459
II_62
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.755
A




{3-[(2-fluorophenyl)isobutylamino]-
MS[M+1]+: 569




propoxy}phenyl)propionic acid


I_460
II_63
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 10.09
A




{3-[cyclopentylmethyl-(2-
MS[M+1]+: 595




fluorophenyl)amino]propoxy}phenyl)-




propionic acid


I_461
II_64
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 8.508
A




(cyclobutylmethyl-o-tolylamino)-
MS[M+1]+: 577




propoxy]phenyl}propionic acid


I_462
II_65
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.089
A




{2-[(3-fluorophenyl)thiophen-2-
MS[M+1]+: 595




ylmethylamino]ethoxy}phenyl)-




propionic acid


I_463
II_66
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 9.325
A




(thiophen-2-ylmethyl-m-tolylamino)-
MS[M+1]+: 591




ethoxy]phenyl}propionic acid


I_464
II_67
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 9.412
A




(thiophen-3-ylmethyl-m-tolylamino)-
MS[M+1]+: 605




propoxy]phenyl}propionic acid methyl




ester


I_465
II_68
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 9.242
A




(furan-2-ylmethyl-m-tolylamino)-
MS[M+1]+: 589




propoxy]pheny}propionic acid


I_466
II_69
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 9.077
A




{2-[(4-fluorophenyl)thiophen-2-
MS[M+1]+: 595




ylmethylamino]ethoxy}phenyl)-




propionic acid


I_467
II_70
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 9.11
A




(phenylthiophen-2-ylmethylamino)-
MS[M+1]+: 577




ethoxy]phenyl}propionic acid


I_468
II_71
(S)-2-(2-Benzoylphenylamino)-3-{4-[3-
rt: 9.251
A




(phenylthiophen-2-ylmethylamino)-
MS[M+1]+: 591




propoxy]phenyl}propionic acid


I_469
IIa_396
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.751
A




{2-[benzyl-(3-methoxypropionyl)-
MS[M+1]+: 581




amino]ethoxy}phenyl)propionic acid


I_470
IIa_397
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.849
A




{3-[benzyl-(3-methoxypropionyl)-
MS[M+1]+: 595




amino]propoxy}phenyl)propionic acid


I_471
IIa_398
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.665
A




{2-[(3-methoxypropionyl)-
MS[M+1]+: 567




phenylamino]ethoxy}phenyl)propionic




acid


I_472
IIa_399
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.85
A




{3-[(3-methoxypropionyl)-
MS[M+1]+: 581




phenylamino]propoxy}phenyl)-




propionic acid


I_473
IIa_400
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.169
A




{3-[(2-fluorophenyl)propionylamino]-
MS[M+1]+: 569




propoxy}phenyl)propionic acid


I_474
IIa_401
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.514
A




{3-[(2-fluorophenyl)pent-4-
MS[M+1]+: 595




enoylamino]propoxy}phenyl)propionic




acid


I_475
IIa_402
(S)-3-(4-{3-[Acryloyl-(2-fluorophenyl)-
rt: 8.046
A




amino]propoxy}phenyl)-2-(2-
MS[M+1]+: 567




benzoylphenylamino)propionic acid


I_476
IIa_403
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.208
A




{3-[but-2-(E)-enoyl-(2-fluorophenyl)-
MS[M+1]+: 581




amino]propoxy}phenyl)propionic acid


I_477
IIa_404
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.701
A




{3-[(2-fluorophenyl)-(3-methylbutyryl)-
MS[M+1]+: 597




amino]propoxy}phenyl)propionic acid


I_478
IIa_405
(R)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.24
A




{2-[phenyl(thiophene-2-carbonyl)-
MS[M+1]+: 579




amino]ethoxy}phenyl)propionic acid


I_479
IIa_406
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.243
A




{3-[(2-fluorophenyl)-(2-
MS[M+1]+: 581




methylacryloyl)amino]propoxy}-




phenyl)propionic acid


I_480
IIa_407
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.232
A




{3-[(3-fluorophenyl)-(2-
MS[M+1]+: 581




methylacryloyl)amino]propoxy}-




phenyl)propionic acid


I_481
IIa_408
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.038
A




{2-[but-2-(E)-enoyl-(2-
MS[M+1]+: 579




methoxyphenyl)amino]ethoxy}phenyl)-




propionic acid


I_482
IIa_409
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.053
A




{2-[but-2-(E)-enoyl-(3-
MS[M+1]+: 579




methoxyphenyl)amino]ethoxy}phenyl)-




propionic acid


I_483
IIa_410
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.541
A




{2-[(2-methoxyphenyl)-(3-
MS[M+1]+: 595




methylbutyryl)amino]ethoxy}phenyl)-




propionic acid


I_484
IIa_411
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.701
A




{3-[(3-fluorophenyl)-(3-methylbutyryl)-
MS[M+1]+: 597




amino]propoxy}phenyl)propionic acid


I_485
IIa_412
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.479
A




{2-[(3-methoxyphenyl)-(3-
MS[M+1]+: 595




methylbutyryl)amino]ethoxy}phenyl)-




propionic acid


I_486
IIa_413
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.513
A




{3-[(3-fluorophenyl)pent-4-
MS[M+1]+: 595




enoylamino]propoxy}phenyl)propionic




acid


I_487
IIa_414
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.596
A




{3-[cyclobutanecarbonyl-(3-
MS[M+1]+: 595




fluorophenyl)amino]propoxy}phenyl)-




propionic acid


I_488
IIa_415
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.583
A




{3-[cyclobutanecarbonyl-(4-
MS[M+1]+: 595




fluorophenyl)amino]propoxy}phenyl)-




propionic acid


I_489
IIa_416
(R)-2-(2-Benzoylphenylamino)-3-{4-
rt: 8.416
A




[2-(cyclobutanecarbonylphenylamino)-
MS[M+1]+: 563




ethoxy]phenyl}propionic acid


I_490
IIa_417
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.082
A




{2-[cyclopropanecarbonyl-(2-
MS[M+1]+: 579




methoxyphenyl)amino]ethoxy}phenyl)-




propionic acid


I_491
IIa_418
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.313
A




{3-[cyclopropanecarbonyl-(3-
MS[M+1]+: 581




fluorophenyl)amino]propoxy}phenyl)-




propionic acid


I_492
IIa_419
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.293
A




{3-[cyclopropanecarbonyl-(4-
MS[M+1]+: 581




fluorophenyl)amino]propoxy}phenyl)-




propionic acid


I_493
IIa_420
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.996
A




{2-[(2-methoxyphenyl)-
MS[M+1]+: 567




propionylamino]ethoxy}phenyl)-




propionic acid


I_494
IIa_421
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.175
A




{3-[(3-fluorophenyl)propionylamino]-
MS[M+1]+: 569




propoxy}phenyl)propionic acid


I_495
IIa_422
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.947
A




{2-[(3-methoxyphenyl)-
MS[M+1]+: 567




propionylamino]ethoxy}phenyl)-




propionic acid


I_496
IIa_423
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.16
A




{3-[(4-fluorophenyl)propionylamino]-
MS[M+1]+: 569




propoxy}phenyl)propionic acid


I_497
IIa_424
(R)-2-(2-Benzoylphenylamino)-3-{4-
rt: 7.952
A




[2-(phenylpropionylamino)ethoxy]-
MS[M+1]+: 593




phenyl}propionic acid


I_498
IIa_425
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.434
A




{3-[(3-fluorophenyl)isobutyrylamino]-
MS[M+1]+: 583




propoxy}phenyl)propionic acid


I_499
IIa_426
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.218
A




{2-[isobutyryl-(3-methoxyphenyl)-
MS[M+1]+: 581




amino]ethoxy}phenyl)propionic acid


I_500
IIa_427
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.424
A




{3-[(4-fluorophenyl)isobutyrylamino]-
MS[M+1]+: 583




propoxy}phenyl)propionic acid


I_501
IIa_428
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.73
A




{3-[(2-fluorophenyl)pentanoylamino]-
MS[M+1]+: 597




propoxy}phenyl)propionic acid


I_502
IIa_429
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.726
A




{3-[(3-fluorophenyl)pentanoylamino]-
MS[M+1]+: 597




propoxy}phenyl)propionic acid


I_503
IIa_430
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.274
A




{2-[butyryl-(2-methoxyphenyl)amino]-
MS[M+1]+: 581




ethoxy}phenyl)propionic acid


I_504
IIa_431
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.447
A




{3-[butyryl-(3-fluorophenyl)amino]-
MS[M+1]+: 583




propoxy}phenyl)propionic acid


I_505
IIa_432
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.222
A




{2-[butyryl-(3-methoxyphenyl)amino]-
MS[M+1]+: 581




ethoxy}phenyl)propionic acid


I_506
IIa_433
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.436
A




{3-[butyryl-(4-fluorophenyl)amino]-
MS[M+1]+: 583




propoxy}phenyl)propionic acid


I_507
IIa_434
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.792
A




{3-[(2,2-dimethylpropionyl)-(2-
MS[M+1]+: 597




fluorophenyl)amino]propoxy}phenyl)-




propionic acid


I_508
IIa_435
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.656
A




{2-[(2,2-dimethylpropionyl)-(2-
MS[M+1]+: 595




methoxyphenyl)amino]ethoxy}phenyl)-




propionic acid


I_509
IIa_436
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.784
A




{3-[(2,2-dimethylpropionyl)-(3-
MS[M+1]+: 597




fluorophenyl)amino]propoxy}phenyl)-




propionic acid


I_510
IIa_437
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.61
A




{2-[(2,2-dimethylpropionyl)-(3-
MS[M+1]+: 595




methoxyphenyl)amino]ethoxy}phenyl)-




propionic acid


I_511
IIa_438
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.483
A




{2-[isobutyryl-(3-
MS[M+1]+: 597




methylsulfanylphenyl)amino]ethoxy}-




phenyl)propionic acid


I_512
IIa_439
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.122
A




{3-[(2-methoxyphenyl)-
MS[M+1]+: 581




propionylamino]propoxy}phenyl)-




propionic acid


I_513
IIa_440
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.213
A




{3-[cyclopropanecarbonyl-(2-
MS[M+1]+: 593




methoxyphenyl)amino]propoxy}-




phenyl)propionic acid


I_514
IIa_441
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.385
A




{3-[isobutyryl-(2-methoxyphenyl)-
MS[M+1]+: 595




amino]propoxy}phenyl)propionic acid


I_515
IIa_442
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.159
A




{3-[but-2-(E)-enoyl-(2-
MS[M+1]+: 593




methoxyphenyl)amino]propoxy}-




phenyl)propionic acid


I_516
IIa_443
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.163
A




{3-[(2-methoxyphenyl)-(2-
MS[M+1]+: 593




methylacryloyl)amino]propoxy}-




phenyl)propionic acid


I_517
IIa_444
(S)-3-(4-{3-[Acryloyl-(2-
rt: 8.015
A




methoxyphenyl)amino]propoxy}-
MS[M+1]+: 579




phenyl)-2-(2-benzoylphenylamino)-




propionic acid


I_518
IIa_445
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.395
A




{3-[butyryl-(2-methoxyphenyl)amino]-
MS[M+1]+: 595




propoxy}phenyl)propionic acid


I_519
IIa_446
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.111
A




{3-[(3-methoxyphenyl)-
MS[M+1]+: 581




propionylamino]propoxy}phenyl)-




propionic acid


I_520
IIa_447
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.246
A




{3-[cyclopropanecarbonyl-(3-
MS[M+1]+: 593




methoxyphenyl)amino]propoxy}-




phenyl)propionic acid


I_521
IIa_448
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.374
A




{3-[isobutyryl-(3-methoxyphenyl)-
MS[M+1]+: 595




amino]propoxy}phenyl)propionic acid


I_522
IIa_449
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.204
A




{3-[but-2-(E)-enoyl-(3-
MS[M+1]+: 593




methoxyphenyl)amino]propoxy}-




phenyl)propionic acid


I_523
IIa_450
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.134
A




{3-[(3-methoxyphenyl)-(2-
MS[M+1]+: 593




methylacryloyl)amino]propoxy}-




phenyl)propionic acid


I_524
IIa_451
(S)-3-(4-{3-[Acryloyl-(3-
rt: 8.045
A




methoxyphenyl)amino]propoxy}-
MS[M+1]+: 579




phenyl)-2-(2-benzoylphenylamino)-




propionic acid


I_525
IIa_452
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.381
A




{3-[butyryl-(3-methoxyphenyl)amino]-
MS[M+1]+: 595




propoxy}phenyl)propionic acid


I_526
IIa_453
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.42
A




{2-[cyclobutanecarbonyl-(2-
MS[M+1]+: 593




methoxyphenyl)amino]ethoxy}phenyl)-




propionic acid


I_527
IIa_454
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.27
A




{2-[isobutyryl-(2-methoxyphenyl)-
MS[M+1]+: 581




amino]ethoxy}phenyl)propionic acid


I_528
IIa_455
(S)-3-{4-[2-(Acryloylnaphthalen-1-
rt: 8.35
A




ylamino)ethoxy]phenyl}-2-(2-
MS[M+1]+: 585




benzoylphenylamino)propionic acid


I_529
IIa_456
(S)-3-{4-[2-(Acryloylnaphthalen-2-
rt: 8.418
A




ylamino)ethoxy]phenyl}-2-(2-
MS[M+1]+: 585




benzoylphenylamino)propionic acid


I_530
IIa_457
(S)-3-(4-{2-[Acryloyl-(3-
rt: 8.172
A




methylsulfanylphenyl)amino]ethoxy}-
MS[M+1]+: 581




phenyl)-2-(2-benzoylphenylamino)-




propionic acidr


I_531
IIa_458
(S)-3-(4-{2-[Acryloyl-(4-
rt: 8.182
A




methylsulfanylphenyl)amino]ethoxy}-
MS[M+1]+: 581




phenyl)-2-(2-benzoylphenylamino)-




propionic acid


I_532
IIa_459
(S)-3-(4-{3-[Acryloyl-(3-fluorophenyl)-
rt: 8.098
A




amino]propoxy}phenyl)-2-(2-
MS[M+1]+: 567




benzoylphenylamino)propionic acid


I_533
IIa_460
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.274
A




{3-[but-2-(E)-enoyl-(3-fluorophenyl)-
MS[M+1]+: 581




amino]propoxy}phenyl)propionic acid


I_534
IIa_461
(S)-3-(4-{2-[Acryloyl-(2-
rt: 7.886
A




methoxyphenyl)amino]ethoxy}phenyl)-
MS[M+1]+: 565




2-(2-benzoylphenylamino)propionic




acid


I_535
IIa_462
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.037
A




{2-[(2-methoxyphenyl)-(2-
MS[M+1]+: 579




methylacryloyl)amino]ethoxy}phenyl)-




propionic acid


I_536
IIa_463
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.081
A




{2-[cyclopropanecarbonyl-(3-
MS[M+1]+: 579




methoxyphenyl)amino]ethoxy}phenyl)-




poropionic acid


I_537
IIa_464
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.384
A




{2-[cyclobutanecarbonyl-(3-
MS[M+1]+: 593




methoxyphenyl)amino]ethoxy}phenyl)-




propionic acid


I_538
IIa_465
(S)-3-(4-{2-[Acryloyl-(3-
rt: 7.884
A




methoxyphenyl)amino]ethoxy}phenyl)-
MS[M+1]+: 565




2-(2-benzoylphenylamino)propionic




acid


I_539
IIa_466
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.975
A




{2-[(3-methoxyphenyl)-(2-
MS[M+1]+: 579




methylacryloyl)amino]ethoxy}phenyl)-




propionic acid


I_540
IIa_467
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.236
A




{2-[ethyl(naphthalene-2-carbonyl)-
MS[M+1]+: 587




amino]ethoxy}phenyl)propionic acid


I_541
IIa_468
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.511
A




{2-[(naphthalene-2-carbonyl)-
MS[M+1]+: 601




propylamino]ethoxy}phenyl)propionic




acid


I_542
IIa_469
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.881
A




{2-[ethyl(quinoline-2-carbonyl)amino]-
MS[M+1]+: 588




ethoxy}phenyl)propionic acid


I_543
IIa_470
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.2
A




{2-[propyl(quinoline-2-carbonyl)-
MS[M+1]+: 602




amino]ethoxy}phenyl)propionic acid


I_544
IIa_471
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.756
A




{2-[ethyl(quinoxaline-2-carbonyl)-
MS[M+1]+: 589




amino]ethoxy}phenyl)propionic acid


I_545
IIa_472
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.077
A




{2-[propyl(quinoxaline-2-carbonyl)-
MS[M+1]+: 603




amino]ethoxy}phenyl)propionic acid


I_546
IIa_473
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.732
A




{2-[ethyl(thiophene-2-carbonyl)-
MS[M+1]+: 543




amino]ethoxy}phenyl)propionic acid


I_547
IIa_474
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.04
A




{2-[propyl(thiophene-2-carbonyl)-
MS[M+1]+: 557




amino]ethoxy}phenyl)propionic acid


I_548
IIa_475
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 6.713
A




{2-[ethyl(pyridine-3-carbonyl)amino]-
MS[M+1]+: 538




ethoxy}phenyl)propionic acid


I_549
IIa_476
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.037
A




{2-[propyl(pyridine-3-carbonyl)amino]-
MS[M+1]+: 552




ethoxy}phenyl)propionic acid


I_550
IIa_477
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 7.924
A




{2-[ethyl-(3-thiophen-2-ylacryloyl)-
MS[M+1]+: 569




amino]ethoxy}phenyl)propionic acid


I_551
IIa_478
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.236
A




{2-[propyl-(3-thiophen-2-ylacryloyl)-
MS[M+1]+: 583




amino]ethoxy}phenyl)propionic acid


I_552
IIa_479
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.572
A




{2-[(3,3-dimethylbutyryl)propylamino]-
MS[M+1]+: 545




ethoxy}phenyl)propionic acid


I_553
IIa_480
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 5.866
A




{2-[ethyl-(3-pyridin-3-ylpropionyl)-
MS[M+1]+: 566




amino]ethoxy}phenyl)propionic acid


I_554
IIa_481
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 6.125
A




{2-[propyl-(3-pyridin-3-ylpropionyl)-
MS[M+1]+: 580




amino]ethoxy}phenyl)propionic acid


I_555
IIa_482
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.138
A




(cyclobutanecarbonylpropylamino)-
MS[M+1]+: 529




ethoxy]phenyl}propionic acid


I_556
IIa_483
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 7.963
A




(isobutyrylpropylamino)ethoxy]
MS[M+1]+: 517




phenyl}propionic acid


I_557
IIa_484
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 7.945
A




butyrylpropylamino)ethoxy]phenyl}-
MS[M+1]+: 517




propionic acid


I_558
IIa_485
(S)-3-{4-[2-(Benzoylethylamino)-
rt: 7.725
A




ethoxy]phenyl}-2-(2-
MS[M+1]+: 537




benzoylphenylamino)propionic acid


I_559
IIa_486
(S)-2-(2-Benzoylphenylamino)-3-{4-[2-
rt: 8.03
A




(benzoylpropylamino)ethoxy]phenyl}-
MS[M+1]+: 551




propionic acid


I_560
IIa_487
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.034
A




{2-[ethyl-(3-phenylacryloyl)amino]
MS[M+1]+: 563




ethoxy}phenyl)propionic acid


I_561
IIa_488
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.102
A




{2-[(2,2-dimethylpropionyl)-
MS[M+1]+: 517




ethylamino]ethoxy}phenyl)propionic




acid


I_562
IIa_489
(S)-2-(2-Benzoylphenylamino)-3-(4-
rt: 8.44
A




{2-[(2,2-dimethylpropionyl)-
MS[M+1]+: 531




propylamino]ethoxy}phenyl)propionic




acid

## Claims

1. A compound of formula I




its stereoisomers and mixtures thereof, its polymorphs and mixtures thereof, and the pharmaceutically acceptable solvates and addition salts of all of them, wherein
R1 represents the radical 2-benzoylphenylamino;
R2 represents —(CH2)s—N(COR3)-A-J-T or —(CH2)s—N(R4)-B-J-T;
R3 represents —(C1-C10)alkyl optionally substituted by one or more substituents selected from —F, —Cl, —Br and —O(C1-C4)alkyl; —(C2-C6)alkenyl; —(C2-C6)alkynyl; —(C1-C3)-alkylene-Y; —(C2-C3)alkenylene-Y; —(C2-C3)alkynylene-Y or —Y;
R4 represents —(C4-C10)alkyl optionally substituted by one or more substituents selected from —F, —Cl, —Br and —O(C1-C4)alkyl; —(C2-C6)alkenyl; —(C2-C6)alkynyl; —(C1-C4)-alkylene-Y; —(C2-C4)alkenylene-Y; —(C2-C4)alkynylene-Y or —Y;
s represents 2 or 3;
A represents —(C1-C4)alkylene-; —(C2-C4)alkenylene-; —(C2-C4)alkynylene-; —(C1-C4)-alkylene-Z-, wherein the alkylene part is attached to the N atom and Z is attached to J; or -Z-;
B represents —(C4)alkylene-; —(C2-C4)alkenylene-; —(C2-C4)alkynylene-; —(C1-C4)-alkylene-Z-, wherein the alkylene part is attached to the N atom and Z is attached to J; or -Z-;
J represents a single bond or a biradical selected from the following groups:
a) —(CH2)1-4—, —O—, —S—, —SO—, —SO2—, —CO—, —OCO—, —COO—, —OCONR5-, —NR5COO—, —CONR5-, —NR5CO—, —NR5-, —NR5SO2—, —SO2NR5-; and
b) —O—(C1-C4)alkyl-, —(C1-C4)alkyl-O—, —S—(C1-C4)alkyl-, —(C1-C4)alkyl-S—, —SO—(C1-C4)alkyl-, —(C1-C4)alkyl-SO—, —SO2—(C1-C4)alkyl-, —(C1-C4)alkyl-SO2—, —OCO—(C1-C4)alkyl-, —COO—(C1-C4)alkyl-, —(C1-C4)alkyl-OCO— —(C1-C4)-alkyl-COO—, —OCONR5-(C1-C4)alkyl-, —NR5COO—(C1-C4)alkyl, —(C1-C4)-alkyl-OCONR5-, —(C1-C4)alkyl-NR5COO—, —CONR5-(C1-C4)alkyl-, —R5CO—(C1-C4)alkyl-, —(C1-C4)alkyl-CONR5-, —(C1-C4)alkyl-NR5CO—, —NR5-(C1-C4)alkyl-, —(C1-C4)alkyl-NR5-, —SO2NR5-(C1-C4)alkyl-, —NR5SO2—(C1-C4)-alkyl-, —(C1-C4)alkyl-SO2NR5-, —(C1-C4)alkyl-NR5SO2—;

T represents —H, —(C1-C4)alkyl, —(C2-C4)alkenyl, —(C2-C4)alkynyl or —Y;
Y represents a monoradical coming from a cycle selected from a (C3-C6)cycloalkane, cyclohexene, a heterocycle, benzene and a bicycle, wherein all these cycles can be optionally substituted with one or more substituents selected from the group —OH, —CHO, —SH, —NO2, —CN, —F, —Cl, —Br, —CO(C1-C4)alkyl, —COO(C1-C4)alkyl, —OCO(C1-C4)alkyl, —S(C1-C4)alkyl, —SO(C1-C4)alkyl, —SO2(C1-C4)alkyl, —SO2—O(C1-C4)alkyl, —O—SO2(C1-C4)alkyl, —NR5R6, —CONR5R6, —(C1-C4)alkyl optionally substituted by one or more —OH or —F and —O(C1-C4)alkyl optionally substituted by one or more —OH or —F, and wherein the cycles (C3-C6)cycloalkane, cyclohexene and bicycle can also be optionally substituted with one or more substituents oxo;
Z represents a biradical coming from a cycle selected from a (C3-C6)cycloalkane, cyclohexene, a heterocycle, benzene and a bicycle, wherein all these cycles can be optionally substituted with one or more substituents selected from the group —OH, —CHO, —SH, —NO2, —CN, —F, —Cl, —Br, —CO(C1-C4)alkyl, —COO(C1-C4)alkyl, —OCO(C1-C4)alkyl, —S(C1-C4)alkyl, —SO(C1-C4)alkyl, —SO2(C1-C4)alkyl, —SO2—O(C1-C4)alkyl, —O—SO2(C1-C4)alkyl, —NR5R6, —CONR5R6, —(C1-C4)alkyl optionally substituted by one or more —OH or —F and —O(C1-C4)alkyl optionally substituted by one or more —OH or —F, and wherein the cycles (C3-C6)cycloalkane, cyclohexene and bicycle can also be optionally substituted with one or more substituents oxo;
R5 and R6 independently represent —H or —(C1-C4)alkyl;
a heterocycle in the above definitions represents a five- or six-membered aromatic ring containing from one to three heteroatoms independently selected from O, S and N, wherein said ring can be attached to the rest of the molecule through a carbon or a nitrogen atom; and
a bicycle in the above definitions represents a partially unsaturated, saturated or aromatic seven- to ten-membered ring optionally containing from one to three heteroatoms independently selected from O, S and N, wherein said ring or rings can be attached to the rest of the molecule through a carbon or a nitrogen atom.

2. A compound according to claim 1 wherein the configuration of the chiral carbon attached to R1 is (S), thus having the formula Ia

3. A compound according to claim 1, wherein R2 represents —(CH2)s—N(COR3)-A-J-T.

4. A compound according to claim 3, wherein R3 represents —(C1-C10)-alkyl optionally substituted by one or more substituents selected from —F, —Cl, —Br and —O(C1-C4)-alkyl; —(C2-C6)alkenyl; —(C1-C3)alkylene-Y; —(C2-C3)alkenylene-Y; —(C2-C3)alkynylene-Y or —Y; and Y in R3 represents a monoradical coming from a cycle selected from a (C3-C6)cycloalkane, a heterocycle, benzene and a bicycle, wherein all these cycles can be optionally substituted as defined in claim 1.

5. A compound according to claim 3, wherein A represents —(C1-C4)-alkylene-; —(C1-C4)alkylene-Z- or -Z-; Z in A represents a biradical coming from a cycle selected from a (C3-C6)cycloalkane, a heterocycle, benzene and a bicycle, wherein all these cycles can be optionally substituted with one or more substituents selected from the group —F, —Cl, —Br, —S(C1-C4)alkyl, —(C1-C4)alkyl optionally substituted by one or more —OH or —F and —O(C1-C4)alkyl optionally substituted by one or more —OH or —F; J represents a single bond; and T represents —H.

6. A compound according to claim 5 wherein Z in A represents an unsubstituted biradical coming from a cycle selected from a (C3-C6)cycloalkane and benzene.

7. A compound according to claim 1, wherein R2 represents —(CH2)s—N(R4)-B-J-T.

8. A compound according to claim 7, wherein R4 represents —(C4-C10)-alkyl optionally substituted by one or more substituents selected from —F, —Cl, —Br and —O(C1-C4)-alkyl; —(C1-C4)alkylene-Y; or —Y; and Y in R4 represents a monoradical coming from a cycle selected from a (C3-C6)cycloalkane, a heterocycle, benzene and a bicycle, wherein all these cycles can be optionally substituted as defined in claim 1.

9. A compound according to claim 7, wherein B represents —(C1-C4)-alkylene-Z- or -Z-; Z in B represents a biradical coming from a cycle selected from a (C3-C6)cycloalkane, heterocycle, benzene and bicycle, wherein all these groups can be optionally substituted as defined in claim 1; J represents a single bond; and T represents —H.

10. A pharmaceutical composition which comprises a compound of formula I as defined in claim 1, together with appropriate amounts of pharmaceutically acceptable excipients.